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Introduction 
INTRODUCTION 
1. GENERAL 
Chemicals/xenobiotics have become an indispensable part of human life, sustaining 
activities and development, preventing and controlling many diseases, and increasing 
agricultural productivity. However, despite their benefits the may cause adverse effects 
on human health and environmental integrity, especially when misused. The widespread 
application of chemicals and pharmaceutical agents throughout the world can, in many 
cases, dramatically alter the structure and function of various mammalian tissues 
producing multiple adverse effects [Parker, 1990; Ozturk et a/., 1997; Ahmad et al., 2011 a; 
Ahmad and \lahmood; 2012]. The diverse deleterious health effects upon exposure to 
various xenobiotics is, therefore, a matter of serious concern and a global issue. Human 
exposure to xenobioucs is pervasive; in a human lifetime, one might be exposed to 1-3 
million xenobiotics. These compounds can be toxic or harmless, but nonetheless they are 
treated by the body as foreign. They are metabolized and ultimately eliminated through 
the urine, bile, and faeces. Xenobiotics can also be eliminated unchanged, but the vast 
majority utilize endogenous mechanisms such as enzymatic functionalization and/or 
conjugation reactions that facilitate their elimination, and they use processes that are also 
involved in the metabolism and transport of endogenous compounds such as bilirubin, 
lipids and steroids. The common effects associated with multiple chemically diverse 
toxicant exposures are that these agents cause the cells to become more oxidized; many 
environmental toxicants have been shown to induce oxidative stress. It has been 
suggested that reactive oxygen species are responsible for the toxic effect of heavy metal 
toxicants, pesticides etc. [Jarup, 2003]. Although the chemical structure of different 
toxicants may be very different from each other, it appears that many of them share the 
same ability to induce oxidative stress in the cells. Prime targets for free radical reactions 
are the unsaturated bonds in membrane lipids. The consequent peroxidation of lipids 
results in a loss in membrane fluidity and receptor alignment and potentially in cellular 
lysis. Free radical damage to various enzymes and other proteins culminates in their 
inactivation, cross-linking and denaturation. Nucleic acids can also be attacked and 
subsequent damage to the DNA can cause mutations that may be carcinogenic. 
Oxidative damage to carbohydrates can alter any of the cellular receptor functions, 
including those associated with hormonal and neurotransmitter responses [Kchrer, 1993]. 
This influences the incidence and expression of various diseases. Multiple organ injuries 
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are the most common side effects associated with xenobiotic toxicity. Histopathological 
studies have revealed that exposure to such compounds engenders severe damage to 
various organs like Ever, kidney and intestine leading to tissue damage (Sanchez ei ud, 
2001; Fatima etal., 2004 and 2005; Barbier eta!, 20051. 
Exposure to several chemicals used in food industries can cause severe organ toxicity. 
The use of food additives has increased enormously in the past 30 years, now totaling 
over 200,000 tons per year. With the great increase in the use of food additives, there 
also has emerged considerable scientific data linking food additive intolerance with 
various physical and mental disorders, particularly with childhood hyperactivity. Another 
form of risk posed by additives is the loss of the nutritional value of the food, which can 
result in inappropriate diets and subdwcal malnutrition. The most common side effects 
associated with the use of food additives usually manifest as allergy, asthma, skin rashes 
and migraine. Like many other synthetic products, additives too are thought to have 
carcinogens which can increase chances of cancer. 
2. POTASSIUM BROMATE- AN OVERVIEW 
KBrO, is a white crystalline compound that has been extensively used in food industries 
and in pettnanent wave neuttali ing solutions. KBrO3 is also used as an oxidizer to 
mature flout during milting, in treating barley in beer making and in fish paste products. 
Bromate is not normally found in water, but may be formed during ozonation of 
bromide containing water. Under certain conditions, bromate may also be formed in 
concentrated hvpochlorite solutions used to disinfect drinking water. However, the use 
of KBrO, has been limited in recent tones due to its multiple organ toxicity and 
carcinogenicity. KBrO, is mutagenic both in tidy and in vino and is classified as a complete 
renal carcinogen in animals and a probable human carcinogen (Group 2B carcinogen) by 
the International Agency for Research on Cancer. 
Kidney is considered to be the primarl- target and exposure of animals and humans to 
KBrO, results in nephrotoxicity. KBrO, causes renal damage due to interactions with 
enzyme protein sulfliydryl groups in the membrane. This high incidence of KBrO,-
induced nphrotoxicity represents an important concern in the use of KBrO3 in the food 
industry. 	j 
Introduction 
2.1 Chemistry and uses 
KBrO, has molecular weight of 167 Da and is a white solid powder with a melting point 
of 350 °C (approx.) and a decomposition temperature of 370 °C. It has a density of 3.27 
g/cm3 and is very soluble in water and slightly soluble in alcohol. The molecular shape is 
most likely a trigonal pyramid [Cotton etal., 1987], with the three oxygen atoms each at a 
vertex fanning away from the bromine atom and the potassium cation loosely bound to 
negatively charged oxygen atom of the bromate anion [Figure 1]. The primary use of 
KBrO, in food industry is that of a maturing agent in flour and as a dough conditioner 
and texture improver in bakery products such as bread, rolls, and blue berry muffins 
[Dupuis, 1997; I:1 RC, 1999; W'I 1O, 2005]. KBrO, has also been used in the malting 
process of barley for the brewing of beer and the production of distilled spirit [FDA, 
20061. It has been used in hair wave neutralizing solutions, in cleaning boilers and in the 
oxidation of sulfur and vat dyes [EPA, 2001]. 
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Figure 1: Structure of KBrO,. 
Bromate is not a natural component of water but is formed during the disinfection of 
drinking water using ozone or a combination of ozone and H2O, and is, therefore, 
frequently detected in tap and bottled water Ivan Dijk-I,00ijaard and van Genderen, 
20001. The concentration of bromide in raw water is a major factor in the formation of 
bromate. The bromine in well waters is primarily inorganic. The major natural sources of 
bromide in groundwater are saltwater intrusion and bromide dissolution from 
sedimentary rocks. Sewage and industrial effluent as well as road and agricultural runoff 
may also contribute to elevated bromide levels in surface waters. Among products which 
contain KBrO; are pesticides (methyl bromide), bromated vegetable oil, citrus flavored 
drinks, cleaners, asthma inhalers, drugs such as sedatives and anticonvulsants, plastic 
products, antiseptics, mouthwash, gargles, fire retardants, mattresses, carpeting, 
electronics, furniture, permanent wave neutralizers, hot tub cleansers, hair and textile 
dyes, fumigant for agriculture and toothpaste. 
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2.2 Reactivity 
KBrO; is a strong oxidizing agent and can react with a large number of reducing agents 
such as glutathionc (GSH) and other thiols, ferrous ion, nitrite, bromide and iodide 
found in vivo [Keith at al., 2006]. Reduction of KBrO; generates ROS that are thought to 
mediate toxicity and DNA damage and associated OS ISallmcir and Fpc, 2006; Ahmad el 
al., 2011x]. KBrO, also reacts with strong acids, such as gastric acid, to produce hydrogen 
bromate which is highly irritating. 
2.3 Absorption, distribution and excretion 
Orally administered KBrO, is absorbed from the gastrointestinal (Go tract from where it 
is disnibuted to blood and other issues. Fujii et ai [1984] have shown that KBrO,given 
orally to rats, was rapidly absorbed from the gastrointestinal system of the animals. Most 
of it was excreted in the urine within 2 It of administration and no bromate was present 
in the plasma after 2 h. In fact bromate was not detected in blood or any rat tissue 24 h 
after administration. Time-dependent and non-linear dose-dependent studies have also 
shown the uptake and distribution of KBrO, from CI tract to other tissues. However, 
the highest levels have been detected in kidney and liver IDelker et aL, 20061. The high 
level of accumulation in the liver could be indicative of first-pass metabolism of bromate 
prior to entering the systemic circulation. Absorption of bromate via the skin is quite 
poor. Bromate is very stable and only small quantities are reduced to the less toxic 
bromide ion. However, the orally admimsteted bromate is rapidly absorbed and degraded 
within a short period [Fujii e/ al., 1984J. The metabolic degradation of KBrO, in specific 
organs, or from other origins, has been reported in several studies which have shown 
that 13-30% bromate was found unchanged in the urine [Kutotn et aL, 1990; EPA, 2001]. 
Other animal studies suggest that bromide formed from hromate is also slowly excreted 
by the kidney [Pavelka el al., 2000]. 
2.4 Toxicological effects in animals and humans 
KGrO, is a potent nphrotoxic agent and has been found to be associated with 
congestion of the central veins in the hepatocytes, infiltration of the interstitial cells 
accompanied with acute nephritis in the nephrons and mild mucosal dysfunction in the 
small intestine and eventual cell necrosis at specific sites within renal proximal tubule 
[Kurokawa et al., 1990; Akanji eta!, 2008]. 'Toxic or ischemic insult is mainly responsible 
for the reversible and irreversible loss of organelle function in which the cells are severely 
affected and undergo dynamic transformation. The bromate induced nephrotoxicity is 
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expressed by raised serum crcatinine and blood urea nitrogen, which are biomarkers of 
nephrotoxiciry [Khan and Sultana, 2005b; Olovede and Sunmonu, 2009; Khan el a/., 
2012a1. In addition to the kidney, the structure and function of other major tissues e.g. 
gastrointestinal tract, hepatic cells and blood have also been reported to be affected 
(Akanji of a/., 2008; Ahmad et at., 2011 a; Ahmad and Mahmood, 2012; Sultan et at., 20121. 
2.4.1 Acute toxicity in animals: KBrO, is a highly toxic compound. A condition known 
as bromide dominance or bromism develops when one is exposed repeatedly to 
products, environment, and food stuffs containing KI3rO . The list of KBrO, poisoning 
symptoms is long and varied and includes: yellowish white discoloration in the iris as a 
crescent on the upper portion of the eyeball, acne or rashes called bromoderma, copper 
colored swatches on the skin, diarrhea or digestive problems, headache, increased 
salivation, metallic taste in mouth, nausea, sneezing, fagitue, sluggishness, loss of 
inhibition, self neglect, impaired memory and concentration, irritability or emotional 
instability, depression and sleep alterations. However, the severe symptoms manifest as: 
confusion, schizophrenia, violence increasing at night, auditory or visual hallucinations, 
stupor and coma, tremors with slurred speech and lack of coordination. 
The acute effects also include a trace amount of methemoglobin in the blood of the rats 
and significant hctnochromatosis in the kidney, spleen and liver [Kaxvana et dl., 1991]. 
Bromate toxicity includes kidney damage, hemolysis and methemoglobinemia [\XJatanabe 
r! al., 2002; Ahmad '/ a/., 2012]. KBrO,-induced methemoglobincmia results from the 
reduction of glutathione peroxidase activity due to increase in superoxide, nitric oxide, 
and peroxynitrite. Kurokawa et al. 11990] have shown that a single intragastric dose of 
KBr0; causes hyperemia of the glandular stomach mucosa, lung congestion and kidney 
damage in mice. Kidney studies have shown that KBrO -induces alteration in several 
brush border membrane enzymes and changes in renal redox and metabolic status in rats 
(Kawana el ail, 1991; Ahmad el al., 20121. 
2.4.2 Acute toxicity in humans: "I he toxic effects of bromate in humans arise from 
acute poisoning. •\cute Svtnptoms include nausea, vomiting, diarrhea, and epigastric pain 
followed by anuria, oliguria, central nervous system depression, tinnitus, deafness, and 
renal failure Rurokawa et (W, 1990; F.PA, 2001 y. Numerous case studies of acute human 
poisoning due to accidental or intentional ingestion of KBrO, have been reported 
[Uchida el aL, 2006 Kurokawa el aL, 19901. The accidental intoxications were typically 
children ingesting brolnate-containing hair care products and the adult Ingestions were 
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mostly suicides or suicide attempts by hairdressers. .-cute exposure to high doses of 
bromate with hearing loss in humans has also been documented [Kutom et al., 1990; 
Campbell, 2006]. Exposure of humans to KlirO, has been shown to affect the 
vestibuloocular reflex system [Young el al., 2001]. However, there is no information 
related to human exposure to bromate compounds and immunological, developmental, 
or reproductive toxicity. 
2.4.3 Genotoxicity and carcinogenicity: Several studies have evaluated the 
genotoxiciry of KBrO, in the in tiro systems following both oral exposure and intra-
peritoneal injection. Bromate is a mutagen that causes chromosomal aberrations in 
Salmonella iyphimiiriiim [Ishidate el al., 1984], increase in aberrant metaphase cells [I7ujie el 
al., 1988] and induces micronuclei formation in femoral bone marrow cells [Hayashi etal., 
1988]. There are several scientific studies that describe the carcinogenic properties of 
KBrO, resulting from exposure via drinking water in animals. The chemical has been 
shown to be a multisite carcinogen in several studies, inducing mesothelioma, kidney 
tumors, and thyroid tumors [Kurokawa et al., 1990; DeAngelo el al., 1998; Shiao el al., 
2002]. Exposure to KBrO, over a long period of time induces renal adenomas, 
adenocarcinomas, thyroid follicular cell tumors and peritoneal mesotheliomas [Kurokawa 
ei al., 1987; Kurata et al., 1992]. Matsushima et al. [ 19861 have investigated the 
carcinogenicity of KBrO3 administered subcutaneously to newborn rats and showed that 
KBrO, has no potential for carcinogenicity in newborn male or female rats. KBrO, is 
classified as a Group 2B carcinogen (probable human carcinogen) by the International 
Agency for Research on Cancer. 
Various bioassays on genotoxicity and cytotoxicity using human cell lines have shown 
that KBrO, induces chromosomal aberrations, micronuclei formation, sister chromatid 
exchange in cultured human peripheral lymphocytes [Kava and Topaktas, 20071. Luan et 
al. [2007] conducted an in vitro genotoxicity study on potassium bromate in human 
ly-mphoblastoid TK6 cells. Acute exposure to bromate results in DNA double-strand 
breaks. KBrO; has also been shown to cause large DNA deletions in human cells [Luan 
et al., 2007; Moore and Chen, 2006], instead of the previously proposed GC>T. 
transversion mediated by accumulation of 8-oxodG [Balhnaier and Epe, 20061. 
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2.5 Pathophysiology of KBrO, in kidney; morphological and biochemical effects 
Several workers have shown that KBr0 is highly toxic with nephrotoxicity being among 
the earliest symptoms of bromate poisoning [Umemura el al., 2004; Khan and Sultana, 
2005b; Zhang et al., 2011]. KBrO, induced nephrotoxicity is often characterized by 
increase in serum creatinine and blood urea nitrogen associated with a marked decrease 
in tubular transport of electrolytes, calcium and magnesium as well as glucose, protein 
and organic anion transport [Gin et al., 1999; Khan and Sultana, 2005b; Nishioka et al., 
2006; Ahmad et a/., 2012]. KBrO, induces histopathological changes in kidney including 
atypical tubular structure, hyperplasia, hyaline droplet degeneration, necrotic changes and 
stratified squamous cell metaplasia and such studies strongly support the concept that 
tubular necrosis is the primary cause of KBrO, toxicity IKuroka«-a et al., 1983; Wolf et al, 
1998; Umemura et al, 2006]. The ultra structural changes in the proximal tubular cells 
includes the loss of the brush border, proliferation and multimembranous restructuring 
of lysosomes, formation of myeloid bodies, distension of the endoplasmic reticulum and 
swelling of the mitochondria [Niwa e! al., 1974; Hamada et al., 1990] leading to total 
disorganization and disruption of cellular organelles, with cellular necrosis [Kuwahara et 
al., 1983; Hamada et al., 19901. The adverse interaction of KBrO, with one or more 
critical intracellular processes leads to impaired renal function and disruption of 
functions of membranes and organelles including mitochondria, 1vsosomes, microsomes, 
BBM and basolateral membrane [Giri d al, 1999; Umemura cct al, 2004; Ahmad et al., 
20121. KBrO3 has been shown to affect various renal enzymes of carbohydrate 
metabolism including glvcoh•sis, tricarboxylic acid ('I'CA) cycle, hexose-monophosphate 
(HMMP) shunt pathway and gluconcogenesis [Sai et al., 1994; Ahlborn et al., 2009; Ahmad 
et al., 2012]. Administration of KBrO, to animals suppresses AO enzymes whereas H,02 
generation, LPO and protein carbonyl content are increased in the renal cortex [Sai et al., 
1992 and 1994; Rahman e1 al, 1999; Murata et al, 2001; Khan and Sultana 2004 and 
2005b; Ahmad <-t al., 20121. 
The observed KBrO, toxicity is probably the result of multiple minor toxic effects which 
act synergistically. The clinical threshold for nephrotoxicity is determined by the balance 
between the rate of necrosis and rate of regeneration of proximal tubular cells. If necrosis 
dominates, overt renal failure ensues. 
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2.6 Pathophysiology of KBrO3 in other tissues 
Although kidney is the major target, KBrO, has been shown to accumulate in various 
other tissues including intestine, liver, heart and ear causing multiple adverse effects in 
these tissues [Kurokawa et al., 1990; Campbell, 2006; Oloyede and Sunmonu, 2009; 
Josiah et al., 20111. Exposure to KBrO. has been shown to cause liver necrosis and 
induction of tumors in hepatic tissues [Hanai et al., 1972; Kurokawa et al., 1990]. KBrO3  
administration affects the AO defenses in liver, indicated by elevated lipid peroxidation 
(LPO) and altered superoxide dismutase and catalase activities [Stasiak et al., 2010]. 
KBrO3 is known to interact with the pulmonary tissues and contribute to the 
pathogenesis of bromate-associated metastasis in lungs [Kurokawa et al., 1990]. It also 
causes chromosomal alterations, hyperemia and LPO in pulmonary tissue [Kurokawa et 
al., 1990; Stasiak etal., 2010]. 
KBrO, affects the intestinal morphology and induces adenomas of the small intestine in 
experimental animals [Kurokawa et al., 1990]. The exposure of gastric mucosa to 
damaging factors results in disturbance of protective mechanisms and disrupture of 
mucosal barrier [Kwiecien et al., 2002]. Bromate, being a water disinfection by-product, 
also alters the intestinal microbial flora in rats [George et al., 2004]. Akanji et al. [2008] 
reported that activities of certain enzymes involved in terminal digestion and glucose 
metabolism were selectively altered in a time dependent manner by KBrO, treatment. 
2.7 KBrO3 and oxidative stress 
Despite a number of reports documenting its toxic effects, the mode of action of 
bromate is still not clear. It has been suggested that reactive oxygen species (ROS) and 
oxidative stress (OS) may contribute to its toxicity. Once bromate enters the cell it is 
reduced by intracellular reductants to the more stable bromide ion. This reduction 
process is accompanied by the production of free radicals and ROS which might 
contribute to its renal carcinogenicity and tissue toxicity [Sai et al., 1994. Formation of 
ROS following reduction of bromate to bromide has been reported earlier [Rabman et al, 
1999; Zhang et al., 2010]. Supporting the involvement of OS in bromate action is the 
observation that KBrO, causes oxidative modification of DNA bases, LPO and protein 
oxidation in the kidney [Karbownik et al., 2006]. Several modified bases are formed but 
the predominant base is 8-oxodG, a promutagenic base lesion in DNA typically removed 
through base excision repair [McDorman et a/., 2005]. KBrO3 induces production of 
superoxide anion, H,O2 and hydroxyl radical in renal tissue [Sai et ad., 1994; Murata et al., 
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2001; Khan and Sultana, 2005b]. It has also been reported to decrease the total SH 
content, increase LPO and the formation of 8-hydroxy-2'-deoxyguanosine (8-oxodG) in 
the isolated rat renal proximal tubules [Sai el al., 1994]. Umcmura et a/. 120041 showed that 
KBrO, in drinking water can exert a carcinogenic effect by way of OS and suggested that 
bromine radicals (Br) or bromine oxides (BrO, BrO2', etc.) are the species directly 
responsible for the observed cellular and cell-free DNA damage. 
2.8 Protection and/or prevention of KBrO3 induced toxicity 
Numerous attempts have been undertaken to protect or enhance the recovery from 
experimentally induced toxicity. The usefulness of these studies is not merely in the 
amount of protection they might bring but also in the insight into the mechanism of 
action of the toxicants, many of which act by inducing OS. The affected tissues/ cells 
have several ways to alleviate the effects of OS, either by repairing the oxidative damage 
or by directly diminishing the occurrence of oxidative damage by means of enzymatic 
and non-enzymatic .1O which scavenge free radicals and ROS. 
I luman exposure to KBrO3 in both occupational and environmental settings is a 
common occurrence. The increased use of KBrO, in food industry and bromate ion 
generation during the water disinfection process has been associated with human health 
hazard. Effective management of this compound is necessary to avoid adverse health 
effects on population. A potential therapeutic approach to reverse the toxicity induced by 
KBrO; would be of immense clinical importance in increasing the safety and protecting 
against bromate exposure. Although bromate ncphropathy and other toxic effects have 
been extensively investigated but only limited studies have been done for protection and 
prevention from KBrO, exposure. In experimental animals several approaches have been 
attempted to reduce the toxicity of KBrO,. 
Since oxygen free radicals are considered to be important mediators of KBrO,-induced 
toxicity [Kawanishi and Murata, 2006, Zhang et u/., 2010, .lhmad et al., 2011a], much 
attention has been paid to the protective effects of natural AO and various plant 
polyphenols against bromate induced toxicities ISai et a/., 1992, Cadenas and Barja, 1999, 
Khan and Sultana, 2005a; Chipman et al., 2006, Nishioka et al., 2006, Yilmaz et a/., 2007]. 
Examples of AO that have been used to ameliorate KBrO, nephroto. icity in rats include 
\C, GSH, and vitamin E ISai et aL, 1992; Cadenas and Barja, 1999]. Other agents which 
have recently been studied include tnelatonin I(:adenas and Barja, 1999, El-Sokkary, 
2000, Karbownik et a/., 2005], resveratrol [Cadenas and Barja G, 1999, Yilmaz et al., 
2007], soy isoflavones (Khan and Sultana, 2004J, coumarin ]khan el a/., 2004!, oligonol, 
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catechin and (-)-epigallocatechin 3-O-gallate [Nishioka et al., 2006], cysteine [Sai el al., 
1992], indole-3-propionic acid, 	rutin [Khan et al., 2012a] and propylthiouracil 
[Karbownik et al., 2005]. Melatonin has been shown to reduce KBrO} induced damage in 
the thyroid gland by increasing the AO defense mechanism [Karbownik et al., 2005]. 
KBrO, enhances the production of H202 by various tissues I Ahmad et al, 201 Ia, Ahmad 
and mahmood, 2012]; H202 can react with transition metals like iron to produce the 
damaging hydroxyl radical. Hydroxyl radical scavengers such as VC and GSH have also 
shown been to prevent KBrO3 induced nephrotoxicity [Sai et al., 1992]. 
A recent interesting development is the use of extracts from some plants, especially those 
with medicinal/AO properties, to protect against KBrO,-induced multiple organ toxicity 
in rats. In view of excellent safety and efficacy profiles, these AO have been found to 
produce good nephroprotection. Such medicinal plants include Hibiscus sabdan/,Ta ('a/x) 
[Josiah et al., 2010], :N ige/!a satira [Khan and Sultana, 2005a; Sultan et al., 2012], l'ernonia 
am}gda/ina (bitter leaf) Uosiah et al., 2012] and Sonchus aiper [Khan etal., 2012b]. Mice fed 
with bilberry extracts were found to be resistant to KBrO3 nephrotoxicity [Bao et al., 
2008]. Apple juice has also been shown to be effective against multiple organ injuries 
caused by KBrO, [Kujawska et al., 2012]. It has been suggested that Ficus racemosa extract 
could be considered a unique treatment for prevention of KBrO3 nephrotoxicity [Khan 
and Sultana, 2005b]. Treatment with water extract of Carica papaya modified the 
biochemical changes that occurred during KBrO, induced multiple tissue damage in rats 
and thus was shown to have potential protective effect Uosiah et al., 2011]. The results of 
these studies suggest that these natural antioxidants may offer comparatively safer 
alternatives to the other AO and seem to possess good potential for clinical use. 
In addition to the above-mentioned agents, some other miscellaneous drugs have been 
tested for their protective/ameliorative effects in KBrO,-induced toxicity. Thus the 
antithyriod drug prop}•Ithiouracil, protects thyroid against LPO due to KBrO in mvo 
[Stasiak etal., 20091. 
The above mentioned attempts, which were made to ameliorate nephrotoxicity generally 
resulted in an improvement of glomerular filteration rate, renal blood flow, decreased 
serum creatinine and blood urea nitrogen levels with increased inutin as well as creatinine 
clearance and in the enhancement of cellular regeneration [Fatima et al., 2007, 
Naqshbandi et al., 2012]. However, the clinical use of the aforementioned mechanisms to 
reduce KBrO,-induced health risks is still limited due to many unexplored concerns, 
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especially, their adverse/side effects which have not been adequately studied. Thus it is 
still important to explore new ways of reducing the effects of KBrO due to its 
immediate or long term action. Therefore the present investigation was undertaken to 
find an appropriate approach to reduce health risks from environmental contaminants 
such as KBrO,. 
3. KIDNEY ANATOMY AND PHYSIOLOGY 
The kidney is a vital organ that plays an essential role in health and disease. 'ihe main 
function of the kidney is to maintain total body fluid volume, its composition and pH 
within physiologic range. This is achieved collectively by the presence of thousands of 
architectural and functional units of the kidney, known as "nephron". A nephron 
consists of glomerulus with an extended tubular structure. A rat kidney contains 30,000-
35,000 nephrons whereas a human kidney is made up of about 1,30,000 nephrons. All 
these nephrons contribute to maintain renal functions by selective reabsorption of 
various ions and solutes. 
3.1 The structure and function of kidney 
The structure of the mammalian kidney apparently looks very homogenous. However, it 
can be viewed as a composite of several tissue organs; geometrically, functionally and 
metabolically [Schmidt and Guder, 19761 [Figure 2]. Thus each nephron courses through 
four concentric planes, the cortex, outer and inner zones of the outer medulla and the 
inner medulla (papilla) [Schmidt and Guder, 1976]. Each plane also has individual 
"organ" characteristics with respect to their ionic contents and metabolic rates [Guder, 
1973; Schmidt and Guder, 19761. 
The proximal tubule is the portion of the duct system of the nephron of the kidney 
which leads from Bowman's capsule to the loop of I lenle. The most distinctive 
characteristic of the proximal tubule is its brush border or striated border. 'I he luminal 
surface of the epithelial cells of the nephron is covered with densely 
packed microvilli forming a border readily visible under the light microscope, the brush 
border membrane (BBM). The BBM of renal proximal tubule is the major site for 
reabsorption of various solutes including amino acids, sugars and other nutrients, certain 
ions and minerals such as Na' and inorganic phosphate [Evan etal.. 1983(. Thus ions and 
solutes such as sodium, phosphate, sugars and amino acids etc. are reabsorbed at the 
BBM of the proximal tubule as secondary active transport which is energized by the 
transcellular transport of sodium ions (primary active transport) from luminal membrane 
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(inwardly) out of the epithelial cell by basolateral membrane [Hammerman and Schwab, 
1984; Kempson and Dousa, 1986]. Reabsorption of most ions and solutes from the 
tubular lumen is coupled to an active transport with sodium (Na') via a carrier located on 
the apical side and is driven by an electrochemical gradient of Na generated by Na/K + 
ATPase located on basolateral side [McCrory et al., 1952; Massary and Fleisch, 1980; 
Bonjour and Caverzasio, 1984]. The transport of Na is considered to be a major work 
function of the kidney upon which all other transports are dependent [Ullrich el al., 1974; 
1977]. The energy for sodium transport is mainly provided by the hydrolysis of ATP at 
anti-luminal membrane site involving Na+ /K'ATPase [Balagura el al., 1973; Evan el al., 
19831. Since the production of ATP is usually coupled to oxidative metabolism occurring 
in mitochondria, Na' transport appears to be linked with the oxidative metabolism 
or oxygen tension (pO1) of the renal tubular cells. A direct linear relationship 
between Oz uptake/utilization and Na- reabsorption has been found [Thurau, 1961; 
Torch i el al., 1986]. There appears to be a reverse cortico-medullary gradient for tissue 
oxygen tension (pO,) i.e., P02 in inner medulla is far lower than in cortical tissue 
[Aukland and Krog, 1960; 1961; .lukland, 1962; Aperia and Liebow, 1964]. 
Several studies have shown that fatty acids, glutamine, lactate, citrate and in particular 
glucose are the major substrates which support the transport work of the kidney [Leal et 
al., 1973; Park el al., 1974; Pitts and Macleod, 1975; Pitts, 1975; 'Mandel and Balaban, 
1981]. It is well established that various nephron subsegments located in different zones 
of the kidney have different functions in solute and fluid transport, as well as in substrate 
metabolism. For example, the renal cortex is characterized mostly by aerobic oxidative 
metabolism [Lee el al., 1962] while the renal medulla is the site of anaerobic metabolism 
and glycolysis. Moreover, the renal cortex is also capable of producing glucose via 
gluconcogenesis [Guder, 1973; Burch et al, 1978; Maleyuc, 1980]. 
Nephron, which consists of various subsegments, shows distinct structural and 
functional differences [Figure 3]. Thus nephron heterogeneity also acids to the variation 
in the kidney functions. Both inter- and intra-nephronal heterogeneity exists in the 
mammalian kidney that depends on the origin and location of the nephrons in the 
cortical region of the kidney [Lise cl a/., 1987; Francois and Danielle, 1985]. The nephron 
which originates in the glomerulus located in superficial cortex is known as "superficial 
nephron" while one which originates from deep cortical region is called as "deep" or 
"juxtamedullary ncphron". These populations of nephrons have been found to be 
structurally and functionally distinct [Francois and Danielle, 1985]. In inter-nephronal 
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heterogeneity, proximal convoluted tubules of superficial nephrons always touch the 
surface of the kidney. In intra-nephron or axial heterogeneity, the proximal tubules have 
been divided into three distinct morphological subseginents namely S„ S,, and S3. 
The early proximal convoluted tubules (PCT), both in superficial and juxtamedullary 
nephrons, is defined as S,-segment and can be identified by its attachment with glomeruli 
on one side. S, is defined as the late superficial proximal convoluted tubule, early 
superficial proximal straight tubule and late juxtamedullary proximal convoluted tubule. 
S, is located principally in the outer stripe of outer medulla and terminal superficial 
proximal straight tubule and entire juxtamedullary proximal straight tubule. S, is 
identified by its medullary location and by its connection with thin limbs on distal part. 
All S -subsegments (pars recta), as they descend from cortex into the outer stripe of the 
outer medulla, change from S2 to S3 cell type. Thus the outer stripe of the outer medulla 
contains proximal tubular cells but only the S, type [Woodhall el al., 19781. These 
segments can be characterized by their biomarker enzymes [Yusufi el al., 1994]. 
The oxidation of glucose in kidney may occur by several different metabolic pathways 
depending on the location and type of a particular ncphron segment in the kidney: (i) the 
T'C:1 cycle in which pyruvate, formed from glucose by glycolysis, is oxidised to CO, (ii) 
the LIMP shunt pathway and (iii) glycolysis in which glucose is partially oxidized to 
lactate [Figure 4J. On the other hand glucose is known to be produced in the kidney by 
gluconeogenesis, perhaps in the proximal tubule of the cortex [Schmidt and Cruder, 19-6; 
Malcquc, 1980; Burch et a/., 1978J. The enzymes belonging to the above pathways are 
found to be present and distributed differentially in the kidney. The renal medulla is the 
major region for production of lactate from glucose by glycolytic enzymes [Hems and 
Gaja, 1972; Guder, 1973] while the oxidative conversion of glucose to CO, was shown in 
renal cortex [Lee et aI... 1962; Cohen, 1979]. 
'I he active transport performed by the kidney has also been shown to be associated with 
the consumption of oxygen and the rate of oxygen consumption in turn has been related 
to the production of cellular ATP. Earlier studies have shown a linear relationship 
between sodium transport and oxygen consumption ['1'orclli el al., 1986] though a direct 
relationship with energy production or utilization could not be confirmed. fatty acids, 
glucose and their metabolites are known to contribute to the energy supply of the kidney 
in various mammals including man Lee el aL, 1962]. The rate of metabolism of the above 
substrates by one or the other pathways seems to be dependent on the availability of 
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oxygen in any particular zone of the kidney. Thus, the transport properties appear to he 
directly or indirectly dependent on the energy producing metabolic activity of the cells. 
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3.2 Acute renal failure 
.\cute renal failure (.\RF) is a process rather than a state. Often it denotes a reversible 
insufficiency of the glomerular and tubular excretory functions which may be triggered 
by renal or extra-renal mechanisms. ARE denotes a dramatic clinical situation in which 
both the kidneys stop their function within a short period of time or immediately, 
depending on the severity of ARF. It is best characterized by increase of nitrogenous 
waste products, such as serum creatinine and blood urea nitrogen and appearance of 
proteinic and enzymic components in the urine. 
The kidney is vulnerable to toxic insults by various drugs and xenobiotics because it 
receives nearly one quarter of the cardiac output and transports, metabolizes and 
concentrates a variety of potentially toxic substances within its parenchyma EI1ukral et 
al., 2005]. Indeed, chemically induced renal toxicity can be the result of various 
mechanisms, such as the concentration of xenobiotics and/or their metabolites up to 
toxic levels as a consequence of the kidney's excretory function, tissue-selective 
activation of xenobiotics and the particular susceptibility of the kidney to the toxicity of 
GSH conjugates and derivatives [Bruggeman et al., 1989; Fatima etal., 2004]. 
A number of environmental variables and heavy metals like chromium, mercury, 
cadmium, lead, uranium [Bank et al., 1967; Cronin et al., 1986; Arivarasu et al., 2008] 
chemicals [Yagil, 1990; Weinberg et al., 1990] including drugs like aminoglycosides, 
cephalosporin, cisplatin etc. [Porter and Bennett, 1981; Basnakian et al., 2002; Fatima et 
al., 200.1; Naqshbandi eta!, 2012] affect the structure and function of the kidney leading 
to .NRF. Generally, ARE caused by drugs and chemicals is much more severe and 
irreversible and the recover- sometimes is not possible. The pathophysiologic 
mechanism of ARE has been investigated extensively in the last few decades. For many 
causes of ARF, ROS have been invoked as a pathway for renal injury. The kidney has 
been studied as an organ that can generate ROS and is vulnerable to the oxidative 
damage. That ROS contribute to the pathogenesis of ARF is supported by the presence 
of OS in models of ARF, the amelioration of renal injury in these models by AO 
maneuvers, and the worsening of renal injury in such models by manipulations that 
exacerbate sustained OS. Oxygen radicals are important mediators of renal damage in 
ARE causing LPO of cell and organelle membranes, disrupting the structural integrity 
and capacity for cell transport and energy production [Greene and Paller, 1991 j. Several 
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eventive measures have also been utilized. However, a definite answer for the 
.Thogenesis and control of :\RF remains a topic of future studies. 
6-Phosphogluconate 
NADPH 
I 
Biosynthesis 
NADPH 
Glucose 
GGPDH 	 j 	 GGPase 
Iv 
Glucose-6-P 
Iij 
Fructose-6-P 
FBPase 	 III 
Fructose 1, 6-  
Bisphosphate 
A 
v 
A 
V 
A 
~lalate 
Acetyl-Co A 
Oxaloacetate 
V 
Phosphoenolpy ruvate 
~fE 	 LDH 
PyruN•ate 	 Lactate 
I 
III 
Acety I-Co .k 
Oxaloacetate 	I 	I 	Isocitrate 
MDH 
1lalate 	
a-ketoglutarate 
I I 
{Fatty acid 
Biosynthesis} 
Fumarate 	I 	/ 	I 	Succinate 
SDII 
Citrate 
Figure 4: Schematic outline of glucose homeostasis pathways: [I] glycolysis, 
[II] TCA cycle, 11I11 gluconeogenesis and [IV) HMP shunt pathway. 
16 
Introduction 
4. INTESTINAL ANATOMY AND PHYSIOLOGY 
Intestine is the most metabolically active tissue in the mammalian/human body. The 
digestion and absorption of food components are major functions of the intestinal 
mucosa. Many complex compounds while passing through the small intestine are 
degraded into simple compounds which cross the intestinal epithelium before reaching 
the various body organs [Figure 51. Thus, the intestinal epithelium not only regulates 
diverse absorptive and secretory processes but also process the substances that traverse 
it. 
4.1 The structure and function of intestine 
The small intestine is about 6-7 m in humans. It extends from the pyloric orifice where it 
is continuous with the stomach to the ileocecal junction where it continues to the large 
intestine. It is divided into three distinct structural and functional parts: 
4.1.1 Duodenum: It is 20-25 cm long in humans, the widest and most fixed part of small 
intestine. It has no mesentry, and thus is only partially covered with peritoneum. For 
descriptive purpose it is divided into four parts. The first and second parts are 
respectively superior and descending, while the third and fourth parts are described as 
horizontal and ascending. 
4.1.2 Jejunum: It is thicker, redder and more vascular than the ileum and has a diameter 
of 4 cm. 'l"he circular folds of its mucous membrane are large and thickly set, and its vii 
surpass those of the ileum in size. 
4.1.3 Ileum: Its walls are thinner as compared to jejunum, but the aggregated lymphatic 
follicles are large and more numerous than in jejunum. The jejunum and ileum are 
attached to the posterior abdominal wall by an extensive fold of fan shaped peritoneum 
termed as mesentry. It allows free movement, so that each coil can accommodate itself to 
changes in form and position. 
The functions of small intestine can be briefly summarized as: 
(a) To transport partially digested food material (chyme) from the stomach to large 
intestine via two types of movements (i) propulsive movements, which cause food to 
move forward along the tract at an appropriate rate for digestion and absorption (u) 
mixing movements, which keep the intestinal contents thoroughly mixed at all times. 
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(b) To complete digestion by secretion of hydrolytic enzymes and enzymes embedded in 
its brush border membrane. 
(c) To absorb the final products of digestion and transport them to blood and lymph 
vessels. The blood vessels of the gastrointestinal tract system are part of a more extensive 
system called the splanchnic circulation, which includes the blood flow through the gut 
itself, plus the blood flow through spleen, pancreas and liver. The blood flow in each 
area of gastrointestinal tract, as well as in each layer of gut wall, is directly related to the 
level of local activity. 
(d) To secrete certain hormones viz. cholecystokinin by "I" cells in the mucosa of 
duodenum and jejunum, secretin by "S" cells in mucosa of duodenum, gastric inhibitory 
peptide secreted by mucosa of upper small intestine. 
To perform these functions, the absorptive surface of small intestine is greatly amplified 
by transverse folds of mucous membrane. The small intestine consists of four layers 
(i) serosa (outermost) 
(ii) muscularis mucosa 
(iii) submucosa 
(iv) mucosa (innermost) 
The absorptive cells of the small intestine are highly polarized tall columnar cells with a 
general architecture and structure that is similar to a number of other epithelial cell types 
whose major function is absorption [Grosser e! al., 19921. They are distinguished by the 
presence of an apical striated border which forms the absorbing surface in contact with 
luminal contents. The plasma membrane of these enterocytes consists mainly of two 
different regions: the brush border and basolateral membranes which are 
morphologically, structurally and functionally different. 
4.2 Brush border membrane (BBM) 
The mucosa of the small intestine has transverse folds known as villi, which are finger 
like projections, 0.5-1.5 mm in length. The villi are lined with a single layer of epithelial 
cells and contain a network of capillaries and lymphatic vessels (lacteals). The free edges 
of the cells of the epithelium of the villi are divided into minute microvilli. The microvilli 
increase the apical surface area almost 14-40 fold [Zetterquist, 1956]. The plasma 
membrane covering the microvilli is covered with a polysaccharide coat referred to as 
glvcocalyx and consists of glycolipids and glycoproteinic enzymes that hydrolyze 
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carbohydrates and pepudes. The cytoplasm beneath the microvilli contains fine filaments 
known as the terminal web. The products of digestion go through the microvillar 
membrane traversing the terminal web into cytoplasm. 
BB,%I lining the enterocytes (intestinal epithelial cells) constitutes one of the most 
important cellular membranes owing to its role in terminal digestion and absorption 
functions which are carried out by certain hydrolytic enzymes e.g. disaccharidases 
(maltase, lactase and sucrase), dipeptidases, oligopeptidases, GGT, and AP [Kenny and 
Booth, 1978]. These enzymes are differentially distributed in the thickness of BB'%I e.g. 
sucrase being superficially located [Brasitus et a!, 1979] whereas AP and A"I Pase are more 
deeply embedded within the membrane [Sigrist-Nelson et al., 1977]. 
The absorption of digested food and various ions occurs by passive as well as active 
transport [Hopfer e! al, 1973; Schultz, 1977]. The transport of sugars and amino acids is 
a Na dependent secondary active transport energized by an electrochemical gradient due 
to differences in Na- concentrations across the BBMI [Hopfer et al., 1973; Schultz, 1977; 
Hopfer, 1978; Ramaswamy et al., 1991]. The role of proton motive force as a source of 
energy (in terms of XI'P) has also been demonstrated [Rajendran e! al., 1987; Vorum ct 
al., 1988; Ganapathy et a/., 19911. This is carried out by sodium pump (Na'/K'.1TPase) 
which is a highly conserved integral membrane protein. 
'11e activities of certain enzymes belonging to glycolysis, TCA cycle, 1-IMP shunt 
pathway, have been reported under various experimental conditions [Budhoski <t aL, 
1982; Farooq et al., 2004; 2006]. The presence of teexokinase, glucokinase, 6-
phosphofructokinase, glucose-6-phosphatase, fructosel,6-bisphosphatase, oxoglutarate 
dehydrogenase, citrate synthase, PEP carboxvkinase and NADP-malic enzyme indicate 
that gluconeogenesis is also operational in the small intestine [Ockermann, 1965; 
Budhoski el al.. 1982]. The function of small intestine appears to be metabolic also, in 
addition to digestive and absorptive. Thus the studies involving metabolic activities may 
in some way reflect the absorption properties of the intestinal mucosa. 
The intestinal microvillar membrane is highly differentiated to perform a variety of 
digestive and transport functions and there is considerable information concerning the 
membrane proteins responsible for many of these discrete mechanisms [Kenny and 
Booth, 19781. These proteins, including BBNI disaccharidases and hrdrolases, have been 
demonstrated to be involved in digestion and absorption of nutrients. The activities of 
these enztines are reported to be influenced by the composition and amount of diet 
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[Deren etal., 196,; Gupta etal., 1992 (b)J, by fasting [McNeil and Hanulton, 19 ,  11, drugs, 
industrial and other toxic pollutants [Bataineh ei al., 1997; Gonzalez et a/., 1995], under 
nutrition imposed during post natal development [Henning, 1981; Jaswal et al., 1990] and 
also by daily rhythmic change [Saito, 1972] as well as by proximal to distal variations in 
the small intestine [Harrison and Webster, 1971]. The enzymatic potential, especially of 
mucosal crypt cells, is of importance in the clinical assessment of absorptive and 
digestive capacity in disease which produces an abnormal gut surface associated with 
interruption of normal maturation process. 
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4.3 Gastrointestinal pathophysiology 
Nutritional stress and a number of environmental variables including certain chemicals, 
metal ions and antibiotics, dramatically modify the digestive and absorptive function of 
the intestinal mucosa, alter the activities of intestinal enzymes and disrupt the normo-
physiology of this tissue [lFarooq et al., 2004; 2006; 2007]. The gastrointestinal tract is 
lined with a single layer of epithelial cells that is capable of self renewal every 4-5 days, 
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and is among the highest proliferative tissue in the organism [Lipkin, 1973]. Small 
intestinal mucosa is one of the largest areas of contact of the human organism with the 
environment [Schumann a al., 1999. Thus, the intestinal tract represents the first barrier 
of defence between the organism and its luminal environment. The intestinal epithelial 
barrier is constantly challenged by diet and endogenous-derived ROS that can accumulate 
and disrupt mucosal redox control with deleterious consequences [Aw, 1999; Circu and 
Aw, 2011; Park etal., 2011]. The principal functions of the gastrointestinal tract that are 
subject to toxic effects of chemicals include propulsion, storage, digestion, absorption, 
secretion, barrier functions and elimination. These functions are carried out by one or 
more of its layered structural elements acting in concert. The structures that are subject 
to chemical toxicity include mucosa, muscle coats, nerves and vascular components. 
The small intestine is thus the primary site for great exposure to hazardous and life 
threatening environmental toxicants and various drugs. Recent studies have clearly 
demonstrated that the enzymes present in the small intestine are not only altered by 
dietary stress such as starvation and fasting [Farooq et al., 2004; 20061 but also by various 
chemicals and drugs such as cisplatin and gcntanucin [Arivarasu ct al., 2007; Farooq et a/., 
2007; Gulgun a a/., 2010; Nasif a i/, 2011]. Besides various metals have also been 
shown to alter the gastrointestinal chemistrti- [Orihuela et al, 2005; Kapur et al, 2005; 
Arivarasu e1 al., 2008]. Various antibiotics, anticancer drugs, chemicals and heavy metal 
ions are also known to alter the activity of the enzymes of intestine [Shimizu et a/., 1991; 
El-Boghdadv, 2011; Arakawa et al., 2012; Arivarasu el a/., 2011 and 2012]. 
Some agents that induce gastrointestinal toxicity act by a single mechanism. However 
most agents act by multiple mechanisms, some involving complex cascades, often with 
different time course. Most prominent pathophvsiological mechanism of gastrointestinal 
toxicity include direct effects on cell membrane, inhibition or stimulation of cell 
membrane, nerve damage, activation of emetic pathways, disruption of intracellular signal 
transduction, generation of ROS, activation or inhibition of enzymes of intracellular 
toxicity etc. 
ROS are also the major causative factors for the mucosal lesions through OS. The major 
toxic effects of ROS include direct cytotoxicin• towards epithelial cells, net fluid secretion 
into the lumen and alteration in functions of intestinal microvasculature that lead to 
increased permeability and membrane damage Grisham et al., 1990]. ROS mediated 
injure- to the small intestine has been demonstrated in several conditions such as 
ischemia/reperfuston, inflammatory bowel disease, surgical stress, usage of various drugs 
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and food additives etc. [Newberne et al., 1988; Halliwell and Gutteridge, 1999; Arivarasu 
et al., 2007; Ballinger, 2008]. 
Thus, foreign chemicals can produce gastrointestinal toxicity by a number of mechanisms 
that results in alterations of normal intestinal functions. Likelihood of toxicities to remain 
unrecognized can be either due to subtle changes or compensation by complex 
regulatory apparatus that protects vital gastrointestinal functions. 
4.3.1 Intestinal redox systems and related enzymes: Like most tissues, the intestinal 
epithelium contains millimolar concentrations of GSH that is maintained by dc novo 
synthesis and regeneration from oxidized GSH [.1w et a/., 1991]. Exogenously 
administered GSH is efficiently taken up and excreted across the intestinal basal 
membrane, thereby increasing plasma GSH levels and GSH bioavailability [Hagen et al, 
1990]. Nlucosal A0 defense is mediated by GSH-dependent enzymes including 
glutathione reductase (GR), glutathione peroxidase (GPx) and glutathione-S-transferase 
(GST) that are ubiquitously present along the intestinal tract. Among these, GR and GPx 
reduce GSSG or GSH-mixed disulfides in targeted proteins through thiol-disulfide 
exchanges [Fernandes and Holmgren, 2004. GST proteins are abundant in the 
gastrointestinal tract. However, GST distribution varies considerably along the digestive 
tract and their activity and expression is influenced by diet, drug exposure and clinical 
conditions [Hoensch et al., 2006]. The decrease in GST activity from proximal to distal 
colon is consistent with decreased colonic xenobiotic detoxication and increased cancer 
risk. The presence of a full complement of thioredoxin reductase (TR) proteins suggests 
their function in antioxidant defence and redox regulation in the intestinal tract [Godoy et 
al., 2011]. Enterocytes are replete with GSII and 1R- dependent systems in all segments 
of the intestinal tract that function to preserve cellular redox homeostasis and intestinal 
cell integrity. 
5. BLOOD: COMPONENTS AND FUNCTION 
Blood is the life maintaining transport fluid that circulates oxygen and nutrients 
throughout the body, carries away waste products, and helps defend against disease. 
Blood consists of numerous types of cells that are suspended in a fluid called plasma. 
The millions of cells that circulate in blood include erythrocytes (red blood cells), 
leukocytes (white blood cells) and thrombocytes (platelets) [Long et al., 1993; Shin et al., 
1998]. Besides transporting vital components, the blood plays an important role in the 
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immune functions of the body and is vitally important to coagulation (ability of blood to 
clot properly). 
5.1 Blood components 
I1ie blood consists of many components. These include: 
1. Plasma (550/o) 
2. Blood cells (45°o). Of these, 99°o are erythrocytes (red blood cells) and lo are 
leucoc~•tes (white blood cells) and thrombocvtes (blood platelets). 
Blood therefore consists of four main parts: red blood cells, white blood cells, platelets 
and plasma [Cohen, 19461. 
5.1.1 Red blood cells (RBC)/Erythrocytes They are the most abundant cells found in 
the blood and make 40-50" 0 of the total blood volume. R13C are disc-shaped biconcave 
cells whose most important function is to transport oxygen around the body. Mature 
RBC are unique in that it they do not contain a nucleus or cell organelles (Figure 61. 
Figure 6: Structure of rod blood cells 
RBC are made in the reticulo endothelial system and released in blood. These 
components are then transported by the blood to the liver where the iron is re-cycled for 
use be new RBC, and the blood pigments form bile salts. Where are approximately 4.5-5.8 
million RBC per .d of healthy blood. RBC contain hemoglobin (Hb) which is a red, iron-
rich protein. Hb enables RBC to carry oxygen from the lungs to all parts of the body. Hb 
in RBC gives blood its color. When the blood is rich in oxygen it is red, and when there 
is little oxygen it is blue. Blood traveling from the lungs to the body usually contains a lot 
of oxygen, so blood in the arteries is normally red. Much of the oxygen is removed from 
the small capillaries by the body tissues, so blood in the veins tends to be bluish in color. 
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RBC have a lifespan of approximately 120 days and are eventually broken down by the 
spleen with the home being converted to iron and blood pigments bilirubin and 
bih-iridin. 
5.1.2 White blood cells (WBC) The WBC defend the body against disease. They 
destroy bacteria and foreign material, they stimulate inflammation and assist in the 
healing process. They produce proteins called antibodies that destroy bacteria, viruses, 
and other microorganisms. WBC move in and out of the blood stream, depending upon 
where they are needed. There are several classes of WBC that circulate in the blood 
which are as follows: 
i) Neutrophils are the most numerous of all white cells. In a normal person there are 
usually 2,500 to 7,500 of these cells per microliter of blood. They form the primary 
defense against bacterial infections. They move out of blood vessels into infected or 
inflamed tissues in order to attack the infection or injury. 
ii) Lymphocytes are an active component of the immune system and are made in the 
bone marrow, lymph nodes, spleen and other lymphatic tissues. In a normal person, 
approximately 1,000-4,800 of these cells are present in each microliter of blood. A major 
function of many lymphocytes is to produce antibodies. 
iii) Monocytes circulate in the blood until they are needed in tissues that are inflamed or 
infected. They then leave the blood and enter such tissues where they mature into cells 
called macrophages. Macrophages are capable of engulfing and destroying harmful 
organisms and other materials. 
iv) Eosinophils play an important role in the response of the body to allergic and 
inflammatory reactions, and to parasitic infestations. 
v) Basophils are the rarest of all %X'BC and are not usually seen in blood samples. They-
participate in many of the same reactions that cosinophils are involved in. 
5.1.3 Platelets They are not cells; they are very tiny disks that look like flat plates. 'l hey 
are produced primarily in the bone marrow. 'Their major function is to plug any leak that 
develops in the walls of blood vessels and to start the process of blood clotting. Platelets 
help the blood to clot. They group together to form clumps, plugging any holes that 
develop in blood vessels. Clumps of platelets form scaffolding upon which a blood clot 
may form. 
5.1.4 Plasma It is the fluid portion of blood. It is a watery mixture of proteins, minerals 
and other chemicals vital to the body. It contains substances such as sodium, potassium, 
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chloride, magnesium, glucose (bl)od sugar), hormones and various enzymes that are 
produced in the liver, pancreas, kidneys, and muscles. Plasma also contains important 
clotting factors and many body waste products. Plasma carries all other components of 
the blood within the blood vessels. If water is lost through dehydration, wounds and 
burns, then the blood can become thickened, almost like sludge, and circulation is 
adversely affected. 
5.2 Toxicity and oxidative stress in blood 
Oxidative stress (OS), a pronounced pro-oxidant state, is caused by the excessive 
production of free radicals or from the weakening of the AO defense system. It is the 
cause of many pathologies, ageing processes and is believed to be a possible cause of 
cancer. Blood is a target of several xenobiotics which induce OS and compromise its AO 
defense mechanism [Edwards and Fuller, 1996; Nohl and Stolze, 1998]. Red blood cells 
(RBC) have been used as a model to investigate oxidative damage in biomembrancs 
because of their high vulnerability to peroxidation. Exposure of RBC to OS leads to 
lipid peroxidation (1,1'(.)), alteration in AO defense mechanism, changes in cellular 
morphology and conformation of membrane proteins, protein cross-linking and 
hemolysis [Kohl and Stolze, 1998; Cruz Silva et ul, 2000; Orhan and Sahin, 2001; Ajila 
and Prasada, 2008; Ahmad et al., 201 lb ; lihatti e! al., 2011; V'ijayapadma et al., 20121. 
Although RBC contain an extensive AO defense system, oxidative damage of membrane 
proteins and lipids contribute to the senescence of normal cells that result in a shorter 
life span for damaged cells. The major source of intracellular ROS in the RBC is 
autoxidation of oxyhemoglobin that generates superoxide which is then converted to 
H2O. Several studies have demonstrated that RBC, when exposed to various toxicants, 
undergo cellular damage causing the release of llh in the medium. 'These toxicants 
include pesticides, herbicides, food additives, various metals and drugs [Rice-Leans and 
Bacsal, 1987; Banerjee el al, 2001; Orhan and Sahin, 2001; Valko el al., 2005; Bukowska et 
al., 2008; Ahmad e< al., 2011 b]. Cigarette smoking and exposure to harmful ionising 
radiations have also been shown to induce OS in blood [Katz et aL, 1996; Muscat e! aL, 
2004. Various pesticides induce morphological changes in RBC, possibly due to OS and 
cause LPO, which is responsible for the adverse biological effects in experimental 
animals [John ci al., 2001; Sutcu ct al., 2(U I-i. 
Normal RBC function largely depends on the intactness of its membrane. The RBC 
membrane, a dynamic system, represents a simple form of cell membrane whose 
structure and function has been well established. It plays an important role in regulating 
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surface deformability, flexibility, adhesion to other cells, immune recognition and is 
considered to be the prime target for free radical attack due to the presence of high 
concentration of polyunsaturated fatty acids. Damage to the membrane, or to one of its 
components, alters the cellular function. Lipid bilayer structure disturbance by LPO 
process or by low molecular weight compound insertion may lead to perturbation in 
RBC deformability (especially by the action of the investigated agent simultaneously on 
protein conformation and function) and eventual cell death. The membrane protein 
structure perturbations also cause RBC-plasma ion exchange imbalance, increase in 
methemoglobin (NietHb) content in the RBC and finally induction of OS. During OS, 
the RBC membrane is stripped of phosphotidylethanolamine and this degredation 
process alters the structural relationship of the integral membrane protein spectrin [Haest 
et al., 1977]. It has been ascertained that free radical-mediated peroxidation of RBC 
membrane lipids and proteins and changes in cyt<>skeleton proteins eventually promote 
hemolysis [Cruz Silva et aL, 2000; Rajasekar et al., 2007]. Various chemicals, drugs, 
herbicides and insectides have been shown to induce severe alterations in RBC 
membrane leading to OS [Gabbianelli et al., 2007; Duchnowicz and Koter, 2003; 
Miahmud et al., 2008; Singh et al., 2008; Bhatti et al., 2011]. Thus, ROS produced by 
various toxicants, induce degenerative changes in RBC that can affect dynamic properties 
of the membranes such as fluidity and permeability and consequently the activities of the 
membrane-bound enzymes [Blasiak, 1990; Hazarika et al., 2001]. 
6. ANTIOXIDANTS - "SAVIORS OF LIFE" 
`1Ye an' what we eat". This adage represents the force behind research efforts in diet 
manipulation as preventive measures and treatments of various diseased states. The 
nature of the relation between diet and disease is the subject of great controversy and the 
last fifty years have been characterized by an understanding of the impact of nutrition 
and dietary patterns on health [Caballero, 2003; Lobo et al., 2010]. 
`Nr trition is the foundation /or all health': The quest for protective dietary compounds for 
the control and management of various chronic diseases has spanned generations of 
scientific research. Since OS has been implicated in the etiology of many disorders, 
renewed interest and vigor has been showered on the role of various AO. Plants provide 
one such dietary source of biologically active A0 components that have been shown to 
be co-preventative and co-therapeutic in a wide variety of ailments [Halliwell, 1996; Kaur 
and Kapoor, 2001]. 
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A number of investigations have already demonstrated that diet supplemented with 
antioxidants has profound beneficial health effects against various pathologies including 
cancers, cardiovascular diseases, diabetes, depression, arthritis, asthma and inflammatory 
and immune disorders of kidney and intestine [Valko el al., 20071. Some of the dietary 
AO are known to be incorporated in cellular membranes especially plasma membranes, 
affecting fluidity and the organization of various membrane enzymes and transport 
proteins. "This alters the functional aspects of various organs especially of kidney, liver 
and intestine; leading to "positive" end points relating to health and disease 111alliwell, 
1996; Young and Woodside, 2001; Seifried et al., 20071. 
Early clues to the possible importance of various dietary AO came from studies showing 
that young humans and experimental animals experienced impaired growth when all AO 
were removed from the diet. Further studies revealed that AO have numerous health 
benefits [Olson and Kobayashi, 1992; Obrenovich et al., 2011]. This stems from the 
observations of the different prevalence of coronary heart disease and other chronic 
diseases in various parts of the world [Butterfield and Keller, 2012]. With dramatic 
changes in industrialization and development of the food industry, intake of AO has 
increased enormously. These dietary imbalances in AO intake, in fact, are sometimes 
thought to be the prime cause of modern sufferings like cancer, hypertension, diabetes, 
depression, cardiovascular and renal disorders. 
The past few years, have seen a great spurt in research relating to the role of naturally 
occurring dietary AO and their ability to confer health and physiological benefits. Role of 
various AO has been extensively investigated and has received a great deal of attention as 
therapeutic options in a variety of clinical situations ranging from cardiovascular diseases, 
cancer, inflammatory and immune disorders, respiratory diseases, depression and 
diabetes [Uddin and Ahmad, 1995; Gordon, 2012]. Various free radical scavengers like 
superoxide dismutase [Matsushima et al., 1998] and AO like vitamins C and E [Durak et 
al., 2002; Fatima et al., 2007], when administered just prior to the ischemic events or toxic 
insult, have been reported to ameliorate toxicity associated with xenobiotics/toxicants. 
6.1 Antioxidant (AO) 
A(-) is a molecule capable of inhibiting the oxidation of other molecules by removing free 
radical intermediates and inhibit other oxidations reactions. AO are widely used as 
ingredients in dietary supplements and have been investigated for the prevention of wide 
spectrum diseases such as cancer, coronary heart disease and even altitude sickness. Non- 
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enzymatic AO are classified into two broad divisions, depending on whether they are 
soluble in water (hydrophilic) or in lipids (hydrophobic). In general, water-soluble AC) 
react with oxidants in the cell cytosol and the blood plasma, while lipid-soluble AO 
protect cell membranes from LPO. Water soluble AO include vitamin C, GSH, lipoic 
acid etc where as lipid-soluble include vitamin E, ubiquinol. AO may be synthesized in 
the body or obtained from the diet. AO are found in fish, fruits, green leafy vegetables 
and meat. The different AO are present at a vide range of concentrations in body 
fluids and tissues, with some like GSH or ubiquinone mostly present within cells, while 
others such as uric acid are more evenly distributed. Some AO are only found in a few 
organisms and these compounds can be important in pathogenesis and can be virulence 
factors. 
Considering the profound beneficial health effects of AO against various pathologies, the 
work embodied in this thesis was undertaken to study the possible protection/prevention 
against KBrO3 toxicity by dietary AO. These included the highly promising 
chemopreventive dietary antioxidants (GSH, VC and taurine) which are abundantly 
found in fruits and vegetables including blueberries, onions, curly kale, broccoli, and leek. 
The results showed that these AO were effective in attenuating the toxicity of KI3rO3. 
6.1.1 Vitamin C: Vitamin C (VC), also known as ascorbic acid, is found in both plants 
and animals. The richest natural sources of VC are fruits and vegetables and among them 
plum and the camu camu (Ayrcaria dubii fruit contain the highest concentration [Figure 
7]. It is also present in some cuts of meat, especially liver. VC is the most widely 
taken nutritional supplement and is available in a variety of forms, including tablets, drink 
mixes, crystals in capsules or naked crystals. VC is an essential nutrient but humans must 
obtain it from the diet as one of the enzymes needed to make ascorbic acid from 
glucose/ galactose has been lost by mutation during primate evolution. Most other 
animals are able to produce this compound in their bodies and do not require VC in their 
diet I1 inster and Van, 2007]. VC is an active reducing agent which is involved in many 
biological processes [Padh, 1990]. It is required for the conversion of procollagen to 
collagen by oxidizing prolinc residues to hydroxyprolinc. In cells, VC is maintained in its 
reduced form by reaction with GSH, a reaction catalyzed by protein disulfide isomerase 
and glutaredoxins. One of the vital roles of VC is to act as an AO and protect cellular 
components from free radical damage. VC is protective against toxicity induced by 
various xenobiotics (Sauberlich, 1994; Fatima et al., 2007] and protects several kinds of 
injuries and neoplasms that involve generation of OS. The use of dietary AO like VC in 
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treating disorders offers great potential since they are inexpensive, widely and easily 
available and can be safely administered to persons [Barja el al., 1994; Gaafa et al., 2011]. 
6.1.2 Glutathione: Glutathione (GSH) is a tripeptide (Glu-Cys-Gly) that contains an 
unusual peptide linkage between y-carboxyl group of the glutamate side-chain and the a-
amino group of cysteine. It is a major endogenous AO produced by the cells, 
participating directly in the neutralization of free radicals and ROS, as well as maintaining 
exogenous AO such as vitamins C and E in their reduced (active) forms [Meister, 1988; 
Scholz et al., 1989; Pompella et al., 2003]. Due to its high concentration and its central 
role in maintaining the cell's redox state, GSH is one of the most important cellular AO 
[Figure 7J. It has been shown to have beneficial role in various diseases [Droge and 
Ilolm, 1997] and in preventing toxicity induced by various drugs/chemicals [Sai et al., 
1992; Prigol et al., 2011]. Dietary GSH occurs in highest amounts in fresh (uncooked) 
meats, in moderate amounts in certain raw fruits and vegetables, and is absent, or present 
only in small amounts, in grains and pasteurized dairy products [Jones et al., 1992]. 
Unpasteurized milk and raw eggs are also a rich source of GSH. 
6.1.3 Taurine: Taurine, or 2-aminocthanesulfonic acid, is an organic acid widely 
distributed in animal tissues and accounts for approximately 0.1% of total human body 
%,,-eight. Taurinc occurs naturally in various foods like eggs, milk and is particularly 
abundant in seafood and meat [Figure 7J. It is a major constituent of bile and can be 
found in the large intestine. Mammalian taurine synthesis occurs in the pancreas via the 
cysteine-sulfinic acid pathway. Taurine has many fundamental biological roles such as 
conjugation of bile acids, anti-oxidation, osmoregulation, membrane stabilization and 
modulation of calcium signaling. It is essential for cardiovascular function, development, 
function of skeletal muscle, the retina and the central nervous system [Huxtable, 1992J. 
Besides, it has been shown to reverse the defects in nerve blood flow, motor nerve 
conduction velocity, and nerve sensory thresholds in experimental diabetic neuropathic 
rats [Li et al., 20061. Considerable evidence shows that taurine can act as a direct AO by 
scavenging ROS or as an indirect ; O by preventing changes in membrane permeability 
due to oxidative impairment [Wright et a/., 1986; '1'unbrell et al., 1995J. Taurine has been 
shown to reduce OS and protect against toxicity of various metals and drugs [Green el 
al., 1991; Gurcr et al., 2001; Sinha e1 al., 2008; Alam ct ii1., 2011J. 
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(A) Vitamin C Chemical formula: C6H 806 
HQ 
HO 	H O O 
HO OH 
B) Glutathione Chemical formula: C10H1.IN 306S 
HS 
O 
H 
HOOC N N~COOH 
= 	 H 
NH2 O 
C) Taurine Chemical formula: C 2H ,NO,S 
0 \S 	NH2 
HOB \O 
Figure 7: The structures of vitamin C, glutathione and taurine. 
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SCOPE OF THE THESIS 
Humans are exposed to a variety of potentially harmful agents in the air they breathe, the 
liquids they drink, the food they cat, the surfaces they touch and the products they use. 
Therefore, it is important to study the molecular mechanisms that mediate the harmful 
effects of noxious substances to which humans are exposed. An important aspect of 
public health management is also the protection from harmful effects resulting from 
exposure to environmental agents and which contribute, either directly or indirectly, to 
increased rates of premature death, disease, discomfort or disability. In this regard the 
last twenty years have been rich in information coming from laboratories all around the 
world concerning the positive impact of nutrition and dietary patterns on human health 
(Caballero, 2003J. Chemoprevention has emerged as a practical approach in reducing risk 
of various ailments. The concept of chemoprcvcntion of certain diseases using naturally 
occurring substances that could be included in the diet consumed by human population 
is gaining attention. At the same time, the endogenous and exogenous factors that 
influence the incidence and progression of many chronic diseases are being better 
defined and understood. Thus the search for effective, nontoxic natural compounds has 
greatly intensified in recent years. 
KBrO, is one such environmental agent that has been extensively used in food 
industries, in cosmetic preparations and is generated as a disinfection by-product during 
ozonation of drinking water. Excessive exposure to bromate exerts adverse effects and 
has been implicated as a risk factor for carcinogenesis. A number of biochemical 
changes, functional impairments and histopathological lesions have been observed in 
KBrO,-treated animals. 
KBrO; is especially toxic to the kidneys which play an essential role in the maintenance 
of total body fluid volume, its composition and acid-base balance by selective 
reabsorption. Ilowever, its gastrointestinal effects, especially on absorption and 
digestion, have not been studied. 'These experiments are important since the intestine is 
among the earliest tissues exposed to orally ingested bromate and comes in direct contact 
with this compound. The blood is also exposed to bromate and the possible hemotoxicty 
of KBrO., is an area of research that has not been greatly explored. 
In the present work, the effects of KBrO3 on human blood and some rat tissues 
were first studied. Then several dietary antioxidants were examined to abrogate 
or attenuate KBrO induced toxicity. 
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The biochemical events/cellular response/mechanism of KBrO,-induced toxicity in 
human erythrocytes (in vitro studies) and other adverse effects in different rat tissues (in 
r'iao studies), have been studied. The effect of dietary anti-oxidants has also been 
determined to observe any protection provided by them against KBrO, toxicity. The 
specific objectives of the planned research included: 
I. Effect of KBrO3 on human and rat blood 
Experiments were done to study the effect of KBrO, on human RBC (in vitro studies) 
and rat blood (plasma and RBC). The effects of various dietary AO like GSH, VC and 
taurine were also determined to observe any protection provided by them against KBrO j  
toxicity. 
II. Effect of KBrO., on rat kidney 
The effect of KBrO3 on various biochemical parameters in rat kidney (cortex and 
medulla) including enzymes of carbohydrate metabolism, brush border membrane 
(B BM), lysosomes and OS were determined. The effects of dietary AO (VC and taurine) 
were also determined to observe any protection provided by them against KBrO, renal 
damage. 
III. Effect of KBrO3 on rat intestine 
The effect of KBrO, on various biochemical parameters and on the enzymes of 
carbohydrate metabolism, BBM, Ivsosomes and antioxidant defense system in small 
intestine was studied. The effects of dietary AO (VC and taurine) were also determined 
to observe any protection provided by them against KBrO3 intestinal toxicity. 
Histopathological and DNA damage studies were also done to study the changes induced 
by KBrO, and to see if they correlate with biochemical observations. 
The following parameters were determined to ascertain their role in bromate induced 
toxicity and possible protection by dietary AO. 
a) Plasma parameters such as BUN, creatinine, inorganic phosphate, glucose, 
vitamin C and xanthine oxidase were assayed to study KBrO, toxicity in various 
tissues. 
b) The effects on carbohydrate metabolism were determined from the activities of 
enzymes of various metabolic pathways (glycolysis, TCA cycle, gluconeogenesis 
and HMP-shunt). 
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c) Activities of ALP, (G[', LAP, maltase and sucrase were measured as these 
enzymes are biomarkers of BBM and were used to assess structural/functional 
integrity of intestinal and renal BBM. 
d) AO power was measured by FR.AP and DPPH assays. 
e) The activities of several AO enzymes (SOD, C.1T, GSH, GST, TR and GPx) 
were determined. Several parameters indicating the induction of OS in the cell 
were determined. These include l.I'O, protein oxidation, total SH, GSH, NO and 
11,0, levels. 
fl 	Histological examinations of kidney and small intestine were done to study 
K.BrO,-induced tissue damage. 
g) 	Genotoxicity of KBrO,was studied in renal and intestinal tissues by Comet assay, 
DNA-fragmentation and DNA-protein cross-linking assays. 
Our results showed that treatment with KBrO, induced OS in human erythrocytes, 
caused specific alterations in various biochemical parameters and in the enzyme activities 
of various systems. KBrO, induced DNA damage and DNA-protein-cross linking in rat 
tissues. Histological observations also revealed the drastic changes induced in kidney and 
intestine by KBr0 . Protection studies showed that dietary, antioxidants taurine and 
vitamin C greatly ameliorated KBrO,-induced alterations in various parameters. These 
studies would be helpful in further understanding the pathogenesis of KBrO,-induced 
toxic insult and its possible prevention or protection. 
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MATERIALS 
Animals and diet. Adult male Albino rats (Wistar strain) were purchased from Central 
Animal House Facility, Jamia IIamdnrd University, New Delhi, India. Standard rat pellet 
diet was obtained from Aashinvaad Industries, Chandigarh, India. 
Chemicals: The sources of chemicals used in the work are }riven below: 
.Sico Resrarcb Inboratoier (.,1lrnnbai, India): Acetic acid, ammonium ferrous sulphate, 
ammonium molybdatc, adenosine 5'-triphosphate (Al?), bovine serum albumin (BSA), 
calcium chloride (CaClz), chloroform, 1-chloro-2,4-dinitrobenzene, copper sulphate 
(CuSO~, creatinine, cysteine hydrochloride, dextrose, 2,6-dichlorophenolindophcnol, 
2,4-diniuopheny1hydrazine, di-potassium hydrogen orthophosphate (K,HPO4), di-
sodium hydrogen orthophosphate (Na,HPO,), diphenylatnine, 3,5-dinitrosalicylic acid, 
5,5 -dithio-bis-2-nirrobenzoic acid, ethanol, ethylenecliaminetetraacedc acid (EDTA), 
ethyl acetate, fern chloride (FeCI,), ferrous sulphate (1''cSO4), Folio's phenol reagent, 
fructose 1,6-bisphosphate, guanidine hydrochloride, glucose, glucose 6-phosphate, 
glucose oxidase, glutarhione oxidised, glutathione reduced (GSH), glycine, glycylglycine, 
horseradish peroxidase, hydrochloric acid (lid), maleic acid, magnesium chloride 
(1tlgClz), mannitol, mercuric chloride, N-2-hy-droxyethyl-piperazine-N-2-ethane sulphonic 
acid (HEPES), nieoti.namidc adenine dinucicotide phosphate (N ADP), nicotinamide 
adenine dinucleoride phosphate reduced (NADPH), nicottinatnide adenine dinucleotide 
reduced (NADH), p-nitrophenvl phosphate, phosphoric acid, potassium dthydrogen 
orthophosphate (KH,PO,), proteinase K, pyrogallol, sodium acetate, sodium dodecyl 
sulphate, sodium carbonate (Na7CO;), sodium chloride (NaCI), sodium hydroxide 
(NaOH), sodium potassium tartarste, succinic acid, sucrose, sulfanilamide, taurine, 
thiourea, tiifluoroacetic acid, trichloroacetic acid (LC_1), tris-(hydroxcmethyl) 
aminomethane (Ttis-base), zinc sulphate. 
Sigma-Aldrich (St. Lath, MO, (ISA): Acetaldehyde, butylated hydroxytoluene, 2,2- 
Biphenyl-l-picrylhydrazvl (DPPH), y-glutamyl-p-nitroandide, glurathione teductase, 
Hoescbt dye 33258. L-leucine p-nitroanilide, low tocltivg point agarose, N-1-
napthylethylenediamine dihydrochloridc, potassium bromate (KSrO,), Roswell Park 
Memorial Institute medium (RPMI medium), sodium nitrite, 2,4,6 ttipvridyl-s-ufiazine, 
vanadium chl,,nde. 
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Himsdia Labomlorier (YIumbai, India): Barium hydroxide [Ba(OH)], calcium carbonate, 
hydrogen peroxide, o-dianisidine, perchloric acid, picric acid, sodium arsenate, sodium 
dlhydrogen orthophosphate (NaH,PO°), sodium fluoride (NaF), sulfosaicvlic acid, 
sulphuric acid (H,SOO. 
I-hha Chemie (fumbai, India): '1'hiobarbituric acid (IBA), sodium azide. 
Kits: Kits for determination of blood urea nitrogen, aspartate transnninase and alanine 
transatninase were purchased from Span Diagnostics (Surat, India). 
Glass distilled water was used for the preparation of all buffers and solutions. 
METHODS 
I. IN VITRO STUDIES USING HUMAN RBC 
Fresh human blood was taken from young (21 to 30 years) healthy non-smoking volunteers 
after getting their informed consent and immediately mixed with glucose-citric acid-
trisodium citrate (2.45 g glucose, 2.2 g trisodium citrate and 0.73 g citric acid in 1(10 ml 
distilled water) as anticoagulant Blood was centrifuged at 2,500 rpm for 10 min at 4 "C in a 
clinical centrifuge and the plasma and huffy coat were removed. The RBC pellet was 
washed three times with phosphate buffered saline (PBS) (8 g NaCl, 0.2 g KCI, 1.44 g 
Na2HPO4 and 0.24 g IQ12PO4 in 1000 ml, pH 7.4) and resuspended in PBS to give a 5% 
(v/v) suspension (5%ohetnatocrit). 
1. Effect of ICBrO, on human RBC: The effect of different concentrations of KBrO, on 
human RBC was first studied. Stock solutions of KBrO, were prepared in PBS. Then 
RBC were incubated with varying concentrations of ICBrO, (0.1-10 m1{) at 37 °C for I 
It in a total volume of 3 ml. Untreated RBC were used as control and similarly incubated 
at 37 ° C for 1 H. The samples were centrifuged at 2500 rpm for 10 min at 4° C. The 
absorbance of supernarants was recorded at 540 nm to determine hemolysis. The cclt 
pellets were washed thrice with PBS and RBC were lysed with 10 volumes of distilled 
water at 4 °C for 2 h. The samples were centrifuged at 3000 rpm for 10 min at 4 °C and 
the supernatants (hetnolysates) were quickly frozen in aliquots and later used for the 
analysis of several biochemical parameters. 
2. Protective effect of different anti-oxidants: In the second set of experiments, 
effect of various dietary AO (GSFI, taurine, and VC) on RBC was studied in presence 
or absence of KBrO,. Stock solutions of KBtO„ GSH, tautine, and `'C were 
prepared in PBS. RBC were incubated for I It at 37 °C with (a) 1.0 mM KBrO, alone, 
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5.0 m\i taurine alone, 3.0 mM[ GSI-1 alone, 3.0 mM VC alone and (b) 1.0 m11 KBrO, 
plus different concentrations of taurine (0.1-5.0 mNI) or GSH (0.1-3.0 miff) or VC 
(0.1- 3.0 m.\1). Untreated RBC incubated at 37 °C for 1 h served as control. The cells 
were centrifuged and hemolysates prepared as above. 
II. IN VIVO STUDIES USING EXPERIMENTAL ANIMALS 
1. Animal protocol: Male Wistar rats weighing 150-200 gm were used in all the 
experiments. Animals were acclimatized for one week prior to the experiment on 
standard rat pellet diet with free access to water. The animal experiments were conducted 
according to the guidelines of Committee for Purpose of Control and Supervision of 
Experiments on Animals (CPCSFA), Ministry of Environment and Forests, Government 
of India. Body weights of rats were recorded at the start and completion of the 
procedure. All animals had free access to diet and water throughout the duration of the 
experiments. 
After acclimatization, the animals were randomly divided into different groups. 
In the first series of experiments, effect of a single oral dose of KBrO, was studied. 
KBrO, in drinking water, was given orally (by garage) as a single dose of 100 mg/kg 
body weight and the animals were sacrificed 12, 24, 48, 96 and 168 Ii later after being 
anesthetized with anesthetic ether. Control animals did not receive any KBrO, but were 
given an equivalent volume of water by gavage and were sacrificed along with the treated 
groups. There were 6 animals in the control and 6 in each of the KBrO3-treated sub 
groups of 12, 24, 48, 96 and 168 h. 
In the second series of experiments, the protective effect of taurine and VC was studied. 
The animals were divided into six groups: 
(i) Control: Rats were given suitable volume of drinking water by gavage and were 
sacrificed along with the treated groups. 
(ii) KBrO. alone: Rats were given a single oral dose of KBrO. at 100 mg/kg body 
weight and sacrificed 48 h later. 
(iii) VC alone: Rats were given two oral doses of \'C (each of 250 mg/kg body weight) 
at 24 h interval and sacrificed 48 h after the second dose. 
(iv) Taurine alone: Rats were orally given taurine at 100 mg/kg body weight/day for 5 
days and the animals were sacrificed 48 h after the fifth dose. 
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(v) VC+KBrO,: Rats were given two oral doses of VC: (each of 250 mg/kg body 
weight) at 24 h intervals. Then 6 h after second dose of VC, they were given a 
single dose of KBrO, (100 mg/kg body weight) and were sacrificed 48 h after the 
administration of KBrO,. 
(vi) 'I'aurine+KBrO,: Rats were orally given taurine (100 mg/kg body weight/ day) for 
five days and KBrO3 (100 mg/kg body weight) was given 6 h after the last dose of 
taurine. Animals were sacrificed 48 h after the administration of KBrO;. 
In general, the rats remained active and alert throughout the study. The daily food and 
fluid intake was similar in various experimental groups of rats. The body weights of the 
rats were recorded at the start and end of each experiment and no significant difference 
was seen among the different groups. 
Solutions of KBrO;, taurine and VC were prepared in drinking water. The whole kidneys 
and the complete small intestines were removed and used for the preparation of 
homogenates and BB:\IV. 
Blood collection: Blood was collected by cardiac puncture and mixed with glucose-citric 
acid-trisodium citrate as an anticoagulant and immediately separated into plasma and 
RBC by centrifugation at 2500 rpm for 10 min at 4 "C. The RBC pellet was washed three 
times with PBS and hemolysates were prepared by lysis with distilled water as described 
above for human RBC. 
2. Histology 
A one cm part of duodenum and one kidney from control and treated animals were 
quickly removed after sacrificing the rats and preserved in 10% formalin for histology. 
The tissues were embedded in paraffin wax and longitudinally sectioned by microtome 
into 10 pm sections. Hematoxylin and eosin staining of the above sections was done by 
routine procedure (Culling, 19741 and slides were observed under a trinocular 
microscope (Olympus BX40, Japan) at 10OX magnification. 
3. DNA damage studies 
(i) 	Gomel assay/ sink/ce celi del e/eetmp/oresL (SCG1 ): A part of the small intestine and a 
small section of kidney was immediately transferred into the Roswell Park Memorial 
Institute medium (RPMII medium) immediately after sacrifice of animals and later 
used for analyzing DNA damage by Comet assay. The tissues were transferred to 
fresh RP\MI containing EDT:\ and were chopped into very small peices in separate 
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Petri dishes. I he solutions were sieved by muslin cloth into fresh Petri dishes to 
collect their cell suspension. The Comet assay was performed under alkaline 
conditions essentially by the procedure of Singh tl a/. [ 1998] with slight 
modifications. Full- frosted microscopic slides precoated with 1.0 % normal melting 
agarosc at about 50 "C (dissolved in Ca`_ and Mg` free PBS) were used. Around 
10,000 cells were mibed with 75 µl of 2.0% low melting point agarose (LMPA) to 
form a cell suspension and pipetted over the first layer and covered immediately by 
a coverslip. The agarose layer was allowed to solidify by placing the slides on a flat 
tray and keeping it on ice for 10 min. The coverslips were removed and a third layer 
of 0.5°  o LMPA (75 µl) was pipetted and coverslips placed over it and kept on ice 
for 5 min for proper solidification of layer. "11ic coverslips were removed and the 
slides were immersed in cold losing solution containing 2.5 M NaCI, 100 m,'\1 
EDT_1, 10 mM 'Iris, pH 10, and 1°.-'o Triton X-100 added just prior to use for a 
minimum of I h at 4 "C . After lysis, DNA was allowed to unwind for 30 min in 
alkaline electrophoretic solution consisting of 300 mM NaOH, 1 mM FDTA, pH 
13. Electrophoresis was performed at 4 "C in a field strength of 0.7 V/cm and 300 
mA current. The slides were then neutralized with cold 0.4 M Tris-HCI, pH 7.5, 
stained with 75 pl ethidium bromide (20 .tg/ml) and covered with a coverslip. The 
slides were placed in a humidified chamber to prevent drying of the gel and 
analyzed the same day. Slides were scored using an image analysis system (Komct 
5.5, Kinetic Imaging, Liverpool, UK) attached to CX41 fluorescence microscope 
(Olympus, japan). The comets were scored at a magnification of 10OX and images 
of 50 cells (25 from each replicate slide) for each sample were scored. Comet tail-
length (migration of 1)N_1 from the nucleus in µm) was chosen as the parameter to 
assess nuclear DN_1 damage. 
(ii) Quantatir'e 1),V ,1 /nçim'nia6o;i assq)- Quantitation of 1)N:1 fragmentation was done 
by the colorimetric diphenvlamine assay [Burton, 19561. The renal and intestinal 
tissues were homogenized in chilled lysis buffer (20 m\1 'Iris-I ICI, 20 mM ED'RA, 
0.5".i Triton N-1(J0, pH .5) and centrifuged at 15,000 rpm for 15 min at 4 °C to 
separate intact DNA in the pellet from fragmented/damaged DN.\ in the 
supernatant fractions. Perchloric acid (final concentration of 0.5 M) was separately 
added to both the pellet and supernatant samples. All samples were heated at 90 °C 
for 15 min and then centrifuged at 4,500 rpm for 1O min to remove precipitated 
proteins. The resulting supernatants, whether containing whole or fragmented 
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DNA, were treated with 58.66 mM diphenylamine for 16-20 h at room temperature 
in dark and the absorbance was measured at 600 nm. IDNA fragmentation was 
expressed as the percentage of fragmented DNA to total DNA. 
(iii) DNA protein cross-links: The renal and intestinal tissues were homogenized in lysis 
buffer (2% SDS, 20 mM Tris-HCI, 20 mM EDTA, p'1  7.5) and the DNA-protein 
cross-links (DPC) were detected by the K`-SDS assay as described by Zhitkovich 
and Costa [1992]. Briefly, the homogenates were vigorously vortexed for 10 sec and 
heated at 65 "C for 10 min and after further addition of 0.5 ml of 0.2 J1 KCI-20 
mM 'Tris-HC1 pH, 7.5, the homogenates were passed five times through a 21-gauge 
needle. The K+-SDS precipitate was formed by cooling of the sample on ice for 5 
min and collected by centrifugation at 8,000 rpm for 6 min at 40 "C. The resulting 
pellets were washed twice by resuspending them in 1 ml of 0.2 11 KCI, passing 
through the needle five times, heating at 65 °C for 10 min, cooling on ice, and 
centrifugation at 8,000 rpm for 6 min at 40 °C. This thoroughly washed precipitate 
was resuspended in 1 ml of 0.1 hl KC1-10 mM EDTA-20 mM Tris-HCI, pH 7.5 
followed by the addition of proteinase K to a final concentration of 0.2 mg/ml and 
incubated at 50 °C for 3 h. The released SDS due to the proteolysis was removed 
by cooling the sample on ice. The amount of DNA in the supernatant was 
determined with the fluorescent Hoeschst dye 33258 (200 ng/ml) in a fluorometer 
(Shimadzu, Japan) with excitation and emission wavelengths at 365 and 460 nm, 
respectively. The total DNA in renal and intestinal tissues was determined by lysing 
them in 1 m1 of 2 NI NaCI-20 mM Tris-HCI, pl-i 7.5. The homogenates were 
vortexed, and then mixed with the fluorescent Hoescht dye. Effectiveness of 
KBrO, in DPC formation was estimated by the ratio of the percentage of DNA 
cross-linked to proteins in KBrO3-treated cells and in the control cells. 
4. Plasma parameters 
(i) 	Creatinine and inorganic phosphite (Pi): The plasma samples were deproteinized with 
3°, o TCA in a ratio of 1:3. After incubation for 10 min at room temperature, the 
samples were centrifuged at 4000 rpm (Remi Centrifuge, India) for 10 min. The 
protein free supernatant was used to quantitate serum creatinine and Pi. 
Creatinine was determined by the method of Levinson and Macl"ate 119691. To 0.5 
ml of deproteinized plasma, 50 µl of 10°4, NaOH and 200 Al of saturated picric 
acid were added and incubated for exactly 20 mm at room temperature. A 
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calibration curve was simultaneously prepared using standard solutions containing 
1-5 pg creatinine. The samples and standards were read at 520 nm in a 
spectrophotometer (Cintra 5, GBC Scientific Equipment, Australia). 
Pi was measured in protein free plasma supernatant by the method of Tauskv and 
Shorr [1953]. The deprotcinized plasma (0.5 ml) was diluted to 3 ml with 1.3 ml of 
distilled water and 1.2 ml of I cSO4 reagent (5 gm FeSO, dissolved in 10 m1 of 10% o
w/v ammonium mol}•bdate in 10 N H,SO4 and diluted to 100 ml with glass 
distilled water) was added. A calibration curve was prepared simultaneously using 
standard solutions containing 30-250 nmoles of KH2PO4. The blue colour obtained 
was read at 600 nm in a spectrophotometer. 
(ii) Blood urea rtilrogen (BC:') andgluco.re: Levels of BUN and glucose were determined by 
standard colorimetric procedures; urea by reaction with diacetyl monoxime and 
glucose by reaction with 4-amino antipy rene using kits from Span Diagnostics 
(Surat, India). 
(iii) Apartate aminotraniferase (_AIS1) and alanine aminotransferase (ALT): The marker 
enzymes of hepatotoxicity, AST and ALT, were assayed in plasma by reaction with 
2,4-dinitroplienyl hydrazine by standard colorimetric procedures using kits from 
Span Diagnostics (Surat, India). 
5. Preparation of kidney (cortical and medullary) and intestinal homogenates 
(i) 	Hono,ena/'s /or the dehww'Wliol o/ m:'lrrbalic enm The kidneys were removed from 
animals and decapsulated. They were sectioned into cortical and medullary regions 
and homogenized separately in 0.1 M Tris-HCI buffer, pH 7.5, by a glass teflon 
homogenizer (Thomas PA, USA) by passing 5 pulses at 4 "C to make a 100/0 w/v 
homogenate. The homogenate was then subjected to high speed Ultra-Turret 
Kunkel homogenizer for 3 pulses of 30 s each with an interval of 30 s between each 
stroke. Homogenate was centrifuged at 2,00() rpm at 4 "C for 10 min in Beckman 
J2-\I1 (Beckman Instruments, Palo Alto, CA, USA) refrigerated centrifuge to 
remove cell debris. The supernatants were saved in aliquots and stored at -20 "C for 
analyses of metabolic enzymes fFigure 101. 
Complete small intestines were removed, washed with 1 mM1 Tris-HCI, 0.9° 0 NaCl, 
pH 7.5 and slit open in the middle. The mucosa was gently scraped with a glass 
slide, the scrapings were homogenized in 0.1 M •1'ris-HCI buffer, pH 7.5, and the 
homogenates prepared as above. 
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(ii) I lojnogenates for ennralic and lion-t,n., Dvnulic .,10 parumeler: A 1 U" o homogenate of 
cortex, medulla and intestinal mucosa was prepared in 0.1 M Tris-HCl buffer, pH 
7.5, in a glass-teflon homogenizer with 5 complete strokes. The homogenate was 
then subjected to high speed Ultra-Turrex Kunkel homogenizer for 3 pulses of 30 s 
each with an interval of 30 s between each stroke. One part of the homogenate was 
saved at -20°C for estimation of total SH, GSH, H2O, levels, protein oxidation, 
LPO and the other part was centrifuged at 5000 rpm for 15 min at 4°C and 
supernatant was stored at -20 °C for analyses of free radical scavenging enzymes. 
6. Preparation of kidney (cortical) and intestinal brush border membranes (BBM) 
(i) 	Corlical BBJ1: The kidneys were decapsulated and kept in ice-cold buffered saline 
(154 mM NaC1, 5 mM rris-HEPES, pH 7.4). Each kidney was cut horizontally into 
two halves and the whole cortex was carefully separated from medullary and 
papillary portions. The BBM vesicles (BBMV) were prepared from cortex using 
MgCl2 for precipitation of membranes other than BBi\1 [Schimtz el al., 1973] exactly 
as described by Yusufi and Dousa [1987] and as outlined in schematic diagram 
[Figure 1]. In each experiment, tissues from two to three animals (control and 
experimental) were pooled to obtain a sufficient amount of starting material. All 
steps were strictly carried out at 0-4 "C unless otherwise specified. 
a) The cortical tissue for preparation of BBMV was homogenized in a solution 
containing 50 m,%l mannitol, 5 mM Tris base/HEPES, pH 7.5 (10 ml/gm 
tissue) with four complete passes by glass-teflon homogenizer. 
b) The homogenate (10% w/v) was diluted by adding equal volume of the above 
solution (20 ml/gm tissue) followed by high speed homogenization (Ultra-
Turrex Kunkel homogenizer) with three pulses of 30 s each with 30 s interval 
between each pulse. 
c) 1 NI MgC1, was added to the homogenate to a final concentration of 10 m?'1 
and kept on ice for 20 min with intermittent shaking. 
d) 'l'he homogenate was then centrifuged at 5000 rpm (2000 x g) for 10 min in a 
Beckman j2-MI1 refrigerated centrifuge using j:1-17 rotor. 
e) The pellet was discarded and the supernatant was recentrifuged at 17,000 rpm 
(35,000 x g) for 30 min in JA-20 rotor. 
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t) the pellet thus obtained was resuspended in a solution containing 300 mM 
mannitol, 5 to\I Tris base/ II[PF.S, pI 1 7.5 with four passes by a loose fitting 
Dounce homogenizer (\Wheaton Il., USA) and centrifuged again at 17,000 rpm 
(35,00O x g) for 30 thin in 15 ml cores glass tube using JA-20 rotor. 
g) The supernatant was discarded and the white outer portion of the fluffy pellet 
was resuspended carefully in a small volume of 5 mM Tris base/ 1-IEPES, 300 
mM mannitol, pH 7.5, leaving the dark brown centre of the pellet undisturbed 
(nutochondrial contamination). 
The suspension thus obtained was homogenized by hand held 1)ouncer or passed 
through a syringe with 21 gauge needle. This BBM1 suspension was quickly frozen in 
small aliquots and used for enzyme analysis. 
(ii) Intl° ,`tual BBSI: The complete small intestines from animals were removed, washed 
with 1 mM "I'ris-HCl, 0.9% NaCI, pl 1 7.5, and slit open in the middle. The tnucosa 
was gently scraped with a glass slide and used in the preparation of BBM. The 
intestinal BBBMM was prepared as described by Kessler el aL [1978] with a few 
modifications, as outlined in schematic diagram [Figure 1 ]. CaCI, was used to 
precipitate membranes other than Iil~\I. All procedures were carried out at 0-4"C 
unless otherwise specified. 
(a) "1'he tnucosal scrapings were homogenized in a buffered solution containing 50 
mM mannitol, 2 mM Tris-HC1, pH 7.5 (10 nil/gm tissue) with four complete 
passes by a glass-tcflon homogenizer to give 10°'o w-/ v homogenate. 
(b) The mucosal homogenate was diluted with the above iris-mannitol buffer (20 
ml/gm tissue) and further homogenized using Ultra Turrex Kunkel 
homogenizer at high speed with three pulses for 30 s each with 30 s interval 
behvecn each pulse. Aliquots of mucosal homogenates \%-ere saved and quickly 
frozen for further analyses. 
(c) Homogenate was then passed through four layers of cheese cloth and CaC1, 
was added to the filtrate to a final concentration of 10 mM, with constant 
stirring and the solution was left on ice for 15-20 min. 
(d) The homogenate was then centrifuged at 5000 rpm (2000 x g) for 10 min in a 
Beckman J2-\11 refrigerated centrifuge using a JA-17 rotor. 
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(e) The pellet was discarded and supernatant was centrifuged at 1-000 rpm (35000 
x g) in jA-20 rotor for 30 min. 
(0 The pellet was resuspended in 1-2 ml of 50 mM sodium malcate buffer, pH 6.8, 
with four complete passes by a loose fitting Bounce homogenizer (Wheaton, 
USA) and centrifuged at 17,000 rpm (35000 x g) for 30 min in a 15 ml corex 
rube using a JA-20 rotor. 
(g) The white outer fluffy portion of the pellet was carefully resuspended in 50 mIv1 
sodium maleate buffer, pH 6.8, leaving the dark brown center of pellet 
undisturbed (mitochondrial contamination). 
The suspension thus obtained was homogenized by hand held Douncer or passed 
through a syringe with 21 gauge needle. This BBM suspension was quickly frozen in 
small aliquots and used for enzyme analysis. 
7. Enzyme assays 
■ One unit of enzyme activity is defined as the amount of enzyme required to catalyze 
the formation of I µmole of product per min or hour under the specified 
experimental conditions. 
• Specific activity is defined as the enzyme units per mg protein. 
• The enzymes of A0 defense mechanism and carbohydrate metabolism were assayed 
in cortical, medullary and intestinal homogenates only and marker enzymes of brush 
border membrane were determined both in respective homogenates and BBMV. 
(A) Assay of carbohydrate metabolism enzymes The assays were carried out in 
homogenates of kidney [cortical homogenate (CH) and medullary homogenate 
(MI-1)J and intestine [mucosal homogenate (IH)] by measuring the absorbance 
changes in a spectrophotometer (Cintra 5, GBC Scientific Equipment, Australia) at 
28-30 "C. The net reaction rate was measured by difference of the absorbance 
values obtained from addition of the substrate only and for actual enzymatic 
reaction following the addition of substrate. The molar extinction coefficient of 
NAI)H and NAI)PH used in calculation of reaction rate was 6.22 rnMI'cm at 340 
nm. G6P and FBI' were assayed at 37 C. 
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RAT KIDNEY 	I 	 I RAT INTESTINE 
1 	
Everted and washed with 
Section into cortex and medulla 	 Tris buffered saline pH 7.5 
	
RAT KIDNEY CORTEX 	 I 	MUCOSAL SCRAPING 
50 mM mannitol, 5 m%l Tds-HEPES, pH 7.5 
high speed homogenization (Uhra-Turrex) 	l+ 
CBBMV IN IIOMOGENATE 	 IBBMV IN HOMOGENATE 
10 mM MgCl2, 30 min 	 10 mM CaCl,, 20 min 
•• Centrifugation at 2000 x g for 10 .....► 
min 
CBBMV IN SUPERNATANT 	+ 	I IBBMV IN SUPERNATANT 
PELLET 
DISCARDED 
•••-........ CBBMVHBBMVpelIetedby ............► 
centrifugation at 35000 x g for 
30 min 
I CBBMV IN PELLET 	 I IBBMV IN PELLET 
SUPERNATANT 
DISCARDED 
"•'•••Centrifugtionat35O0Oxg 
1 
for 30 min 
...•••••........►~ 
CBBMV IN PELLET I IBBMV CN PELLET 
Sut 	nded in 300 mM mannitol 5 S Suspended in mM Trix-AFPES, pH 7.4 DISCARDED 50 mM sodium. nmleate, pH 6.8 
DISCARDED 
Figure 1: Schematic representation of BBMV preparation from rat renal cortex and 
intestinal mucosa (CBBtvW=cortical BBIt1V, IBBIIV= intestinal BtihfV). 
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(i)Lactate deh drogenare (1 DF1, E.G 1.1.1.27): The activity of LDH was determined 
by the method of Kornberg [1955]. The reaction mixture, in a total volume of 3 
ml, contained 150 µmoles Tris-HCl buffer pH 7.4, 10 µmoles MgCL, 5 µ.moles 
sodium pyruvate, 0.24 µmoles NADI-1 and 1-4 mg protein. The enzyme activity 
was measured from the decrease in absorbance, by pvruvate dependent NADH 
oxidation to NAD, for 5 min at 340 nm. 
(ii) Ma/ate dejjdingenase (L1DH, E.G. 1.1.1.37): The activity of MMDH was measured 
by the method of Meyer et al. [1948]. The reaction mixture, in a total volume of 
3 m1, contained 100 j.imoles Tris-HC1, pH 7.4, 2.5 }lmoles oxaloacetate (OAA, 
pl I neutralized to 7.4), 0.24 llmolcs NAIDII and 1-5 mg protein. The activity 
was measured from decrease in absorbance, by OAA dependent N.1DH 
oxidation to NAD`, for 5 min at 340 nm. 
(iii) Alalic enjrne (VIE, E.G. 1. 1. 1.40): CIF, was assayed by the method of Ochoa et al. 
[1948]. The reaction mixture, in a total volume of 3 ml, contained 100 µmoles 
Tris-HCI, pH 7.4, 10 µmoles hlnCl,, 5 µmoles L-malic acid (pll adjusted to 
7.4), 0.24 tmoles NADP+ and 0.8-3 mg protein. The activity was measured 
from increase in absorbance, by the tnalic acid dependent reduction of NADP` 
to NADPH, for 5 nun at 340 nm. 
(iv) Glucose G phorphate deh3drogenare (GGPD, E.C. 1. 1. 1.49): G6PD was assayed by the 
method of Shonk and Boxer [1964]. The reaction mixture, in a total volume of 
3 ml, contained 50 mM Tris-HCI, pl1 7.4, 3.0 mMI %IgCl,, 3.3 mNI glucose 6-
phosphate, 2.2 m,%l NADP and 0.8-3.0 mg protein. The activity was measured 
from increase in absorbance, by glucose-6-phosphate dependent reduction of 
N.\I)P' to NAI)PH, for 5 min at 340 nin. 
(v) Iletokinase (11K, E.C. 2.7.1.1.): HK was assayed by the method of Crane and 
Sols [1953]. The reaction mixture in a total volume of I ml contained 50 µmoles 
Tris-HC1 buffer, pH 7.4, 2 µmoles KH2PO4, 10 µmoles MgCl., 5 µmoles .V1'P, 
2 }.!moles glucose and 1-1.5 mg protein. The reaction was incubated at 37 '' C 
for 1 h and stopped by the addition of 0.5 ml each of 10°4, ZnSO4 and 10% 
Ba(OIH),. The samples were centrifuged at 4000 rpm (Remi Centrifuge, 
Mumbai, India) and the remaining glucose was determined in the protein and 
phosphorylated derivatives free supernatant by the method of Nelson (1944] 
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using arsenomolybdatc reagent. A calibration curve was simultaneously 
prepared using standard solutions containing 5-45 µg of glucose. 
(vi) Glucose 4phoipbatare (G6P, C.C. 3.1.3.9): G6P was assayed by the method of 
Shull et al. [19561. The reaction mixture, in a total volume of 1.5 nil, contained 
50 µmoles This-HCI, pH 7.4, 10 gmnles MgC1,e 10 µtholes glucose 6-phosphate 
and 0.3-1.5 mg protein. The reaction was incubated at 37 " C and stopped after 
60 our by adding 1 nil of 10% TCA. The samples were centrifuged at 4000 rpm 
(Rehm Centrifuge, Mumbai, India) and Pi was determined in the protein free 
supernatant by the method of Taus6-y and Shorr [19531. 
(vii) Fm.¢ose 1, 6-hi phosphatare (FBP, C.C. 3.7.3.11): FBP was assayed by the method 
of Freedland and Harper X19591. The reaction mixture, in a total volume of 1.5 
ml, contained 50 µZnoles Tris-IICI pH 8.4, 10 µmoles MMgCl2, 12 pmoles 
cysteine-HCI, 10 µmoles fructose 1,6-bisphosphate, 0.3-1.5 mg protein. The 
reaction was done at 37 °C and stopped after 60 mm by adding I ml of 10% 
TCA. The samples were centrifuged at 4000 rpm (Rehm Centrifuge, Ihlumbai, 
India) and Pi released was determined in protein free supernatant by the 
method of Taurky and Shorr [19531 using ferrous ammonium molybdate as 
coloring reagent. 
(B) Assay ofacid phosphatase and total ATFase 
(i) Add pbagihatase (ACP, F,.C:. 3.(.3.2): The activity of lysosomal marker enzyme ACP 
was determined in corneal, medullary and intestinal homogenates by the method of 
Verlee [1969]. The reaction mixture contained 2.4 m1 of 50 mM sodium acetate 
buffer, pH 4.5 and 100 ii homogenate (30-150 hg protein). The reaction was 
started by the addition of 0.5 ml of 4.8 mlvl p-nittopbenll phosphate (final 
concentration 0.8 mM in 3 nil) and incubated for 15 min at 30°C. The reaction was 
stopped by adding 2 ml of 2 N NaOH. A calibration curve of known 
concentrations of p-nitrophenol (0.05-0.4 µtholes) was ptepared simultaneously. 
The yellow colour developed was read at 405 ram against a reagent blank. 
(u) To/al ATPare The total ATPase activity in cortical, medullary and intestinal 
homogenates was determined by the method of Kunkel et aL I1996 . The reaction 
mixture, in a total volume of 1.5 ml, contained 4.8 mM ATP, 120 mM NaCI, 24 
mM KCI, 72 mM MgCI,, 50 mM Tris-HCI, ph l 7.6 and 100 pl homogenate (30-i 5U 
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pg protein). The reaction mixture was incubated for 15 min at 37 " C and then 
terminated with 0.3 ml of 30 % '1'CA. The samples were centrifuged at 4,000 rpm 
(Remi Centrifuge, Niumbai, India) and Pi released was measured in protein free 
supernatant by the method of Tausky and Shorr [1953] using ferrous ammonium 
molybdate as coloring reagent. 
(C) Assay of marker enzymes of BBM: The BBM enzymes were assayed in IH, 
intestinal BBMV, CH, cortical BBMV and MH. 
(i) f1lkazine phoiphata.re (A', E.C. 3.1.3.1): The activity of AP was determined by the 
method of Shah e/ al. [1979] as modified by Kempson et al. [1979]. The reaction 
mixture contained 1.4 ml assay buffer (55 mil glycine, 36 mM NaCl and 45 
mM NaOH, ph i 10.5) and 100 pl H/ BBMV (25-50 pg protein for 
homogenates and 10-15 pg for BBMV). The reaction was started by adding 15 
j.11 of 0.6 N1 p-nitrophenyl phosphate (final concentration 6 mN[) and incubated 
at 37 "C for the required time (5-20 min). The reaction was stopped by adding 
50 W of 5 N NaOH. A calibration curve was prepared simultaneously by using 
solutions containing 0.01-0.2 }!moles of p-nitrophenol. The yellow colour was 
read at 405 nm against a reagent blank. 
(ii) y-Gemom}'/ tranfera.+e (GGT, E.C. 2.3.2.2): The activity of GGl' was determined 
by the method of Glossman and Neville [1972] as modified by Kcmpson et aL 
[1985]. The reaction was started by adding 100 jil H/ BBNIV (20-70 pg protein 
for homogenates and 10-15 µ.g for BBMV) to 1.9 ml substrate buffer (20 mM 
MgC1,, 2 mM y-glutamyl-p-nitroanilide, 4 mM glycylglycine, 100 mM Tris-base, 
pH 8.2) and incubated in a shaking water bath at 37 "C. After 30-60 min, the 
reaction was stopped by adding 100 µl of 1.5 M acetic acid. A calibration curve 
containing 25-200 timolesp-rtitroaniline was prepared simultaneously. The 
yellow colour developed was read at 405 nm against a reagent blank. 
(iii) L-I eii ine amthopeptidase (L=1P. I,.C. 3.4.11.2): The enzyme was assayed by the 
method of Goldmann et al. [1976]. The reaction was started by adding 100 pl 
H/BBMIV (50-70 µg protein for homogenate and 10-20 jig  for BBMV) to 1.9 
ml substrate buffer (50 mM sodium phosphate buffer, 4 mM NlgCl., 2.1 mNl L-
leucine p-nitroanilide, pH 7.2) and incubated at 25 "C for 15-30 min. The 
reaction was stopped with 100 pl of 1.5 M1 acetic acid. .% calibration curve 
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containing 25-200 nmoles p-nitroaniline was prepared simultaneously. 'I he 
yellow color obtained was read at 405 nm against a reagent blank. 
(iv) Sucru.ce (E.0 3.2.1.48,): Sucrase was assayed in IH/ IBBMMV by the method of 
Miller [1959]. The reaction mixture (0.3 ml) contained 50 t1 of 0.1 NI sodium 
maleate buffer, pH 6.0, 200 jil of diluted BBM or IH and 50 µl of 0.1 NI 
sucrose solution. The assay mixture was incubated at 37 °C for 10 min followed 
by addition of I ml of 3, 5-dinitrosalicylic acid reagent (1 g of 3,5-
dinitrosalicylic acid and 30 g of sodium potassium tartarate in 100 ml of 0.5 N 
NaOH) immediately followed by heating in a boiling water bath for 5-1 ) min. 
The tubes were cooled, 3 ml of distilled water was added and the colour was 
read at 540 nm against a reagent blank. A calibration curve was simultaneously 
prepared using known amounts of glucose (0.5-2.5 µmoles). 
(v) 3faltase (F.C; 3.2.1.20): Nialtase was assayed by the glucose oxidase-peroxidase 
method [Bergmeyer and Bernt, 1974]. This method consists of incubating the 
BBMIV or CI1/NIH with maltose and then measuring the glucose released upon 
hydrolysis. The reaction was started by addition of 15 µl H/ BHH1N (40-60 xtg 
protein for homogenate and 10-15 pg for BBMV) to 1 ml substrate buffer (56 
mM maltose in 0.04 \I phosphate buffer, pl I 6.5). Then 2.0  ml of assay reagent 
(1250 U of glucose oxidise, 250 U of peroxidase and 10 mg o-dianisidine in 100 
ml of 40 mM phosphate buffer, p'1 6.5) was added and incubated at 37 °C for 
30 min. The reaction was stopped by addition of 2 ml of 12 N H,SO4. A 
calibration curve of glucose (0.5-2.5 µmoles) was also prepared simultaneously 
and the color was read at 420 ncn. 
(D) In vitro inactivation of BBM enzymes by KBrO, 
BB\IV (protein concentration I mg/ml) in 50 mM sodium maleate buffer, pl-I 6.0 (for 
intestine) or 300 mM mannitol, 5 mM Tris—HCI buffer, pH 7.5 (for renal cortex) from 
control animals were incubated at 37 °C with 1 rnNI KBrO, in a total reaction volume of 
0.5 ml. At different times after the addition of KBrO,, aliquots were removed from the 
reaction mixture and assayed for the 1313MI enzyme activities by standard procedures 
given above. BBNIV samples kept on ice (and not incubated with KBrO,) served as 
control. 
(E) Assay ofAO enzymes: The tissue homogenates were centrifuged at 5,000 rpm for 
15 min at 4 °C and the supernatants were used for enzyme assays. The activities of 
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enzymes of the AO defence system were measured in the hemolysatcs and intestinal 
homogenates. 
(i) Supevxide dismutase (SOD, F.C. 1.15.1.1): SOD was assayed by the method of 
hiarklund and hfarklund [1974]. To 10 µ1 hemolysate or 80 µl of intestinal 
homogenate was added 2.9 ml of 1 mM EDTA-50 mM Tris-succinate buffer, 
pH 8.2 and incubated at 25 °C for 20 min. The reaction was started by adding 
0.1 ml of 8 mM pyrogallol (in 10 mNl HCI). The change in absorbance per 
minute was immediately recorded for the initial 3 min at 420 nm. A reference 
set, containing 0.08 m1 distilled water instead of sample solution, was also nin 
simultaneously. SOD was calculated in U/mg protein (One unit of SOIL is the 
amount which causes 50°'b inhibition of pyrogallol oxidation in a reaction 
volume of 3 ml). 
(ii) Calalase (CAT, E.C. 1.11.1.6): This enzyme was assayed by the method of Aebi 
[1984]. The assay mixture contained 1.95 ml of 50 mM potassium phosphate 
buffer, pH 7.0, 1 ml of 30 mM hydrogen peroxide and 0.05 ml homogenate or 
0.02 ml hemolysate in a final volume of 3 ml. The decrease in absorbance at 240 
nm was immediately noted after every 30 sec for 3 min. Enzyme activity was 
calculated using the molar extinction coefficient of H202 (43.6 NI' cm' at 240 
nm). 
(iii) Gin/alb/one pe~nudase ('GP-, E.C. 1.11.1.9): The activity of GPs was determined 
by the method of Flohe and Gunzler [1984]. The assay mixture contained 0.5 
ml of 1 m.11 EDTA-0.1 M potassium phosphate buffer, pH 7.0, 50 µl of 1 mM 
sodium azide, 50 pl of homogenate or 10 p1 hemolysate, 25 µl glutathione 
reductase (0.24 U) and 100 pl of 10 mho GSH. The mixture was pre-incubated 
for 10 min at 37 "C. Then 100 µl of 1.5 mM NADPH solution was added and 
the hydrogen peroxide independent consumption of NADPH was monitored 
for 3 min. The overall reaction was started by adding 100 µl of prewarmed 2.5 
mM hydrogen peroxide solution and the decrease in absorbance at 340 nm was 
monitored for 5 min. Enzyme activity was calculated using the molar extinction 
coefficient of NAPDH (6.22 x 103M 1 cm'). 
(iv) Thioredo.vin reductase (JR, E.C. 1.8.1.9): 'IR was assayed by the method of 
Tamura and Stadtman [1996]. The assay mixture of I ml contained 890 gI of 
50 mhi potassium phosphate-50 mM KCI-10 mil EDTA- 0.2 mg/ ml BS.1 
buffer, pH 7.0, 50 gl of 4.8 m.11 NADPH, 50 pl of 50 mM DYNB solution (in 
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absolute ethanol) and 50 pl of homogenate (50-100 .tg protein) or 25 µ1 
hemolysate (0.1-0.6 mg Fib). The change in absorbance at 412 nm was 
monitored for I min at 30 C. Since I mole of NADPII yields 2 moles of 
thionitrobenzoate, final absorbance was divided by 2 and the enzyme activity 
was calculated using the molar extinction coefficient of NAPDH (6.22 x 10; M' 
ctn'). 
(r) Glidathione-S-tranjferase (GST. L.C. 2.5.1.18): GST was assayed by the method of 
Habig et al. [1974]. The reaction mixture contained 1.65 ml of 0.1 `I sodium 
phosphate buffer, pI-I 6.5, 0.1 ml of 20 mM CTSH, 0.05 ml of 40 mM 1-
dichloro-2,4-dinitrobetvcnc (in ethanol) and 0.2 nil homogenate or 20 p1 
hemoirsate in a total volume of 2 ml. The change in absorbance at 340 nm was 
recorded and the enzyme activity calculated as nmole CI)NB conjugate 
formed/min/mg protein using a molar extinction coefficient of 9.6 x 10 lei 
'cm'. 
(vi) Glutatbione redmiase (GR. 1. (1. 1. 8. 1. 7): The activity of GR was assayed by the 
method of Carlberg and ;\(anner~•ik [1985]. The reaction mixture of I ml 
contained 100 pl of 10 mil oxidized glutathione, 50 pl of 2 m.Nl NADPII, 800 
pl of 0.5 niNI l:U'1'.\-U.1 M sodium phosphate buffer, p1 1  7.6. Then 100 .tl 
tissue homogenate (50-100 µg protein) or 5 µl hetnolysate (20-120 tg Eli)) was 
added to give a change in absorbance of 0.05 to 0.30 per min. The oxidation of 
1 µmole of N_1DPH/train/mg protein under these conditions was used as a 
unit of GR activity. l- nzvrne activity was calculated using the molar extinction 
coefficient of N.APD11 (6.22 x l0' \1'cm'). 
(vii)Xuntbine oviduse (XO, l.C. 1.17.3.2): The activity of XO in plasma was 
determined by the method of Bergmeyer el al. [1974]. The reaction mixture 
contained 1.9 nil of 50 mNI potassium phosphate buffer, pH 7.5, 1 ml of 0.15 
mNI xanthine, 0.1 ml plasma in a total volume of 3 ml. The change in 
absorbance at 290 nm was recorded and the enzyme activity calculated as 
nmoles uric acid formed/min/mg protein using a molar extinction coefficient 
of 1.22 x 10 NI'cm'. 
8. Parameters indicating OS 
The non-enzymatic parameters of OS were determined in various tissue homogenates, 
hcznolvsatcs and plasma. 
Materials and Metfwis 
(i) Reduced glutnthione (GSH): (7S1 I in hemolvsates and tissue homogenates was 
determined spcctrophotometrically by the method of follow el al. [1974]. To 
0.5 ml of tissue homogenate or hemolysate was added 0.5 ml of 4% 
sulfosalicylic acid. After incubation for 1 h at 4 °C, the mixture was centrifuged 
at 4,000 rpm for 15 nun to remove precipitated proteins. Then 0.2 ml 
supernatant was mixed with 1.1 ml of 0.1 M potassium phosphate buffer, pH 
8.0 and 0.2 ml of DTNB (4 mg/ml in 0.1 NI potassium phosphate buffer, pH 
8.0). After 20 min at room temperature the absorbance was read at 412 nm. A 
calibration curve with different amounts of GSH (10-85 nmoles) was prepared 
simultaneously to calculate GSH in the samples. 
(ii) 'I ota! S11 grouups Total SI-I groups were determined by the method of Sedlak and 
Lindsay [1968]. To 0.4 ml homogenate or 50 ;i1 hemolysate was added 2.1 ml of 
0.1 M Tris-HC1 buffer pH 8.2, 0.5 ml of 10% SDS and 0.3 ml of 0.1 MI EDT. 
The tubes were covered and placed in a boiling water bath for 5 min. After 
cooling to room temperature, 0.1 ml DTNB (40 mg/ 100 ml methanol) was 
added. The samples were left at room temperature for 30 min and the 
absorbance was read at 412 nm. A calibration curve containing different 
amounts of cvsteine (20-160 nmoles) was also constructed and used to calculate 
total SH groups in the samples. 
(iii) Protein o.v7dalion: Carbonyl content, a marker of protein oxidation, was 
determined by the method of Levine et al. [1990]. To 0.2 nil hemolysate or 
tissue homogenate was added 0.2 ml of 20% TCA and left on ice for 10 min. 
The mixture was centrifuged at 12,000 rpm for 10 min and the protein pellet 
was mixed with 0.5 ml of 10 m.%f 2,4-dinitrophenv i hydrazine (in 2 N HCI) and 
left at room temperature for 1 h. Then 0.5 ml of 20° o TCA was added and the 
mixture was centrifuged again at 12,000 rpm for 3 min. The supernatant was 
discarded and the pellet was washed three times with ethanol:ethvl acetate (1:1) 
solution and each time centrifuged at 12,000 rpm for 5 min. The protein pellet 
obtained after this washing was solubilized by resuspending in 1 nil of 6 NI 
guanidine HC1 solution and kept at 37 °C for 30-60 nun. The samples were 
again centrifuged at 12,000 rpm for 3 min and the absorbance of supernatant 
was read at 360 nm against a reagent blank. 'I he carbonyl content was calculated 
using a molar extinction coefficient of 22 x 10 NI' cm'. 
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(iv) Lipid pero idation (LPO): I.PO was determined from malondialdehyde (an end 
product of LPO) content by the method of Beuge and .dust [1979]. The tissue 
homogenates or hetnolysates were made to 1 ml with distilled water and 2 ml of 
coloring reagent (15% trichloroacetic acid, 0.01% butylated hydroxytoluene and 
0.375°0 thiobarbituric acid in 0.25 N HCl) was added . The tubes were covered 
and incubated for 1 h in boiling water bath. .After cooling to room temperature 
and centrifugation at 10,000 rpm for 10 min to remove precipitated proteins, 
the absorbance of supernatant was read at 535 nm against a reagent blank. 
Malondialdehyde content was calculated using a molar extinction coefficient of 
1.56 x 10 Ill' cm. 
(v) F ydrooen pero.\ide (f -  1,n_): 11,0, levels were determined in various tissues and 
hcmolysatcs by the method of Gay and Gcbicki [2000]. To 0.1 ml hemolysate 
or tissue homogenate was added 340 distilled water and 660 µl of coloring 
reagent (37.5 mill H,SO4, 150 mNl sorbitol, 225 1tM xylenol orange and 375 .tM 
ammonium ferrous sulfate). The reaction was incubated at room temperature 
for 30 min and the colour was read at 560 nm. A calibration curve of H2O, was 
also prepared simultaneously. 
(vi) \-itiir oxide (.\O): NO is unstable with a very short half-life and is rapidly 
converted to nitrite and nitrate. Nitrate is first reduced to nitrite and total nitrite 
is then determined spectrophotonletrically by Grciss reagent. Nitrite in 
deproteinized hemolysates and plasma was measured by the method of Miranda 
et al. 12001]. The samples were first deproteinized by the following procedure. 
To 120 µl sample was added 80 µl of 75 mil ZnSO, and centrifuged at 12,000 
rpm for 5 min at room temperature in a microfuge. The supernatant (200 µl) 
was mixed with 120 tl of 55 mM NaOH and recentrifuged at 12,000 rpm for 5 
min. To 150 tl supernatant, 50 µd distilled water was added followed by the 
addition of 200 µd vanadium chloride (0.4 g in 50 ml of I N HCI), to reduce 
nitrate into nitrite, followed by 80O µ1 Grciss reagent 13.86 mM N-(1-
naphthyl)ethylenediatnine dihydrochloride (O.lg/100 ml distilled water) and 58 
mM salfa1Hilamide (1g in 5°„ o-phosphoric acid)]. The reaction mixture was 
incubated in dark at room temperature for 30 min and the absorbance was read 
at 540 nm against a reagent blank. A calibration curve with different amounts 
of sodium nitrite (1-15 nmoles) was also prepared simultaneously. 
52 
Materials and ~l-fethods 
(vii) I itamin C (VC): VC in deproteinized plasma samples was determined by the 
method of Omaye et al. [1979]. Briefly, 0.5 ml plasma was mixed with 0.5 ml of 
100 TC A, left at room temperature for 10 min and centrifuged at 3500 rpm for 
20 min. Then, 0.5 ml of supernatant was mixed with 0.5 ml distilled water, 0.1 
ml of DTC solution (3 g of 2,4-dinitrophenyl hydrazine, 0.4 g thiourea, and 0.05 
g CuSO4 in 100 ml of 9 N H2SO4) and incubated for 3 h at 37 °C. After the 
addition of 0.75 ml of 65" o H,SO4 the tubes were left for 30 min at room 
temperature. The absorbance was read at 520 nm against a reagent blank. A 
calibration curve of `'C (0.6-6 nmolcs) was also prepared simultaneously. 
9. Assay of AO status 
The AO status of hcmolysatcs and plasma was assayed by the ferric reducing/antioxidant 
power (FRAP) and 2,2-diphcnvl-1-picrylhydrazyl (DPPI1) assays. 
(i) FRAP assay The FRAP assay was done as described by Benzie and Strain [1996]. In 
this assay 50 µl of hemolysate or 10 µl plasma was mixed with 1.5 ml of pre-warmed 
FRAP reagent (20 mM FeCI3, 10 mM 2,4,6-tripvridyl-s-triazine, 30 m\1 sodium 
acetate buffer, pH 3.6). After 4-5 min at room temperature the absorbance at 593 nm 
was recorded. An aqueous solution of ferrous sulfate (0.1-10 µmoles) was used as the 
standard. 
(ii) DPPH aJsa): The DPPH reduction assay was done by mixing 20 µl of hemolysate or 
10 µl plasma with 480 µl of 10 mMI sodium phosphate buffer pl  7.4, followed by 
addition of 500 µl of 0.1 m.'M1 solution of DPPH in methanol Uanaszewska and 
Bartosz, 2002]. Another tube containing 500 µl DPPH and 500 µl buffer was taken 
as reference. The mixtures were incubated at 21 °C for 30 min and then centrifuged 
at 12,000x g for 10 min. Absorbance of the supernatants was read at 517 nm against 
a blank containing sodium phosphate buffer only. A low absorbance of the reaction 
mixture indicates a high free radical scavenging activity. The percent quenching of 
DPPH was calculated by the formula: 
reference— test 
% quenching of DPPH = 	 )XIOO  
reference 
53 
Materials an I Methods 
10. Methemoglobin and methemoglobin reductase in hemolysates 
(i) .IIc'ihenno~/obis (\Deli Ib) la..'e/S MetHb levels were determined from the absorbance of 
hemolvsatcs at 540, 576 and 630 nm and expressed as \IctHbx 10 moles/ litre 
[Benesch etal. 1973]. The MetHb levels were calculated using the following equation: 
[Mctl lb] = [2.985A(,,+0. 194A576 -0.4023A] X 10 ' 
(ii) Methem o Tobin /Y!lih'/a.u' (.IIetf IGR, !..C. 1.6.2.2.): The activity of MetHbR in hemolvsates 
was determined by the method of Kama el al. [1972]. The reaction mixture contained 
2.6 ml distilled water, 0.1 ml of 10 m:`I EI)TA, 0.05 ml of 1.2 mM 2,6-
dicholorophenolindophcnol, 0.05 ml of 1.0 M '1'ris-HCI, pH 7.5 and 0.1 ml 
hemolvsate. This solution was first incubated at 25 "C for 5 train and the reaction was 
started by adding 0.1 ml of 4 mM NA 1)1 I solution. I he activity was measured by 
following the decrease in absorbance at 600 ram for 5 min. A molar extinction 
coefficient of 22 x 10' `1' cm for 2,6-diehhropKenolindophenol was used. 
11. Protein and hemoglobin (Hb) determination 
Protein was measured by the method of Lo~v ry et a/. [1951!. The samples were made to 
1.0 nil with double distilled water. Then 5 ml of alkaline copper reagent (1 ml of 1°'„ 
CuSO4, 1 nil of 2° sodium potassium tartarate, 3-4 pellets of NaOH and 2 g of Na_.0O3 
in 100 ml of distilled water) was added and after 10 min at room temperature, 0.5 ml of 1 
N Folin's reagent was added with brisk shaking and incubated for 30 train at room 
temperature. The blue colour obtained was read at 660 nm. A calibration curve of BSA 
was prepared simultaneously. Ilb in hemolysates was determined by Drabkin's reagent 
using kits from Crest Biosystems (Goa, India). 
III. STATISTICAL ANALYSIS 
Unless specified, all animal experiments were done at least three times to document 
reproducibility. All data are expressed as mean±Sl..:NI. Significance of difference in mean 
values were evaluated using either one-way analysis of variance (_NOVA) followed by 
Post-Hoc tests for comparison between two mean values using Origin Software (USA). 
A probability level of P< 0.05 was selected as indicating statistical significance. Most of 
the changes between various gro)ulp, \\rrc co)mupared with control values for better 
understanding and clarity. 
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Effect of potassilini broniate on human  (111(d rat 
blood and protection by some anti-oxidants: 
in vitro and in vivo studies 
Publications from part I 
Ahmad MK, _lmani S. '\lahmood R (201 1) Potassium bromate causes cell Ivsis and 
induces oxidative stress in human cru- thrc>c%- tcs. (iiiuQp l o.viol1)()I: 10.1002/tn v 2O7St) 
Ahmad MK, \lahmood R (2012) Oral administration of potassium bromate, a major 
water disinfection byproduct, induces oxidative stress and impairs the antioxidant power 
of rat blood. (.hemoiphe' 7:50-56. 
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PART-IA 
EFFECT OF 
	
ON HUMAN ERYTHROCYTES AND PROTECPION BY 
KNTI-OXIDANTS: IN VITRO STUDY 
Experimental design., The effect of different concentrations of KBrO, on human 
erythrocytes was first determined. Human erythrocytes were incubated with 0, 0.1, 0.5, 
1.0, 2.5, 5.0 and 10.0 mM KBrO, for 60 min at 37 °C. They were then pelleted by 
centrifugation, washed with PBS and hemolysates prepared as described under 
"Methods" section. The hemolysates were assayed for various parameters. 
In the next experiment, the protective effect of GSH, \'C and taurine against erythrocyte 
changes induced by 1 mM KBrO, was studied. This concentration of KlirO, was selected 
in protection studies since the above experiment with different concentrations showed 
that treatment of erythrocytes with I mM KBrO, resulted in significant changes in all the 
parameters studied. Erythrocytes were incubated with 1 mn.\l KBrO3 either alone or in 
presence of different concentrations of VC, GSH or taurine for 60 min at 37 °C. The 
erythrocytes were pelleted, washed and hemolysates prepared as described in ":Methods" 
section. Erythrocytes incubated with VC, GSH or taurine alone were also used while 
untreated erythrocytes served as control. 
Results 
Several parameters were determined in hemolvsatcs prepared from: 
(i) erythrocytes treated with different concentrations of ItlirO, and 
(ii) erythrocytes treated with I ml KBrO, in presence or absence of VC, GSH or 
taurine. 
In both cases hemolysates from untreated erythrocytes served as control. 
1. Generation of reactive oxygen species (ROS) 
The intracellular formation of ROS was determined by using 2,T-
dichlorodihydrofluorescein diacetate (DCIFH-DA). This non-fluorescent probe diffuses 
freely across the cell membrane and is hydrolyzed by intracellular esterascs to I)CFH. In 
the presence of ROS, the 1)Cl l I is rapidly oxidized to the highly fluorescent DCFF. The 
fluorescence intensity is proportional to the ROS generated. This assay is extensively 
used to detect both intracellular and extracellular production of ROS. Frvthrocvtes were 
first loaded with the probe and, after removal of e%tracellular I CI H DA, they were 
treated with different concentrations of KBrO,. Fluorescence measurements showed 
increased ROS production in KlirO treated en.throcytes, with a dramatic increase in 
fluorescence between 5 and 10 ni\1 [Figure 11. 
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Figure 1: Intracellular ROS production. Erythrocytes at 3°%o hematocrit were incubated with 10 
µ1i DCI IF-DA for 1 h at 37 °C, centrifuged and washed with PBS. The RBC pellet 
was resuspended in PBS to get %'o hematocrit and then treated with different 
concentrations of KBrO3. After 15 min the fluorescence intensity at 530 nm was 
measured on a spectrofluorometer using an excitation wavelength of 485 nm. 
Results are mean±SEM of six different experiments. 
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2. Hemolysis 
Erythrocytes were incubated at 37 °C for I h with different concentrations of KBrO. 
Untreated en-throcytes were also incubated at 3 °C and used as controls. l lemolvsis of 
crythrocytes releases hemoglobin (fib) in the medium which absorbs at 540 nm. Samples 
were centrifuged and the absorbance of supernatant,; was recorded at 5.10 ntn. KBrO, 
untreated erythrocytes, which were not incubated at 37 °C, were completely lysed by 
distilled water and used as reference (l00° 0 hemolvsis). There was a marked increase in 
hemolysis of erythrocytes with increasing concentration of KBrO, (Figure 21. This must 
have been due to erythrocyte membrane damage caused by KBrO,. 
In the next step, erythrocytes were incubated with 1 mM KPn(), and different 
concentrations of GSH, \'C and taurine. Untreated crvthrocytss were also incubated at 
37 °C and used as controls. There was marked hemolysis induced by KRrO alone but 
the presence of either GSH, VC or taurine protected them from this KBrO, induced 
damage. VC was more effective in protecting erythrocytes from hemolysis induced by 
KBrO, followed by GSH and then taurine [Figure 31. 
3. Methemoglobin (MetHb) levels and methemoglobin reductase (MetHbR) 
activity 
NIetHb is formed when the iron of Ill) in ferrous form is oxidized to the ferric form. 
There was a tremendous increase in \Ietl lb levels as the concentration of KBr03 was 
increased. Even at the lowest KBrO , concentration (0.1 m\I) the \Ietl ib level was 
almost four times the control value. The activity of '.\Ictl-IUR was then determined. This 
enzyme converts NlctYlb back to Ilb by reducing ferric to ferrous form and uses NADH 
as cofactor. The increase in ,MetHb level was accompanied by a corresponding increase 
in NletHbR activity [Table 1 J. Simultaneous treatment of erythrocytes with varying 
concentrations of either GSH, taurinc or \'C significantly abrogated the KBrO;-induced 
alterations in Merl lb level and MetHbR activity. Treatment with (1sF1, VC and taurine 
alone did not significantly alter either of these two parameters [fable 21. 
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Figure 2: Hemolvsis of erythrocytes with different concentrations of KBrO3. 
Results are mean±SFMM of six different experiments. 
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Figure 3: Effect of GSI1, VC and taurinc on KBrO;-induced hemolysis in envthrocytes. 
Results are mean±SJ Nf of six different experiments. 
I: control; II: 1.0 mM KBrOi alone, III: 3.0 mitt (;SI I alone; IV: 1.0 mNl GSI I+1.0 mM K.BrO ; 
V: 2.1) mM (S1 l+1.0 mM KBrO;; VI: 3.0 mNf GSH+1.0 mM KBrO:; VII: 3.0 mM \"C alone; 
VIII: 1.0 mkt V'C+1.0 mM KBrO3; IX: 2.0 m\f \'C+I.0 mkt KI3r0;; X: 3i) mM V(:+1.0 rnNf 
KBrO , XI: Si) m\l taurinc alone; XII: 1.0 m\1 taurine+ 1.0 mitt KBrO;; XIII: 2.5 mM 
taurine+ 1.0 mM KBr(>:; XIV: Si.) mM taurine+ 1.0 mM KBr0 
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Table 1: Effect of K13rO, on \IetHb levels and :%IetHbR activity-. 
Control 	0.1 mM 	0.5 m\I 	1.0 m3I 	2.5 rnM 	5.0 mkt 	10.0 m\t 
Merl lb 	0.95±0.07 	3.68±0.13* 	4.73±0.45' 	6.15±0.24 	6.88±0.49* 	8.16±0.86* 	11.2±1.05* 
\IctHbR 1.V6±0.15 2.78±0.30' 3.15+0.41 3.88±0.22' 5.34±0.54' 7.25±0.62* 9.63±0.87* 
Results are mean±SENI of six different experiments. 
MetHb level is in moles/litrex 10 4 and MetHbR activity is in nmoles/mg protein/min. 
* Significantly different at p<0.05 from control. 
Nictl Ib, tnethemoglobin; Mfetl lbR, methernoglobin reductase. 
Table 2: Effect of GSH, VC and taurine on KBrO,-induced changes in MetHb levels 
and Nicti 1bR activity. 
Met! lb Mct1 lbR 
Control 0.92±0.05 2.01±0.08 
KBrOs alone (1.0 m\I) 6.08±0.19' 4.07±0.22* 
GSH alone (3.0 m\I) 0.93±0.05 1.98±0.04 
GSH (1.0 m.\i)+KBrCt3 (1.0 m\1) 5.84±0.17' 3.89±0.14' 
GSH (2.0 m\l)+KI3r03 (1.0 m\I) 3.12±0.13" 3.41±0.12• 
GSI I (3.0 rnN)+KBrOi (1.0 m.\t) 1.98±0.11' 2.74±0.11' 
\'C alone (3.0 cnMI) 0.94±0.06 2.05±0.09 
VC (1.0 m_\I)+KBrO3 (1.0 m.\I) 5.04±0.17* 3.81±0.22' 
VC (2.0 m.\I)+KBrO3 (1.0 m\f) 2.21±0.11' 2.94±0.12• 
VC (3.0 m\i) 4 KBr03 (1.0 m.\1) 1.15±0.07* 2.37±0.11' 
Taurinc alone (5.0 m\I) 0.94±0.06 2.08±0.09 
Taurine (1.0 m,\i)+KBrO3 (1.0 m:\i) 5.91±0.18' 3.95±0.17* 
Taurine (3.0 m.\1)+KBr03 (1.0 mil) 4.01±0.14* 3.36±0.15' 
Taurine (5.0 m.\Q+KBrO (1.0 nn-N) 2.37±0.09' 2.81±0.12' 
Legend same as in Table 1. 
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3. Parameters of OS 
AO status is a potential biomarker for determining the physiological state of the cell, 
tissue or organ. The ROS generated under conditions of OS can cause increase in I.PO, 
protein oxidation as well as oxidation of protein and non-protein (mainly GSH) 
sulfhydryl groups. These parameters were determined in hemolysates. Incubation of 
erythrocytes with KBrO3 increased the carbonyl content (a measure of protein oxidation) 
in a concentration dependent manner [Table 3]. At 5 and 10 m\f KBrO, the carbonyl 
content was more than four times the control value. 'There was a significant increase in 
malondialdehydc (KIDA) production (an index of lipid peroxidation) after treatment of 
erythrocytes with 0.1 nM KBrO,. At higher concentrations, the MIDA content was more 
than six times the untreated control. KBrO y treatment of erythrocytes led to decrease in 
total sulfhydu-1 (SH) content of hemolysates. A significant reduction in SI-I content was 
seen at 0.1 mMI KBrO, followed by further decrease at higher concentrations. There was 
also a marked increase in H20,, an ROS, levels in hemolysates with increasing 
concentration of KBrO3 [Table 3]. 
These KBrO3-induced changes were significantly attenuated by the presence of GSH, 
VC or taurine in the reaction [Table 4]. Incubation of erythrocytes with GSH, VC or 
taurine alone did not significantly alter any of these parameters and thus these 
compounds do not change the AO status of the cell and also do not induce oxidation of 
cellular components. The above results show that GSH, VC and taurine protect the 
erythrocytes against KBrO, induced OS and consequent oxidation of lipids and proteins. 
VC was more effective than GSH and taurine in protecting human erythrocytes against 
KBrO3-induced OS. 
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Table 3: 	Effect of KBr0 on some parameters of oxidative stress. 
Control 0.1 mM 0.5 mM 1.0 mM 2.5 mM 5.0 rnMI 	10.0 mM 
SID.\ 	0.88±0.04 1.65+0.11 2.73±0.39* 4.85+0.45' 5.25±0.54* 5.91±0.56' 	-.14±0.48* 
Carbonvl 	4.89±0.21 ,.25±0.58' 8.56±0.86* 8.88±0.75* 13.65±1.42' 18.96±1.51` 	23.4±1.95* 
Total Sf 1 	6.14±0.18 4.32+0.21' 4.01±0.11' 3.87±0.25* 3.56+0.14' 2.94±0.19* 	1.89+_0.12* 
11202 	220.12±10.1 281.6±12.13` 309.15±11.8' -2.1+13.4' 405.3+15.1* 618.3±18.7' 	731.6+16.4' 
Results are mean±SEMI of six different experiments. 
\1DA, carbonyl content and H202 are in nmolcs/mg protein while total SII is in lrmolcs/mg 
protein. 
* Significantly different at p<0.0S from control. 
MD.\, malondialdehyde; SI I, sultliydry l; I I-,O" hydrogen peroxide. 
Table 4: Effect of GSH, VC and taurine on KBrO -induced changes in some 
parameters of oxidative stress. 
MDA Carbonyl Total SI I H202 
Control 0.89±0.04 4.66±0.19 6.41±028 212.14±7.14 
1'RrOi alone ;1.0 mM) 5.97±0.22* 851±0.32* 3.98±0.17* 368.72±11.24* 
GSH alone (3.0 mM) 0.91 ±0.05 4.37±0.18 6.55±0.31 198.14±6.85 
(S11 (1.0 m\1)+KBrO3 (1.0 mM) 5.47±0.19* 7.73±0.29* 4.36+0.19' 324.27±10.76* 
GSI-I (2.0 m.\l)+KBrOi (1.0 m\I) 3.51±0.14* 6.59±0.24* 5.15±0.17* 292.64±9.47* 
(,Sl1 (3.0 m\f'j+KBrO3 (1.0 m\I) 2.07+0.11* 5.88±0.18* 5.86±0.18* 264.24±9.18* 
\-C alone (3.0 mM) 0.92±0.04 4.71±0.14 6.86±0.31 204.35±7.56 
VC (1.0 m\I)+KBrO3 (1.0 mM) 5.15±0.18* 7.16±0.31* 4.76±0.19 315.6±10.01* 
VC (2.0 m-Nl)+KBr0ti (1.0 m\f) 2.94±0.14" 6.15±0.25'* 5.96±0.21 266.31±9.15* 
VC (3.0 m\1)+KBrO} (1.0 mM) 1.22±0.08* 5.05±0.19* 6.08±0.24 234.69±8.24' 
I'aurine alone (5.0 mM) 0.91±0.06 4.58±0.15 6.48±0.29 210.72±8.68 
Taurine (1.0 m-\l)+I13r03   (1.0 mM) 5.86±0.19' 7.89±0.2?* 4.24±0.17* 348.07±10.22' 
Taurine (3.0 m.\i)+K13r03 (1.0 mM) 3.74+0.14` 6.74±0.25* 5.09±0.18' 301.62+_9.14' 
Taurine (5.0 m_\i)+KBr0 (1.0 rn-\I) 2.19±0.08' 5.92±0.19* 5.69±0.16' 21.53±8.89' 
Legend same as in Table 3. 
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4. AO enzymes 
The scavenging of highly potent superoxide radicals and their conversion to water 
depends upon the activities of SOD and C.T. These enzymes were differently affected 
when erythrocytes were incubated with KBrO3. "I'he activity of SOD increased while 
CAT activity decreased after treatment of erythrocytes with KBrO,. The activities of 
G6PD, GPx, GR, and TR declined while the activity of GST was significantly enhanced 
upon treatment of erythrocytes with KBrO, [Table 51. 
In the next step, the effect of GSH, VC and taurine on KBrO -induced alterations in the 
activities of these enzymes was determined in hemolysates [fables 6, 7]. The results 
showed that the KBrO3-induced changes in AO enzymes were significantly attenuated by 
GSH, VC or taurine. Thus, there is marked protection by these antioxidants against 
KBrO,-induced alterations in the cellular AO defence system of human erythrocytes. VC 
was more effective than GSH and taurine in protecting against KBrO,-induced changes 
in the activities of these AO enzymes. 
5. FRAP and DPPH assays 
The intracellular AO power of erythrocytes was assayed by the ferric 
reducing/antioxidant power (FRAP) and 1,l-diphenyl-2-picrylhydrazyl radical (DPPII) 
reduction assays. FRAP assay uses AO in the sample as reductants that convert ferric to 
ferrous form. The ferric reducing activity in KBrO3 treated erythrocytes was decreased 
when compared to untreated controls [Table 8]. The free radical scavenging activity of 
hemolysates was determined by the DPPH reduction assay. DPPH gives a stable colored 
free radical in solution that is decolorized upon quenching. 1'he quenching of DPPH 
radical was less in hemolysares from KBrO3 treated erythrocytes as compared to control 
[Table 81. The results of these assays show that the metal reducing and free radical 
quenching power of erythrocytes is compromised upon treatment with KBrO,. 
The presence of GSH, VC and taurine greatly reversed the decrease in AO power that 
resulted upon treatment of erythrocytes with KBrO, [Table 91. The ability of erythrocytes 
to scavenge free radicals and reduce metal ions (Fe'- to IFe`') was restored to a great 
extent by these three AO. VC was more effective than GSH and raurine in ameliorating 
the changes in FRAP and DPPH values induced by KBrO,. 
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Table 5: F.ffect of KlirO, on the activities of some anti-oxidant enzymes. 
Control 0.1 mM 0.5 mM 1.0 m\I 2.5 m11 5.0 m\1 10.0 mM 
CAT 10.2±0.65 7.52±0.47' 5.84±0.161 5.01±0.22 4.71±0.18* 3.68±0.15* 3.15±0.17* 
SOD 69.2±3.04 106.3±6.22-  116.4±6.71-  123.8±7.03* 131.5±8.15* 144.5±7.94* 156.24±9.58* 
GST 0.54±0.05 0.84±0.09• 0.98±0.07' 1.18±0.11' 1.35±0.191 2.49±0.18* 3.56±.0.25* 
GR 11.5'±0.-5 8.69±0.41` 7.12±0.18* 6.73±0.24* 5.37±0.11* 2.85±0.11* 1.35±0.09* 
G6PD 2.98±0.16 1.34±0.07 1.01±0.14' 0.85±0.14 0.74±0.15• 0.62±0.08* 0.48±0.07* 
GPx 21.19±1.36 11.01±1.191 9.52±1.05 7.63±1.01* 7.01±0.86* 5.01±0.55* 2.12±0.15* 
TR 6.27±021 5.68±0.18' 4.T±0.45 3.59±0.29* 2.84±0.22* 2.05±0.31* 1.51±0.19* 
Results are mean±SEM of six different experiments. 
Specific activity of SOD is in units/mg protein (One unit is the amount which causes 50°o 
inhibition of py-rogallol oxidation in a reaction volume of 3 ml). 
Specific activities of CAT, GST, GR, G6PD, GPx, and 'IR are in nmoles/mg protein/min. 
* Significandc different at p<0.05 from control. 
CAT, catalase; SOD, Cu-7.n superoxide dismutase; GST, gletathionc-S-transferase; GR, 
glutathione reductase; G6PI), glucose 6-phosphate dchydrogenase; GPx, glutathione peroxidase; 
TR, thioredoxin reductase. 
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Table 6: Effect of GSH, VC and taurine on KBrO3-induced changes in the activities of 
Cu-Zn-superoxide dismutase, catalase and glutathione S-transferasc. 
SOD 	 CAT 	 GST 
Control 65.64±3.86 11.04±0.33 0.61±0.08 
KBr03alone (1.0 m\I) 118.01±7.22* 5.29±0.17" 1.35±0.13* 
GSI I alone (3.0 m.\1) 66.73±4.01 12.14±0.33 0.68±0.09 
GSH (1.0 mMi)+KBrO3 (1.0 mti!) 101.42±6.24' 6.41±0.17* 1.22±0.12* 
GSH (2.0 mM)+KBrO3 (1.0 mM) 89.74±5.66* 7.88±0.22 1.08±0.11* 
GSH (3.0 m\i)+KBrOi (1.0 mM) 75.48±4.12' 9.92±0.31* 0.91±0.09* 
VC alone (3.0 mM1) 67.32±4.18 13.05±0.42* 0.68±0.07 
VC (1.0 mM)+KBrO3 (1.0 m-\I) 98.54±6.79' 6.86±0.27* 1.15±0.11' 
VC (2.0 rnNf +KBrO3 (1.0 m\I) 80.42±4.27* 8.94±0.29* 1.01±0.08* 
VC (3.0 m.\1)+KBrO3 (1.0 m\M 69.28±3.47 10.28±0.31* 0.81±0.07* 
Taurine alone (5.0 m'\i) 64.97±3.74 11.46±0.29 0.65±0.05 
Taurine (1.0 niN)+KBrO3 (1.0 m-M1) 109.81+7.06' 6.23±0.22* 1.25±0.11* 
Taurinc (3.0 mJM+KBrO.3 (1.0 m_\1) 92.34±5.91* 7.56±0.29* 1.09±0.09* 
Taurine (5.0 mM1)+KBrOi (1.0 cn_\i) X7.02±4.48* 9.27±0.31' 0.96±0.06* 
Results are mean±SCSI of six different experiments. 
Specific activity of SOD is in units/mg protein (One unit is the amount which causes 50% 
inhibition of pyrogallol oxidation in a reaction volume of 3 ml). 
Specific activities of CAT and GST are in nmoles/tng protein/min. 
*Significantly different at p<0.05 from control. 
CAT, catalase; SOD, Cu-Zn superoxide dismutase; GST, glutathione-S-transferase; 
Table 7: l affect of GSH, VC and taurine on KBrO,-induced changes in the activities of 
glutathione reductase, glutathione peroxidase, glucose 6-phosphate 
dchydrogenase and thiorcdoxin reductase. 
GR 	 GPx 	G6PD 	TR 
Control 13.47±0.45 22.41±1.86 3.05±0.24 6.54±11.41 
KBrOj alone (1.0 m\I) 6.11±0.21' 8.29±0.47' 0.88±0.07' 3.78±0.24* 
GSII alone (3.0 m,\I) 14.01±0.48 23.04±1.91 3.11±0.27 6.88±0.43 
GSH (1.0 m\i)+KBrO+ (1.0 m\f 7.84±0.32* 12.37±0.46* 0.98±0.08* 4.27±0.28* 
GSH (2.0 m.\I)+KBrO3 (1.0 m\I) 9.8+0.36* 16.74±0.51' 1.47±0.09' 5.05+0.31' 
GSH (3.0 m\i)+KBrO3 (1.0 m.\I) 11.69±0.39* 19.01±0.56* 2.74±0.11' 6.04±0.33 
VC alone (3.0 m.\M 14.15±0.44 22.68±1.77 3.18±0.29 6.98±0.45 
VC (1.0 m\M +-KBrOti (1.0 m_NI 8.43±0.34' 13.41±0.57' 1.09±0.09' 4.63±0.34' 
VC (2.0 mJI)+KBrO, (1.0 m.\1) 10.16±0.38' 16.04+0.61' 2.55±0.11' 5.42±0.37' 
VC (3.0 m\i)+KBrOi (1.0 rnNo 12.14+0.41' 20.15±1.01 3.01±0.19 6.24±0.39 
Taurine alone (5.0 mM) 13.84±0.44 22.57±1.81 3.14±0.27  6.62±0.42 
Taurine (1.0 mM)+KBrOi (1.0 mMI) -.41±0.29* 11.84±0.33' 0.92±0.08' 4.15±0.29* 
Taurine (3.0 mMM+KBrOi (1.0 mM1) 9.08±0.31 * 15.71±0.46' 1.29±0.11' 4.89±0.36` 
Taurine (5.0 mMM+KBrO3 (1.0 mMf) 10.86+0.33* 18.69+0.55* 2.32±0.12` 5.76±0.38" 
Results are mean±SEM of six different experiments. 
Specific acuvities are in nmoles/mg protein/min. 
* Significantly different at p<0.05 from control. 
GR, glutathione reductase; G6PD, glucose 6-phosphate dehvdrogenase; GPs, glutathione 
peroxidase; TR, thioredosin reductase. 
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Table 8: Effect of KBr(_), on antioxidant power of erythrocytes as determined by /anti 
and DPPH assays. 
Control 	0.1 mM 	05 mM 	1.0 mM 	2.5 mkt 	5.0 mM 	10.0 mM 
FRAP 	1.95±0.18 	1.31±0.12' 	1.01±0.07' 	0.86±0.09* 	0.71±0.06' 	0.56±0.04* 	0.43±0.07' 
DPPI-{ 57.6±3.35 48.2±1.0" 43.24±1.65 37.5±1.90* 29.8±2.11 19.16±1.59' 16.4±1.48' 
Results are mean±Sl N1 of six different experiments. 
FRAP results are in units/mg protein while DPPH results are shown as percent quenching of 
DPPI I radical. 
*Significantly different at p<O.05 from control. 
FRAP, ferric reducing/antioxidant power; DPPI I, 2,2-diphenyl- I -picrt lhy drazt 1. 
Table 9: Effect of GSH, VC and taurine on KEit:0 induced changes in antioxidant 
power of en•throcvtes as determined by FRAP and DPPH assays. 
FRAP 	 DPPH 
Control 2.i 11 ±0.1 F 58.01 ±4.45 
KBrOjalone (1.0 m\1) 0.91±0.08` 37.46±3.14' 
GSH alone (3.0 m\1) 2.14±0.19 61.19±4.84 
GSH (1.0 m\M+KBrO3  (1.0 m-\1) 1.01±0.09" 42.67±3.22' 
GSII (2.0 m\[)+KPrOj  (1.0 mMM 1.35±0.11` 48 29±3.6„ 
GSH (3.0 m\1)+KBrO3  (1.0 mM) 1.88±0.12 52.07±3.81 
\•C alone (3.0 m\1) 2.27±0.14 62.19±4.14 
\'C (1.0 m'\f)+K13rOi (1.0 mM) 1.15±0.09' 45.23±3.25* 
\'C (2.0 m\I)+K13rOi (1.0 mM) 1.64±0.11* 49.11±3.74 
VC (3.0 mM)+K13rOi (1.0 mM) 1.96±0.12 54.27±4.01 
Taurine alone (5.0 mil) 2.11+0.13 60.47±4.58 
Taurine (1.0 m\I)+KBrO3 (1.0 m\1) 0.98+0.09' 40?8±3.23' 
Taurine (3.0 mM +KBrO, (1.0 mM)  1.15+0.11' •15.71±3.81" 
Taurine (5.0 m.\l)+K13rOz (1.0 mM) 1.53±0.12* 49.97±4.11' 
Legend same as in Table 8. 
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PART-IB 
EFFECT OF KBrO3 ON RAT BLOOD AND PROTECTION BY VITAMIN C 
AND TAURINE: IN VIVO STUDY 
Experimental design: The effect of single oral dose of KBrO, on rat blood was first 
studied and the duration at which maximum effect is seen was determined. Animals were 
given a single oral dose of KBrO, at 100 mg/kg body weight and then sacrificed 12, 24, 
48, 96 and 168 h later. Control animals did not receive any KBr(-);. 
The protective effect of VC and taurine on KBrO, induced changes in rat blood was 
then determined. Animals were pre-treated with V'C or taurine, then given single dose of 
KBrO~ (100 mg/kg body weight) and sacrificed 48 h later. This time was selected since 
the first experiment showed that KBrO3-induccd changes were maximum 48 lir after 
administration of this compound. There were six groups of rats in this experiment (i) 
untreated control (ii) KBrO, alone (iii) vitamin C alone (iv) vitamin C+KBrO, (v) taurine 
alone and (vi) taurine+KBrO,. 
Blood was collected and used for the preparation of hemolysates and plasma as described 
in ":Methods". 
Results 
The effect of single oral dose of KBrO;, either alone or after pre- treatment with VC or 
taurine, on various parameters in hemolysates and plasma was determined. 
1. MetFIb levels and MetHbR activity 
The NfetHb levels were determined in the hemolysates prepared from erythrocytes of 
control and KBrO, treated rats. There was a significant increase in the Metl Ib levels in all 
the KBr03 treated groups. In the 48 h group MetHb level was more than 1.5 times the 
control value [Figure 4J. The increase in NfetHb level was accompanied by a concomitant 
increase in MetHbR activity. Maximum increase was observed at 48 h after 
administration of KlirO; and then recovery took place [Figure 5I. However, pre-
treatment treatment with taurinc or VC significantly abrogated the KBr();-induced 
alterations in MietHb level and MetHbR activity [Figures 6, 7J. Treatment with taurine or 
`'C alone did not significantly alter \1etHb levels or change the activity of MetHbR in 
the rat crythrocvtes. 
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2. Plasma parameters 
Significant changes in plasma levels of blood urea nitrogen (BUN), creatinine, glucose 
and inorganic phosphate (Pi) were seen in KBrO1 treated animals in a time dependent 
manner with maximum change at 48 h. BUN and creatinine levels, which are markers of 
kidney damage, were elevated in KBrO, treated animals indicating nephrotoxicity. The 
magnitude of change was greatest at 48 h and after 96 h recovery had taken place. 
Glucose and Pi levels were decreased in plasma of animals that were administered K13rO, 
as compared to untreated control. The maximum changes were again observed at 48 h 
[Table 101. A significant increase in the activities of both ALT (7.5-fold) and AST (8.5-
fold) was seen in the plasma of KBrO, treated rats compared to control values at 48 Ii 
[Table 10]. This suggests induction of liver damage in rats as both AI:1' and AST are 
markers of hepatotosicty. Pre-treatmnent of animals with either VC or taurine, prior to 
KBrO. administration, resulted in significant attenuation in the KBrO;  induced 
alterations in all these plasma parameters [fable 11]. Thus VC or taurine can protect the 
animals from KBrO,-induced nephrotoxicity and hepatotoxicity. 
Treatment of rats with KBrO, led to decrease in VC levels (3.3-fold) in plasma [Table 
10]. However, a significant increase in NO levels both in plasma (2.6-fold) and 
Kemolysates (4-fold) was observed in KBrO, treated rats [Table 12]. The maximum 
change in NO and VC concentration was seen at 48 h after which recovery towards 
control values was seen. Xanthine oxidase (NO), an enzyme of purine metabolism, was 
also assayed in plasma. KBr03 administration resulted in significant elevation in the 
activity of XO; the maximum change at 48 h was almost 9 times the control value [Table 
14]. Administration of VC or taurine significantly attenuated all these changes induced by 
KBrO. VC or taurine alone did not have an effect on these parameters which were 
similar to control values [Tables 11, 13 and 15]. Thus these AO by themselves do not 
alter the biochemical parameters that were determined in blood in this study. 
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Figure 4: Effect of KBr03 administration on Merl lb level in hemolysates. 
MetHb concentration is in moles/litrex 10 4. 
Results are mean±SEM of six different samples. 
'Significantly different at p<0.05 from control. 
MetHb, methemoglobin. 
Figure 5: Effect of KFrO, administration on Met! ibR activity in hemolysates. 
Results are mean±ST:M of six different samples. 
Metl-lbR activity is in nmoles/mg protein/min. 
*Significantly different at p<0.05 from control. 
MetHbR, methemoglobin reductasc. 
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Figure 6: FF.ffect of pre-treatment with VC and taurine on KBrC)3-induced alterations in 
Mctl-lh levels in hcmolvsates. 
Results are mean±SEM of six different samples. 
Met! lb concentration is in moles/litreX 10-4. 
'Significantly different at p<0.05 from control. 
Met! Ib, methemoglobin. 
10 
Figure 7: I affect of pre-treatment with VC and taurine on KBrO3-induced changes in 
Mctl lbR activity in hemolvsates. 
Results are mean±Sl .%I of six different samples. 
Met! IIA activity is in nmoles/mg protein/min. 
*Significantly different at p<O.05 from control. 
Metl IbR, methemoglobin reductase. 
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Table 10: Effect of [CBrO3 on some plasma parameters. I 
llivation after ad3iwusvation of KB1O 
Control 	12 h 	24h 48 h 96 h 168h 
1 
BUN 	15.18±1.86 	21.05±2.04* 	28.42x2.18* 35.02±3.14* 29.77+_2.74* 26.71±2.98* 
Creatmine 	033±0.03 	059±0.07* 	0.78!0.06* 1.25±0.11* 0.89±0.07* 0.64±0.04* 
Phosphate 	34.75+_3.01 	26A8±2.15" 	22.27±1.41* 12.34+_1.04* 15.4731.17* 22.86±2.16* 
Glucose 	154.74±8.12 	131.47±5.7* 	112.4±6,724 91.14±5.14+ 98.14±4.27 12991±5.78* 
AS'l' 	17.89±1.15 	3004+204* 	60.78+_3,48* 141.72±8.64* 95.14!6.12* 38.12!211* 
ALT 	12.14±1,08 	27.65±2.06 	43.52±a78* 98.15+4.86 52.74+3.15* 30.84+2.24* 
VitC 	237±0.21 	1.07±0,14* 	1.14±0,08* 06R±0.06* 133±11,12- 1.91±0,19* 
Rcsultn arc mcan+SEb1 of six diffcrcnt prcparahons. 
BUN, creatinute and glucose levels are in mg/ 100 ml while phosphate and Vit C are in µg/ml. 
AST and ALT are in IU/L. 
*Significantly different at p'0.05 from control. 
BUN, blood urea nitrogen; AST, aspartate transaminase; ALT, alanine transaminase; Vit C, 
vitamin C. 
Table 11: Effect of taurine and VC pre-treatment on KBxO, induced changes in some 
plasma parameters. 
Control 	KBAs alnne 	VC alone VC+KBr03 Taunne alone Taurinc+KBrO3 
BUN 	14.28+1.25 	34.46±1.89* 	12.67±0.94 15.89+_1.01* 12.44±0.74 19.75!1.11* 
Crcatninc 	0.39±0.04 	1.36±0.131 	0.38±0.04 0.41±0.06 0.37±0.03 0.47±0,05* 
Phosphate 	40.21±2.41 	12.01±1.01* 	41.57±2.19 38.7342.01 41.04+_2.24 34.17±2.84* 
Glucose 	148.81+8.41 	88.25±524* 	147.09±7.92 135.47+_684 146.95!9.17 120.45±7,84* 
AST 	16.791154 	127.13±10.04* 	15.02±1.95 19.27±2,04 14921.14 2124±2.04* 
ALT 	12.19±1.04 	101.12±8.14* 	12.22+1.11 16.14±121* 11.18±0.98 19.46±1.97* 
Vit C 	3.01±0.14 	0.88±0.02* 	3.97+0.18 2.86±0.12 3.4220.17 257+0.11'* 
Legend same as in Table 10. 
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Table 12: Effect of KBrO, treatment on some parameters of oxidative stress in plasma 
and hcmolvsates. 
Duration after administration of KBrOi 
Control 	12 h 	2.1 Ii 	48 It 	96 h 	168 h 
MDA 
Plasma ,.01±1.04 11.-5±1.9' 13.88±2.04' 22.75±2.89* 15.23±1.14' 10.08±1.67* 
Ilemohvsatc 1.5±-0.07  2.95±0.15* 7.08±0.85* 12.45±1.01 7.66±0.42* 2.68±0.18* 
Carbonyl 
Plasma 21.44±1.89 31.65±2.04* 39.78±2.76k 54.01±3.01' 43.78±2.76* 34.86±2.55* 
Ilemohvsate 2.69+0.11 3.58±0.18* 8.01±0.73' 15.24±1.08' 10.87±0.89' 6.88±0.44' 
Total SH 
Plasma 19.15±1.6 16.44±1.12 12.05±0.89' 7.01±0.5," 12.85±0.88* 15.06±1.01* 
llemoh•satc 9.95±0.97 7.01±0.64* 5.97±0.33* 3.61±0.21" 5.01±0.48' 7.41±0.58* 
GSH 
Plasma 6.58±0.49 3.89±0.31* 2.79±0.22' 1.54±0.08' 2.01±0.11' 2.85±0.16* 
1lemoksate 1.48±0.11 0.91±0.08" 0.69±0.04' 0.51±0.02* 0.-'4±0.09* 1.01±0.08* 
H202 
Plasma 108.21±6.8 124.18±9.51 161.12±10.2' 201.42±13.7' 151.14±12.1* 128.'6±11.7 
1 icmuly sate 92.77±4.84 106.12±8.7.1 139.47±9.14' 209.13±15.3* 132.01±11.2* 104.13±10.8* 
NO 
Plasma 8.01±0.79 13.44±1.04' 1 7.11±1.46' 21.04±1.88' 14.89±1.14* 11.01±1.01' 
I icmolcsate 3.4±0.11 5.01±0.36' 8.05±0.8" 14.12±1.01' 8.14±0.61' 6.01±0.32* 
Results are tncan±SE`l of six different preparations. 
K[DA, carbonyl content, 112O2 and NO are in nmoles/mg protein for plasma and nmoles/mg 
Hb for hemolysates. Total SH and GSH are in µmoles/tng protein for plasma and µmoles/mg 
1-lb for hemolvsates. *Significantly different at p< 0.05 from control. 
MDA, malondialdch}'dc; SI 1, sulf hvdrvl; GSI 1, reduced glutathione; I I,O2, hydrogen peroxide; 
NO, nitric oxide. 
Table 13: Effect of taurine and VC pre-treatment on KBrO,-induced changes in 
oxidative stress parameters in plasma and hemolysates. 
Control 	KBrOialone 	VC alone 	VC+KBrO3 	Taurine alone 	Taurinc+K.BrO 
MDA 
Plasma 6.6±0.78 23.01±3.24' 5.46±0.38 ".21±0.42 5.94±0.61 8.92±0.71' 
Hemolvsate 1.48±0.09 12.74±0.81' 1.21±0.11 2.64±0.19' 1.41±0.05 4.25+0.14* 
Carbony l 
Plasma 19.68±1.27 49.52±3.11' 18.14±1.01 22.68±2.07 18.01±1.19 25.74±2.52' 
l lemolvsate 2.8" ±0.44 16.1'7±1.03` 2.56±0.F 3.07±0.32' 2.44±1)14 6.4"±0.9-' 
Total SH 
Plasma 20.-1±1.47 ".-6±0 24' 23.r±1.94 19.24±1.67 22.14±1.86 17.85±1.-- 
1 lemtilvs;ate 11.21±0.98 3.35+0.21 ' 14.01±1.01 10.13±0.87 12.66+0.92 9.04±0.81* 
GSH 
Plasma ,.25+0.41 1.96±0.04' 8.54±0.46 6.57±0.41 8.01±0.70 5.14±0.31' 
IIcmolvsate 1.6-±0.0 0.61±0.03' 1.694.08 1.51+0.09 1.88±0.03 1.35±0.05' 
H202 
Plasma 101.49±9.14 191.42±19.81' 94.1-+8.62 115.0'±8.62 96.25±6.48 128.21±10.62* 
lIenokwve )6.35±6.42 215.63±20.12' 87.14±6.44 101.94}7.86 89.71±7.44 11-.9.1±13.27*. 
NO 
Pla>ma y ;-±1.04 21.59±2.11' 8.01±0.69 10.01±0.81 ".98±0.87 12.22±0.5' 
IIemoh-satc 3.8-+0.12 14.9"±1.0-' 3.62±0.1- 4.66±0.18` 3.51±0.21 5."2±0.14' 
Legend same as in Table 12 
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Table 14: Effect of KBrO, treatment on the activities of some pro- and anti- oxidant 
enzymes in plasma. 
Duration after administration of KBrO.3 
Control 	12 h 	 24 h 	 48 h 	 96 h 	 168 h 
XO 0.98±0.07 3.47±0.11' 7.05±0.87* 9.14±0.98' 3.97±0.19* 1.46±0.27* 
CAT 68.01±2.93 51.49±2.41" 33.42±2.04* 26.48±1.89* 34.28±2.14* 54.16±2.24* 
SOD 63.45±2.01 90.14±3.01 * 115.47±8.28* 150.18±10.6* 112.14±9.72* 74.08±6.61 
GPx 12.89±1.44 9.47±0.88* -.14±0.64* 3.86+0.13' 6.12±0.42* 8.67±0.82* 
Results are mean ± SEM of six different preparations. 
Specific activities of 1O, CAT and GPx are in nrooles/mg protein/min and SOD is in U/mg 
protein *Significantly different at p< 0.05 from control. 
XO, xanthine oxidase; C:1'1', catalase; SOD, Cu-Zn superoxide dismutase; GPx, glutathionc 
peroxidase. 
Table 15: Effect of taurine and VC pre-treatment on KBrO,-induced changes in the 
activities of some pro- and anti- oxidant enzymes in plasma. 
Control KBrO3 alone VC alone V'C+KBrO} Taurine alone Taurine+KBrO3 
XO 1.04±0.01 9.85±0.14-  1.15±0.91 3.17±0.14* 1.11±3.17 4.67±0.22' 
CAT 69.71±3.08 27.24±2.14 68.14±3.27 64.01±3.01 70.01±3.97 58.09+2.97* 
SOD 66.01 ±3.44 154.75±9.47* 6.04±3.17 69.11±4.04 67.14±4.11 75.68±5.11 * 
GPx 1128±1.67 3.24±0.11' 12.27±0.96 9.11±0.98 12.01±1.14 8.85±0.74' 
Legend same as in Table 14. 
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3. Parameters of OS 
Administration of KBrO; to rats increased protein carbonyl groups, a measure of protein 
oxidation, in a time dependent manner both in plasma and hemolysates. At 48 h, there 
was maximum increase in carbonv1 content in KBrO, administered animals when 
compared to the control group. There was a significant increase in %IDA level in plasma 
as well as hemolysates after KBrO, administration indicating enhanced LPO [Table 12]. 
The treatment of animals with KBrO; led to decrease in total SH groups in rat blood. A 
significant reduction in total SH and GSH content was seen at 24 h followed b}• further 
decrease at 48 h. There was also a marked increase in H 2O; levels in plasma as well as 
hemolysates with maximum increase again observed at 48 h after which recovery took 
place ['fable 12]. 
Thus, the administration of KBrO; alone greatly enhanced LPO, protein oxidation and 
H2O, levels and lowered total SH and GSH content [Fable 12]. However, these KBrO,-
induced changes were significantly attenuated by administration of either taurine or VC 
prior to treatment with KBrO,. Administration of taurine or VC alone did not 
significantly alter any of these parameters [Table 13]. The results indicate marked 
protection by both taurine and VC against KBrOs-induced OS in blood. \'C was more 
effective than taurine in reducing KBrO,-induced OS in rat blood. 
4. Anti-oxidant enzymes 
.Maintenance of normal cellular functions largely depend., on the efficiency of the defence 
mechanisms against free-radical mediated OS and .10 enzymes are considered to be a 
major line of cellular defence. The damaging ROS, superoxide radicals and H202 are 
detoxified by SOD and CAT. These enzymes were differently affected be the 
administration of KBr(_);. The activity of SOD increased while CAT activity decreased in 
plasma as well as hemoirsates of KBrO3 treated animals [Tables 14 and 16]. However, a 
decline in the activities of GPs, G6PD, GR and '1R was seen upon treatment with 
KBrO, while the activity of GST was greatly enhanced [Tables 14 and 16]. The changes 
in the activities of these enzymes were again maximum at 18 h after treatment with 
KBrO;. Recovery in enzyme activities took place after 96 h in all cases. The activities of 
.10 enzymes which were significantly altered by administration of KBrO, to animals, 
were greatly abrogated by pre-treatment with either taurine or \'C [Tables 15 and 171. 
When these compounds were given alone to the animals they had no effect on the 
activities of these enzymes. Thus both VC and taurinc be themselves do not alter the 
enzymatic cellular AO defence system of blood. 
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5. Anti-oxidant power 
The intracellular AO power of plasma and hemolysates was measured by FR.AAP and 
DPPH assays. The ferric reducing/antioxidant power of plasma and hemolysatesn 
KBrO1 treated animals was decreased when compared to controls [Table 181. The 
percentage quenching of DPPH radical was also less in hemolysates and plasma from 
KBrO3 treated animals as compared to control [Table 18]. These results show that the 
AO power of plasma as well as erythrocytes is compromised upon administration of 
KBrO} to animals. The maximum decrease in AO power was at 48 h after administration 
of KBrO, after which recovery took place, although the FR.1P and DPPH values were 
not completely restored to control levels. 
Prior administration of VC or taurine greatly reversed the KBrO,-induced changes. 
Consequently, the .\O power of both plasma and erythrocytes was greatly restored 
[Table 19]. Administration of either VC or taurine alone to animals had no effect on the 
:O power of blood since the l-R.-AP and DPPH values were the same as in controls. 
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Table 16: Effect of KBrO, treatment on the activities of some anti-oxidant enzymes in 
hemolysates. 
Duration after administration of KBrOti 
Control 12 h 24 h 48 h 96 h 168 h 
C.\T 34.81±2.01 22.44±1.8-' 16.31±1.14' 12.27±1.01` 17.42±1.25' 29.42±1.56* 
SOD 38.44±2.17 '2.45±2.94 109.4±10.1' 164.18±13.61* 101.13±9.96* 64.21±3.29* 
GPx 14.01±1.07 10.12±0.89' 8.41±0.47' 4.87±0.26' 7.92±0.63* 11.14±0.97* 
GST 0.91±0.08 1.57±0.14 2.89±0.21* 3.08±0.48* 1.98±0.18* 1.37±0.11* 
GR 3.89±0.55 2.67±0.31' 1.97±0.15* 1.43±0.12* 1.89±0.19* 2.84±0.38* 
TR '.02±0.85 5.98±0.65 4.36±0.38• 2.92±0.25' 4.12±0.31* 5.38±0.19* 
G6PD S.12±0.47 3.61±0.22' 2.47±0.17* 1.88±0.11 `  2.67±0.19* 3.66±0.21* 
Results are mean±SEM of six different preparations. 
Specific activities of CAT, GPx, GSI', GR, 'FR and G6PD are in nmoles/mg fib/min and SOD 
is in U/mg Jib. 
*Significantly different at p < 0.05 from control. 
CAT, catalase; SOD, Cu-Zn superoxide dismutase; GPx, glutathione peroxidase; GST, 
glutathione-S-transfcrase; GR, glutathione reductase; G6PD, glucose 6-phosphate 
dehvdrogenase; TR, thioredoxin reductase. 
Table 17: Effect of taurine and VC pre-treatment on KBrO,-induced changes in the 
activities of sonic anti oxidant enzymes in hemolysates. 
Control KI3ro) .done \'C alone VC + KI3rOt 1'aurune Alone Taurine 4 KBrO} 
CAT 36.15±2.12 13.68±1.54* 38.11±3.01 32.46±2.97 37.04+_2.38 29.14±176* 
SOD 39.56±3.01 166.53±12.89' 41.2"±224 43.19±3.21 40.01±2.64 45.1-7±3.74* 
GPx 13.8±1.41 4.25±0.24k 13.47±1.16 12.87±1.09 14.01±1.07 10.25±0.96* 
GST 1.05±0.02 5.03±0.30` 1.19±0.11 1.74±0.14' 1.13±0.08 2.14±0.12* 
GR 4.22±0.19 1.6 	±0.15' 4.38±0.28 3.98±0.27 4.1'±0.32 3.42±0.3"'* 
TR 6.94±0."4 3.14±0.23' 7.01±0.44 6.23±0.49 6.87±0.41 5.01±0.38* 
G6PI> 5.01±0.38 1.66±0.11 • 5.67±03-  4.89±0.32 5.14±0.38 4.46±0.19' 
Legend same as in 'fable 16. 
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Table 18: Effect of KBrO, on the antioxidant power of blood as determined by I'RAP 
and DPPH assays. 
Duration after administration of KBrOi 
Control 	12 h 	24 h 	48 h 	96 h 	168 h 
FRAP 
Plasma 4.12±0.37 3.68±0.14* 2.57±0.19* 1.84±0.11" 2.56±0.18' 2.87±0.17' 
Hemolvsate 3.09±0.28 2.43±0.16* 2.01±0.14' 1.64±0.12• 1.88±0.13' 2.21±0.11' 
DPPH 
Plasma 81.14±6.68 75.19±4.04 60.45+5.19' 52.17±3.71' 62.41±5.70' 69.27±2.89* 
Hemolvsate 65.22±4.91 51.87±3.24' 40.17±3.64* 29.55±2.86' 37.11±3.18' 47.24±2.94* 
Results are mean±SEMI of six different preparations. 
FRAP results are in units/mg protein for plasma and units/mg Hb for hemolysate while DPPI I 
results are as percent quenching of DPPI I radical. 
*Significantly different at p<0.05 from control. 
FRAP, ferric reducing/antioxidant power; DPPII, 2,2-diphenyl-l-picrylhydrazv1. 
Table 19: Effect of taurine and VC pre-treatment on KBrO,-induced changes in 
antioxidant power of blood as determined by FRAP and DPPH assays. 
Control 	KBrO' alone 	VC alone 	VC+KBrOi 	Taurine alone Taurine+KBrO3 
FRAP 
Plasma 4.22±0.14 1.74±0.09* 5.01±0.22 3.94±0.17 4.31±0.22 3.57±0.13' 
I lemolvsate 3.19±0.24 1.58±0.07* 3.97±0.14 3.01±0.08 3.22±0.19 2.89±0.08• 
DPPH 
Plasma 78.94±3.71 48.01 ±2.18* 82.14±4.11 ,4.65±3.87 80.11±1.19 '017±3.21' 
Hemolrsate 64.12+2.32 30.11±1.97* 66.78±3.04 62.43±2.36 65.02±1.47 59.87±2.17' 
Legend same as in Table 18. 
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DISCUSSION 	 - / 
E;rvthrocytes are terminally differentiated cells \\-here most of the biosynthetic pathways 
are absent. They are among the first cells to be exposed to a xenobiotic regardless of the 
route of exposure (inhalation, ingestion or applied on skin). Due to their role as oxygen 
carriers, en.throcytes are in constant danger posed by intracellular oxygen radicals and 
also from external sources. In addition, the high content of polyunsaturated lipids in their 
membrane and presence of transition metals (especially iron) makes them especially 
vulnerable to oxidative damage. As a consequence, erythrocytes have a well developed 
AO system which builds up an efficient defence against the cytotosic effects of ROS 
[Cimen, 20081. Due to their simple structure and the case of study, erythrocytes have 
been extensively used as a cellular model to study oxidative damage by a variety of 
agents. 
Orally administered KBrO, is rapidly absorbed from the gastrointestinal system of rats 
and enters the bloodstream where it interacts with various blood components [Fujii et al., 
19841. Most of the bromate was excreted in the urine within 2 h of administration and no 
bromate was present in the plasma after 2 h [Fujii et al., 198.11. In fact bromate was not 
detected in blood or any rat tissue 2.1 h after administration, even though the half life of 
bromate in water is greater than 182 days [Fujii rt aL, 1984]. The toxicity symptoms of 
bromate arc, however, manifested much later [Kurokawa et al., 1990] and seen in our 
studies also. 
.\lthough the effects of KBrO, on various animal tissues have been reported in several 
studies there is no detailed study concerning its effect on erythrocytes. We have used 
human erythrocytes and rat blood as a model system to study the hematologic effects of 
KBrO, under in vitro and in vivo conditions. The in vitro experiments involved 
incubating human erythrocytes with KBrO; for 60 min, either alone or in presence of 
VC, GSH or taurine. The in Vivo studies involved giving a single dose of KBrO, to 
animals and then determining the time when it produced maximum changes in 
erythrocytes and plasma of animals. Then, KBrO, was given after treatment with taurinc 
or VC and animals were sacrificed 48 h later, when maximum bromate-induced changes 
were seen. 
Treatment of human ervthrocvtes with different concentration of KBrO resulted in 
concentration dependent hemolvsis; at higher concentrations almost 45°o hemol sis took 
place under in vitro conditions. This hemolysis is probably because of erythrocyte 
membrane damage due to I YO, resulting in leakage of Hb in the medium. This 
77 
Part-I : cults and Discussimt 
observation could explain the incidence of anemia reported in acute cases of bromate 
intoxication [EPA, 2001]. 
Since induction of oxidative stress has been postulated to play a role in bromate toxicity 
[Delker et al., 2006; Umemura et al., 2009; Zhang et al., 2010, 20111 several parameters 
were determined to see if a similar thing happened in human erythrocytes and rat blood. 
Treatment of animals with KBrO3 significantly increased LPO in both plasma and 
erythrocytes. LPO is well known to be caused by excessive generation of ROS and the 
accompanying damage to plasma membrane has been postulated to cause hemolysis 
[Edwards and Fuller, 1996]. Excessive peroxidative damage due to high levels of MDA 
suggests a high concentration of hydroxyl radical because of the reduced activity of 
hydroperoxide scavenging enzyme CAT. Increase in protein carbonyl content, 1-120, 
levels and depletion of SH groups was also seen upon treatment with KBrO;, both under 
in vitro and in vivo conditions. Carbonyl content is a measure of protein oxidation since 
carbonyl groups are introduced into proteins when amino acid residues are attacked by 
ROS [Halliwell and Gutteridge, 19991. Unlike LPO, protein oxidation does not have 
features of a chain reaction and the damaged proteins appear to have a long half life. 
Thus evaluation of carbonyl content in proteins provides a significant clue to the 
magnitude of oxidative stress in the cell. The depletion of GSI1 and total SH groups 
could have occurred due to their oxidation by ROS that are generated upon treatment 
with KBrO;. Diminished SH content has been shown upon in vitro incubation of rat 
renal proximal tubules with KBrO, [Sai et a/., 1994]. The increase in LPO, protein 
carbonyls, 1-1,0, levels and decrease in SI I content all indicate that KBrO, induces OS in 
human erythrocytes and rat blood. As a consequence the AO power, as measured by the 
ability to reduce ferric ions to ferrous and quenching of DPPH radicals, of the human 
erythrocytes and rat blood is also compromised. 
Several previous studies have suggested a role for ROS in bromate toxicity. However, 
there is no direct evidence to date of its pro-oxidant activity. We have investigated this by 
a fluorescent assay using DCFFI-l)A as the probe. The DCF assay which detects all the 
oxidizing species provides a global approach for evaluating the intracellular production of 
ROS [Keller a a/., 2004; Bukowska et al., 2008]. Our results provide conclusive evidence 
that Klir(), increases ROS production in erythrocytes in a dose-dependent manner. The 
increased generation of ROS could possibly explain the KBrO,-induced OS observed in 
erythrocytes under in vitro conditions. 
Part-1: QeSU is and Discussion 
Since KBrO; causes OS, as shown by enhanced LP() and protein oxidation, we 
investigated its effect on the enzymatic AO defence system under in vitro and in vivo 
conditions. The first line of defence is provided by SOD and CAT which are responsible 
for catalytic dismutation of the highly reactive and toxic superoxide radical to H2O, 
which is then decomposed to water and oxygen. The activities of these two enzymes 
were differently affected upon KBrO, treatment. SOD activity was increased significantly 
while CAT was reduced. The activity of G6PD was also reduced upon treatment with 
KBrO,. G6PD is the first enzyme of the LIMP pathway and generates NADPH which, 
along with GSH, provides the reducing power in the cell. This reduced activity of GGPI) 
will result in lowered levels of NADPI I and consequently the (.,R activity will also be less 
since it uses NADPH provided by G6PD to convert oxidised glutathione back to GSH. 
The decreased activity of GR will, in turn, lead to lower levels of GSI I which is a 
necessary cofactor for the detoxification of H,02 and organic peroxides by GPx. As a 
result, the concentration of H20,, an ROS, is also increased in both plasma and 
hemolysates due to reduced activities of CAT and GPx. The GPx activity could also have 
been reduced due to direct inactivation of the enzyme by higher concentrations of NO 
and peroxynitrite anion [Asahi e/ al., 1995]. The co-ordinated activities of GR and GPx 
maintain the intracellular redox status and a decrease in their activities, as seen here, will 
result in lower quenching and greater levels of ROS and free radicals. The reduced levels 
of NADPII will also lead to lowered activity of '1R, an enzyme that is a major 
component of cellular disulfide reductase and also functions in defence against OS 
[Amer and Holmgrcn, 2000]. The reduced activities of CAT, GR, GPx and '1R must 
have overcome the enhancement in the activity of GS'h (which is involved in the 
detoxification of drugs and poisons by conjugating them with GSLI) and SOD. The 
activity of xanthinc oxidise, which is a pro-oxidant enzyme since its reaction generates 
superoxide anions, was also elevated. The overall consequence of altered AO enzyme 
activities is enhanced OS resulting in increased LPO, protein and SH group oxidation, 
thereby causing damage to, the erythrocytes and reducing the AO power of blood. 
'I he levels of NO, a gas that functions as an important extra- and intra-cellular 
messenger, were also determined in erythrocytes and plasma to see if enhanced OS is 
also accompanied by nitrosative stress under in vivo conditions. A greatly increased level 
of N() was observed both in plasma and envthrocytes of KBrO treated animals. NO 
forms complexes with transition metal ions, including those found in home proteins, and 
also reacts with protein SH groups directly giving rise to S-nitrosothiols [Radi, 20041. 
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This will result in elevation of peroxynitrite anion/ nitric acid level resulting in oxidative 
modifications of lipids, proteins and nucleic acids. The increased nitrosative stress 
coupled with OS will lead to greater damage to the erythrocytes as seen here. 
A major target of ROS and NO in erythrocytes is Hb [Edwards and Fuller, 1996]. The 
resulting oxidation of ferrous ion to ferric form in heme ring results in the conversion of 
Hb to MetHb. The MMetf-Ib with ferric ion has very high affinity for oxygen accompanied 
by a drastically reduced ability to release oxygen to tissues. MetHb is, therefore, useless as 
an oxygen transporter and its enhanced formation results in tissue hyposia. A significant 
elevation in MetHb concentration was seen upon treatment with KBrO3, both under in 
vitro and in vivo conditions. The increased level of MetHb could be due to higher H,02 
and NO levels, both of which stimulate the oxidation of ferrous ion in oxyHb to form 
ferric ions resulting in generation of MetHb. In addition, both nitrite and nitrate, the end 
products of NO metabolism, are also well known to enhance the conversion of Hb to 
MetHb 1I'itov and Petrenko, 2005]. NO at high concentrations reacts with superoxide 
radical forming the highly reactive peroxynitrite anion which is a powerful oxidant and is 
highly cytotoxic. Increased levels of denatured Hb were also seen in erythrocytes from 
KBrO, treated animals (data not shown). Significantly we have found that the activity of 
MetHbR, the enzyme which converts MecHb back to Hb, was increased indicating that 
the higher Metl-lb levels were not due to inhibition of this enzyme. The increased activity 
of MetHbR must have been an adaptive response to the higher MetHb formed upon 
exposure to KBrO,. 
Elevated levels of BUN and creatinine in plasma confirm previous reports that KBrO3  
ingestion causes acute kidney damage [Kurokawa el al., 1990; Bao el al., 2008]. The 
several fold increase in the activities of aspartate aminotransaminase and alanine 
aminotransferase, markers of hepatic damage, suggests possible hepatotoxicity causing 
leakage of these enzymes from the liver into blood under in vivo conditions. An increase 
in the activities of these enzymes in serum of rats fed bread containing KBrO, has been 
reported earlier [Oloyede and Sunmonu, 2009. The increased OS generated by 
administration of KBrO, could have resulted in liver damage as suggested for other 
hepatotoxic agents Daeschke el al., 2002; Amin and l lamza, 2005]. 
The changes introduced by administration of single oral dose of KBrO , under in vivo 
conditions showed a similar pattern. Alterations were seen even at the earliest time point 
(12 h) followed by further increase at 2.1 h. The magnitude of KBrO,-induced changes 
peaked and was maximum at 48 h after treatment. This was followed by recovery 
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towards control values on subsequent days. However, this recovery was not complete 
even after 168 h as most of the parameters had not returned to control values. 
Significantly, our results show that the changes induced by a single exposure to KBrO, 
appear to be reversible. These results are in agreement with previously published reports 
in which bromate induced kidney damage was shown to be reversible, both in humans 
and animals, with full renal function being restored several days after the withdrawal of 
the toxicant [EPA, 20011. 
The production of ROS may have deleterious effects on cells due to lipid and protein 
oxidation. Various :\O have been reported to alleviate the tissue toxicity of KBrO, 
probably by quenching the free radicals generated by this compound and thereby 
reducing OS lKhan and Sultana, 2005a; Bao et aL, 2008; Khan et al., 2012a; Sultan el u/., 
2012. Chemoprevention of cell, tissue and organ toxicity by using naturally occurring 
dietary substances has gained increasing acceptance in recent years. In this study \VC have 
used GSH, taurine and VC as potential protective agents against toxicity induced by 
KBrO;. These compounds are well known antioxidants; they are found in several foods 
and have been shown to reduce the risk of various forms of cancer, cardiovascular 
disorders and renal disorders. They exhibit protective effects against several 
environmental agents due to their.\(), antimutagenic and anticarcinogcnic properties. 
Administration of taurine or \'C, beforee treatment with KBrO, resulted in significant 
recovery of :BIetl lb levels along with NletHbR activity implying that they can inhibit Hb 
oxidation induced by KBrO,. It also resulted in significant recovery in LPO, protein 
carbonvl, H2O, levels, total SH content. 'Treatment of animals with VC or taurine also 
results in significant recovery in hepato- and nephro-toxicity markers (AST, ALT, BUN, 
creatinine, Pi, and glucose levels) under in vivo conditions. 1.'he alterations in various 
:10 enzymes were also attenuated, and the altered enzyme activities returned to near 
control values. Thus the KBrO, induced toxicity and subsequent OS both under in vitro 
and in vivo conditions can be significantly attenuated by taurine or VC. The protective 
effects of these AO in mitigating KBrO,-induced cell damage is probably due to the 
quenching of free radicals/ROS induced by KBrO, treatment. Vitamin C was more 
effective than both GSII and taurine in preventing the KBrO, mediated free radical 
damage both under in vitro and in vivo conditions, probably because it is a stronger .\O. 
'Thus, taurine or V(: protect the blood from oxidative and nitrosative stress induced by 
KBr0;, both under in vitro and in vivo conditions. Their administration strengthens the 
enzymatic and non-enzymatic .1O system of the erythrocytes and also prevents oxidation 
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of Hb to Nietl Ib. The protective effects of GSH, taurine and VC reported in this study 
are summarized in Figure 8. The protection by either GSH, taurine or VC against KBrO., 
can be attributed to their intrinsic AO properties. These findings show the importance of 
GSH, taurine and VC on the functions of blood, especially en•throcvtes, and provide an 
insight into the mechanisms by which the bromate-induced tissue toxicity can be 
attenuated. However, further studies are necessary to determine the exact molecular 
events underlying the protective mode of action of taurine and VC. 
KBrO3 
Intracellular re ductionproce ss 
GSH/ TA-C  
ROS and 
RNS 
KBr 	 4. GSH/ TXC 
I Alterations in enzymatic and non-enzymatic AO 
I Redox imbalance 
Lipid peroxidation 	Protein oxidation 	Hb oxidation 
L'Iembrane damage 	Reduced ability of blood to transport oxygen 
Figure 8: Summary of KBr() i effects on rat blood. KBrO; enters the cell where it is reduced to 
Kl3r by intracellular reductants. This process generates ROS and RNS which then 
induce oxidative and nitrosative stress in the blood. The ROS and RNS cause 
depletion of anti-oxidants like GSII and vitamin C and alter the activities of AO 
enzymes. This results in redox imbalance in the blood and oxidation of proteins, 
lipids and hemoglobin. The consequences are increased cell injury. GSH, taurine and 
vitamin C protect the cell either by inhibiting the intracellular reduction of KBrO3 to 
KBr, or more likely quenching of free radicals and ROS/ RNS by their well 
documented A0 property. 
AO, anti-oxidant; GS[ E. reduced glutathione; KBr, potassium bromide; ROS, reactive 
oxygen species; RNS, reactive nitrogen species; .1., taurine; VC, vitamin C. 
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PART-II A 
EFFECT OF KI3rO3 ON RAT HIDNEV 
Experimental design. Adult male Wistar rats were orally ypven a single do c of I<Rr03 
(100 mg/kg body weight) and the animals were sac tfccd 12, 24, 48, 96 and 168 h later. 
Control animals were given an equivalent volume of water by gavage. There were six 
:udurals in each group (one control and Live KBrC), treated). Blood was colhctcd in tubes 
containing and<oagulant following cardiac puncture and the plasma was separated from 
cells by cenitifugerion. the kidneys were removed and processed for the pxepatadon of 
homogenates and BBMV as described in "Methods". 
Results 
The effect of oral zdmynisrrmtIoii of KBTO, on various parameters ¢t at plasma and 
kidney was determined. 
1. Effect of KBrO4 on some plasma parameters 
Single oral dose of KBnO, treatment resulted in sign ficant changes in ?lasma leads of 
blood ones nitrogen (BUN), cieatinine, glucose and inorganic phosphate tut)  with 
maximum change at 4% h. BUN and eteatinaic levels were elevated in KBrO3 treated 
animals odnatmg neph_-oto.3airy. The magnitude o{ change. was Raate=_r at 48 hand 
after 96 h recovery had taken place. Glucose and Pi levels were decreased in animals that 
were administered KBrO, n. compared to control. The maximum changes were again 
observed at 48 6 fable 1]. 
2. Effect of KBrO3 on the activities of BBM marker enrymes 
The effect of in vitro iccubaton of BUM'! with KlirO, on BBM nxaxkec enzymes LAP, 
AP, GGT and maltase was first studied. 'lie BBMV from control rats were separately 
incubated with different concentrations of KBrO, (0, 0.1, 0.25, 1.0 and 2.0 mM) at 37" C. 
Aliquots were removes at various umrtr and assayed for enzyme activity. BBMV not 
incubated with KBrO~ and kept on ice .served as control. 'hr in airs incao-sinn of 
BB\IV with KBrO, resulted in inhibition of all the membrane bound enzymes. Among 
the four BBM enzyanes, LAP was most sensitive to uxaclidtipr byC}CgrCs and showed 
maximum inhibition. Only 45A enzyme ut.dtrC remained after 2 h irevbu7pn with 20 
mM KBrO; at 37° C. AP, GGT end maltase showed much less inhibition under sunilai 
coudidom ( F'iguro Id. 
The effect of ISBrO, administration to rats on BBM enzymes in renal homogenares and 
isolated BBMV was xtndied tract. A significant dccrea$e in the activities of all four 
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enzytnes was observed in both cortical and mcdullan• homogenates at 12, 24, 48 and 96 h 
after administration of KBrO} to animals, when compared to the control group. 'ilic 
decrease in activities of these enzymes was greater in the cortex than medulla, but the 
pattern of change in both was the same. All enzyme activities declined in 12 h group but 
the maximum change was at 48 h. At 96 h the magnitude of decrease was less than 48 h 
and all enzyme activities recovered to almost control values at 168 h [Table 21. 
The effect of oral administration of KBrO3 on the activities of BBA1 marker enzymes in 
isolated BB11V was then studied. In this experiment, BB'1V were prepared from the 
cortical homogenates of animals 48 h after administration of KBrO;, when maximum 
change in enzyme activities had taken place. The specific activities of all enzymes 
declined significantly in the purified BBAMV also [fable 3[. The magnitude of decrease in 
the specific activities of all enzymes was slightly more in BBMV than in homogenates. 
Among the four BBM marker enzymes, the activity of maltase was inhibited the most 
[Figure 2) 
Since KBrO, altered the activities of all the BBN1 marker enzymes assayed in BBMMV their 
kinetic parameters, Michaelis constant (KM and maximum velocity (~',,,,J, were 
determined in purified BBM V. The enzymes were assayed at different substrate 
concentrations and Kit and V were determined from double reciprocal Lineweaver-
Burk plots (I/v vs I/(S]). 'The results indicate that V,,,, values of all four BBA[ marker 
enzymes were significantly lowered in BBMV from KBrO, treated rats compared to 
controls ['fable 4). 'There was no change in the K,1 values ui these enzymes. 
3. Effect of KBrO3 on total ATPasc and acid phosphatase (ACP) activities 
The effect of KBrO, treatment on total A'I'pase and ACP, a lysosomal marker enzyme, 
was determined in homogenates. The activities of these enzymes were altered different) 
[Table 5]. Total ATPase was decreased whereas the activity of ACP was increased. 
However, the changes in the activities of both enzymes were maximum 48 h after 
treatment with KBrO~. Recovery to almost control values was observed at 168 h after 
KBrO j treatment. 
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Figure 1: l.ffect of in vitro incubation of BBM1\" with KBr); on the activities of LAP, AP 
GGT and maltase. 
BB lV (protein concentration 1 mg/ml) in 300 mhl mannitol, 5 mill Tris-1IC1 buffer, 
1 11 7.5 from control animals were incubated at 37 °C with different concentrations of 
KBrO3 in a total reaction volume of 0.5 ml. At different times after the addition of 
KBrO,, aliquots were removed from the reaction mixture and assayed for enzyme 
activities. Results are expressed relative to enzyme activities in KBrO,-utureatcd 
RBNIV samples kept on ice which served as the control. 
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Table It Effect of KHtO, on some plasma parameters. 
Duration after adriicnc ,tion of KBrO3 
Control 12h 24h 48h 96h 168h 
BUN 16.19±125 22.61±142* 27.96±1.87 41.98±2.68*  29.74±2.12* 20.56±1.95* 
Creatinine 0.43±0.09 0.85±0.09* 0.87+0.11* 1.32+0.09' 0.92±0.05* 0.64±0.03' 
Phosphate 69.71+3-87 54.125.97* 40.18±2.44* 22.1732,14*  33.45+_2.78`  51.17±3.01* 
Glucose 154.74±8.12 131,47±67* 112.4±4.98* 91.14+5.14* 98.14±4.27* 129.71+5.78* 
Vit C 4.12+0.98 3.01 10.45° 2.1130.22* 1.28±0.12* 2.46±0.17* 3.18_`036* 
Results are mean±SEM of six different preparations. 
Glucose, BUN and creatinine levels are in mg/ 100 mlwbile phosphate and Vit Care in pg/ml. 
*Sigidicetit]y different from control at p < 0.05. 
BUN, blood urea nitrogen; Vit C, vitamin C. 
Table 2: Ff£ect of KBrO, treatment on the activities of BBNI marker enzymes in 
cortical and medullary homogenates. 
Duration after administration of K11z0, 
Control 	12h 	24h 	48h 	96 h 	163h 
LAP 
Cortex 4.34±0.11 3.68±0.28* 3.132 0.41* 2.60±0.19* 3.0130.25" 3.79±0.52*  'fedoll. 3.58±0.09 3.16±0.18* 2.80±0.15* 2.20±0.17* 191±0.23* 3,26t0.421  
AP 
Guns 3.90+0.18 3.46+0.11* 2.66!0.14* 2.06!0.08* 2.75±0.10* 3A7+0.16* tfedtilla 3.34±0.22 3.01±0.15* 2-62±0,14* 1.98!0.09* 2.85±0.12' 3.01+0.14* 
GGT 
Cortex 2.70+0.16 2.18+_0.10* 1.97±0.07* 1.29±0.04* 1.85±0.08* 2.28±0.11* Medulla 2.15±0.14 1.97±0.09* 1.6810.08* 1.1810.07* 1.6610.08* 2.05±0.11* 
Maltase 
Cortex 23.41±2.01 17.36±1.74` 13.19±1.32` 10.86±1.08` 14.48!1.14* 19.50±1,65* Medulla 15.95±1.87 12]5±1.34` I0.01±1-IS-  7.8530.95* 9.92±1.01* 13-88-1.18* 
Results are mean±SRM of six different preparations. 
Specific acti,ieles are in uncles/mg protein/h. 
*9igniEicantby different at p < 0.05 from control. 
LAP, leucinr aminopeptidase; AP, alkaline phosphatase; GGT, y-glutamyl transferasc 
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Table 3: Effect of KBrO., treatment on the activities of BBM enzymes in isolated 
BBMV. 
Enzymes 	 Control 	 KBr03 treated 	% Change 
LAP 19.89±1.55 10.09±1.04* -49.27 
AP 15.14±1.11 7.52±0.85" -50.33 
GGT 11.08±1.01 4.94±0.72* -55.41 
Maltase 113.65±2.85 46."6±1.67` -58.85  
B13MV were prepared from animals 48 h after administration of KBrOi 
Results are mean ± SE\I of four different BBMiV preparations. 
Specific activities are in umoles/mg protein/ hr. 
*Significantly different at p< 0.05 from control. 
LAP, leucine arninopeptidase; :P, alkaline phosphatase; GGT, y-glutamyl transfcrase. 
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Figure 2: I•.ffect of KBrO:  treatment on the acti-ities of 13BM marker enzr•mes in cortical 
ho)nmgenates. 
This figure was drawn using values from Table 3. 
I..\1, leucine atnInUpepcldase; AP, alkaline phosphatasc; GG'F, •j-glutamvl 
transferase. 
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Table 4: Effect of KBxO;  treatment on kinetic parameters of BBM enzymes in isolated 
BBMV. 
Group KM V„ue, %Decrease in V. 
LAP 
Control 0.13 505 
KBIO, 0.13 2.67 47.13 
AP 
Control 30.3 19.63 - 
KBtO3 30.3 11.52 41.31 
GGT 
Control 1.78 10.35 
KBeo, 1.78 3.46 66.57 
Maltase 
Control 16.94 75.64 
KPrO1 16.94 45.61 39.70 
KM and Vm„ were calculated from double reciprocal (1/v vs 1 /[S]) Lineweavee-Burk plots 
KMi$ in wmnoles/L and Vm1 in µmoles/mg protein/hr. 
L\0, leucine aminopepddxse; AP, alkaline phosphatase; GGT, y-glutamyl tansferase. 
Table 5: Effect of KBrO, treatment on total ATPase and acid phosphatase activities in 
cortical and medullary homogenates. 
Duration after udminsteadQa ofKBrO, 
Control 	12 h 	24 h 	48 Ii 	96 h 	168 h 
Total ATPase 
Cortcx 7.89±0.68 6.24±0.31* 2.92±0.22" 1.44±0.17+ 4.09±0.42* 6.03±0.31* 
Medulla 6.61±0.46 5.5030.29* 3.56±0.17* 1.64±0.15* 3.62±0.42* 5.25+0.26* 
ACP 
Cortex 0.69±009 t03±007r LS1±0.19* 2.94±0.16* 1.50!0.14* 0.91±0.05* 
Medulla 1.26±0.06 2.06±0,11* 2.45±0.li` 7.31!010° 2.01+0.09* 1-51±0.08+ 
Results are mean±SEM of six different preparations 
Specific activities are in lunoles/mg protein/hr. 
*Silmificandy different at p< 0.05 from control. 
ACP, acid phosphatase. 
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4. Effect of KBrO3 on some parameters of OS 
To ascertain the effect of KBrO, on the _1() system in kidney, several parameters of OS 
were determined in the renal homogenates of control and KBrO, treated rats. There was 
a significant increase in LP() after KBrO, administration. MID;\ levels were higher at all 
times in the KBrO,-treated groups compared to the control group. The maximum 
increase in MMD;\ level was 48 h after KBrO, treatment. 'Treatment of rats with KBrO, 
increased the protein carbonyl content in a time dependent manner. There was maximum 
increase in carbont-1 content in KBr(), administered animals at 48 h when compared to 
the control group. Administration of KBrO; resulted in significant reduction in total SH 
and GSI I content at 24 h followed by further decrease at 48 h. 11,O, levels were 
markedly increased with maximum change again observed at 48 h after which recovery 
took place [Table 6]. The extent of decline was more in cortex compared to medulla, 
except NIDA levels which were higher in medulla. 
5. Effect of KBrO, on activities of enzymes of carbohydrate metabolism 
The treatment of animals with KBr()3 resulted in changes in the specific activities of 
various enzymes of carbohydrate metabolism in the cortical and medullary homogenates 
[Table 1. The activity of the tricarboxvlic acid (1'CA) cycle enzyme malate 
dchydlrogenase (MIDI-I) decreased significantly in both homogenates. Ilowever, the 
activity of lactate dchydroyenase (LDI-i), a marker of anaerobic glycolysis, was 
significantly increased. 
Administration of KBrO3 significantly decreased the activities of gluconeogenic enzymes, 
glucose 6-phosphatase (G6P) and fructose l,6-bisphosphatase (I=BP) in cortex and 
medulla [Table 7]. The effect of KBrO, treatment was also determined on glucose 6-
phosphate dehvdrogenase (G6PI)) and malic enzyme (NIE), which are the source of 
N:~I)PH needed in reductive anabolic reactions. KBrO; administration significantly 
decreased GOD activity while the activity of malic enzyme was increased [l'able 7]. The 
changes in activities of all carbohydrate metabolic enzymes were tna`imum 48 11 after 
treatment with KBrO;. The alterations in the metabolic enzymes were greater in the 
cortex compared to medulla except NIICI I and G6P. Rec<,vvcry in enzyme activities to 
almost control values took place in all cases, with the exception of i\li?. 
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Table 6: Effect of KBrO, treatment on some parameters of oxidative stress in cortical 
and medullary homogenates. 
Dumtion after adujijusnarion of KBrO, 
Control 	12h 	24 h 	48h 	96h 	168h 
Cortex 
Medulla 
Carbonyl 
Comex 
Medulla 
Tend SH 
Cortex 
Medulla 
GSH 
Cones 
bledolk 
H2Oz 
Cortex 
71.46±1.95 82.54±2.20* 107.50±2.49* 14554+3.61* 88.39±3.01* 77.23±1.33* 
49.04±1.06 71.31±1.89* 89.85±2.52* 116.70±1.59* 79.16±2.04 56.08±1.78* 
88.64± 2.07 172.7325.79* 220.28±5.90* 266.82±6.69* 198.30±6.25* 140.1± 3.10* 
59.10± 2.82 113.6423.59* 145.46+4.57' 172.1933.28* 120.45±3.71* 82.45±1.67* 
1628±113 14.19±0,87* 9-60±0.92` 7.97+057* 10.89±0.88* 13.68±1.11' 
12.60±1.01 11,16±1,41 9.21+0.94` 6.54+-0.86' 9.54±1.21' 10.953134* 
2.01±0.11 1.66±009* 129±0.06" 0,70!0.02* 094±0.04* 1.52±0.02* 
1.62±0.07 136±0,04* 1.23±003* 268±0.02* 0.90±0-03* 1.38±0A5* 
262.24±7.05 337.84+11.51* 505.20±23.18* 7389236.56* 435.60+-13.47' 326.16410.25t 
18(1,04±6.79 236.22±7.37' 286.45~835' 357.18±10,11* 296.53+9.76* 210.44+-8.35* 
Results are mean ± SEM of six different preparations. 
MDA, carbunvl content and H202 le\els are ul nmoles/g tissue while total SH and 0S11 ate in 
lunoles/g tissue. 
*Significantly different at p<  0.05 from control. 
Milk, malondialdehyde; SH, sulfyhdryl; GSH, reduced glutathione;11202, hydrogen peroxide. 
Table 7: Effect of K19rO3 treatment or, the activities of metabolic enzymes in cortical 
and medullary homogenates. 
Duration after administration of NErO> 
Control 	12 h 	24 h 	481, 	96 h 	168 h 
Cortex 21.56±1.08 34.47±1.S7* 43,62±201' 63.80+257 41.05±199' 2954±1.62 
Medulla 23.6531.17 29,06+169* 3951-211* 52.96±2.95* 34.03±1.48* 25.8411.83' 
HK 
Cceex 8.01±0.32 10.12+0,48* 15.24+1.01' 19.65±1.19* 17.861098* 14.73±0,87' 
Medulla 7.46±0.27 9.78±0.54* 13.17+0.98' 18.84±1.24* 15.43±1.04' 10.14±0,71* 
MDH 
Comex 16.18±0.82 14.01±0.39* 9.754 0.22* 5.80_0.20' 11.10!0.38* 13.30±0.51* 
Medulla 12.69±0S7 942+0.17' 673+0.12* 4.08-011^ 8.22±0.22* 10.02±0.14' 
ME 
Cortex 1,67±0.11 5.67±0,29* 9.03±034* 14,62±1.41* 10.49±0,44* 5,84±0.31* 
Medulla 2.97-0.17 5.6210.28* 11.8810.43' 22.03±1.01* 12.11±0.65' 5.97±0.28* 
FBP 
Comex 1.06±0.09 0.7320.06* 0.45±0.03' 0.23+_0.03* 0.50±0.05' 0.83±0.07* 
Medulla 132±0.12 1.24+0.08* 098*006* 0.74±0.07* 1.05±1.06* 1.16+_0.08* 
G6P 
Cortex 0.32+005 0.26+1103* 47.22+0.02* 015+_0.01* 0.24+0.03* 028+_0.01* 
Medulla 0,46±0.07 0.35±0.04* 0.30±0.05' 0.18±0.02* 0.32±0.03* 0.38±0.04* 
GGPD 
Cortex 17.56±185 1205-1.32' 9.87±1,11* 7.20±0,91* 10.33+1.22* 15.15±151* 
Medulla 1357+J34 9,64+1-11* 786+0.94* 6,45+0.%3" e.19±1.01* 12.05±1.28` 
Results are mean + SEM of six different preparations. 
Specific acUvi¢cs of LDH, HK, Mlles, ML and GOP!.) are in nmoles/mg protein/train while 
FDP and  G6P are in µrnoles /mg protein /hr. *SigniIcantly different at p< 0.05 from control. 
LDH, lactate de±ydrr,gcmasG HK, hexok3nase; wIDes, palate dvhrdroga;tiast; ME, make enzyme; FliP, 
fructose 1,6-lvsphoxphatase; G6P, glucose 6-phosphatase; G6PD, glucose 6-phosphate dehydrogenzse. 
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PART-II B 
PROTECTIVE EFFECT OF TAURINE AND VITAMIN C ON KBRO3 
INDUCED NEPHROTOXICITY IN RATS 
Experimental design: _ldministration of KBrO, to rats caused significant alterations in 
several parameters of renal tissue with maximum changes observed 48 h after the 
treatment. VC and taurine, both known to have strong AO potential, were used in the 
present study to see if they could protect against KBrO, induced nephrotoxicity. Since 
the previous experiments had indicated that KBrO, induced nephrotoxicity was 
maximum after 48 h, the effect of pre-treatment with VC or taurine was, therefore, 
studied 48 h after administration of KBrO,. 
In this series of experiments, there were six groups: control, KBrO, alone, VC alone, 
N'C+KBrO3, taurinc alone and taurine+KBrO,. 'There were six animals in each group. 
After the completion of dosage, the animals were sacrificed and blood and kidneys were 
removed. Plasma was separated by centrifugation of blood at 2000 x g for 10 min. The 
kidneys were processed for the preparation of homogenates and BBM1V as described in 
"Methods". 
Results 
The effect of KBrO; alone and in combination with VC or taurine was determined on 
various parameters in rat plasma and kidney. 
1. Effect of taurine and VC pre-treatment on KBrO3 induced changes on some 
plasma parameters 
Administration of KBrO; to rats resulted in significant increase in serum creatinine 
(+239.440 0) and BUN (+145.92%) but decrease in Pi (-70.84%) and glucose (-42.06%) 
levels, compared to control rats..\dminstration of taurine or VC to KBrO, treated rats 
resulted in significant reversal of various KBrO,-induced alterations in these plasma 
parameters. Both taurine and VC prevented KBrO; -induced increase of creatinine, BU N 
and decrease of serum Pi and glucose. However, VC was more effective than raurine in 
alleviating these KBr(); induced changes in plasma [Table 8J. 
2. Effect of taurine and VC pre-treatment on KBrO,-induced changes in activities 
of BBM marker enzymes 
the specific activities of BBM enzymes (:1P. GGT, 1..\P and maltase) were determined 
in renal homogenates and isolated BB.\IV prepared from animals in the six groups. 
Treatment of rats with KBrO, alone resulted in a significant decrease (35-65%) in the 
activities of these enzymes in the homogenates of both cortex and medulla ('fable 9j and 
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also in isolated BBMV ITable 101. VC and taurine pre-treatment resulted in a significant 
amelioration in the KBrO,-induced reduction in the activities of these enzymes 
compared to control; the activities of all enzymes recover significantly in VC+KBrO3  
and taurine+KBrO3 groups. The activities were, however, not completely restored to 
normal values. VC was more effective than taurine in ameliorating the KBrO3 induced 
alterations in BBM marker enzymes. Administration of either VC or taurine alone had no 
effect on the activities of these enzymes and they were the same as in control group. 
The kinetic parameters, K., and \'mom; values of LAP, AP, GGT and maltase were 
determined in BBMIV prepared from cortical homogenates of all six groups. K.1 and 
of these BBNI enzymes were determined from Lineweaver-Burk plots by assaying the 
enzymes at different substrate concentrations. 
Treatment with KBrO, led to significant lowering of V, values of all BBMM enzymes 
[Table Ill. However, pre-treatment with VC or taurine led to significant recovery in the 
V1,,,, values of all the BBhi enzymes. Administration of VC or taurine alone did not cause 
significant changes in VT1 compared to the control group. The Km values of VC alone, 
taurine alone, KBrO., alone, VC+KBrOS and taurine+KBrO3 treated groups showed 
insignificant changes compared to the control group. 
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Table 8: Effect of taurine and VC pre-treatment on KBrO3 -induced changes in plasma 
parameters of rats. 
Conrrol 	KBrO, alone 	VC alone 	VC*YBrO3 Taurine alone Tatuine+KBr03 
13UN 1028±_1.15 26.51±1.89* 9.16!0.66 1187±0.94* 9.86±0.74 15.75±097* 
Cxeetiitine 038+0.94 1.29+_0.13* 0.36+0.05 0.44±0.07 0.37±0.02 0.48±0.05* 
Phosphate 42.21±1.07 12.31±0.87* 43.46±1.28 32.620.88' 40.56±1.11 35.37±0.64- 
Glucose 150.93±3.4 87.25±2.24* 143.11±8.4 132.8±7.52* 148.75±3.17 121.45±2.84* 
Vit C 3.42±0.14 0.92±0.04* 4.081008 3.05±0.06*  3.8920.11 2.67}0.07*  
Results uc mean±$FM of xis different preparations. 
Glucose, 13UN and creatrune levels are in mg/ 100 nd while phosphate and Vit C are in ig/td 
*Signiticandv different from control at p < 0.05. 
BUN, blood urea nitrogen; Vit C, vitamin C. 
Table 9: Effect of taurine and VC pre-treatment on KBiO;  induced changes in the 
activities of BBNl marker enzymes in cortical and medullary homogenates. 
Control 	KBrO; alone 	VC alone 	VC+K$rOa Taurine alone Tauriue+l3rO3 
Cortex 4.84±0.25 2.79±0.16* 4.79+0.27 4.2930.22 4.91±0.22 3.5630.18* 
Medulla 3.85+0.17 2.44±'0.11* 3.98+0.18 3Ill+D19 3.9"+0.19 2,94±0.11* 
AP 
Cortex 4.04±0.21 2.21±0.11* 3.98+011 3,57+0.19 4.11±0.18 3.01±0,18* 
Medulla 3.6630.18 1.87±0.09* .3.75±p_14 3,22+014 3.7540.74 3.0230.12* 
GGT 
Cortex 3.10±0.11 1.54+0.09` 3.07+_0.12 2.96±0.11 3.17±0.12 2.74±0.19* 
Medulla 2.49±0.08 1.13±0,07-  2.3820.11 22430.09 2.55±0.12 2.1030,14* 
Maltase 
Cortex 21.17+.47 8.09+1.52* 2115+122 20.24±2.01 21.94±1.89 19.28±2.06' 
Medulla 14.10+1_19 5.16+0.68* 1178±1.07 13.132103 15.31+_1.68 12.08+_170-  
Results are mean±SEM of sic different preparations. 
Specific actvifex of enzymes are in pmoles/mg protein/ht. 
*Signtfcandy different from control at p< 0.05. 
LAP, leucute aminopeptidase; AP, alkaline phosphatase; GGT, y-glutanryl transferase. 
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Table 10: Effect of marine and VC pre-treatment on KBrO3- induced changes in the 
activities of BBM marker enzymes in isolated BBMV. 
Control KBro, alone 	VC alone 	VC+KBr03 Tatuite alone 	Taunve+KgrO 
TAP 	4625±3.47 23.69+1.57* 	44.07+3.48 	38.61±3.41* 47.01±3.58 	33.122.01* 
Al' 	37.63±3.01 18.4221.19* 	35.42+3.09 	32.13+2.98* 38.80±2.45 	27.42±1.41+ 
GGT 	24.28+1.25 11.23±027* 	26.71 	.49 	23.09±2.71 24.89±1.57 	19.99±1.64* 
Maltase 	194.01±6.25 78.94±3.52 	18606±5.94 	181.06±7.41 196.86+11.9 	174.52±R.57` 
Results are mean±SEM of four different preparations. 
Specific activities of enzymes are in .moles/mg protein/hr. 
*Significantly different from control at p< 0.05. 
LAP, leucine amutopeptidase; Al', alkaline phosphatase; GGT, y-glutamyl transferase. 
Table 11: Effect of tautine and VC pre-treatment on KBrOc  induced changes in the 
kinetic parameters of BBM market enzymes. 
Groups Km (mM) Vmu (µmoles/mgpmtein/h) 
LAP 
Control 0.18±0.004 18.87+_122 
I 	rQ3 0.16±0.002 9.37±0.63* 
VC 0.17±0.003 19.62+_0, 76 
VC+KBcO, 0.20±0004 15.37+_0.84* 
Taurine 0.15±0.001 20.12+1 76 
Tauline+KliiO 0.21+0.004 14.72+1.12* 
AP 
Control 34.48±1.60 74,8013.35 
KBrO3 31.25±1.45 37.82±1.79^ 
VC 32.88±172 72.87+1.84 
VC+IMrO3 35.07=1.87 59.74±136* 
Tavnne 32.41±1.39 75.14±2.31 
Taunan,+KBiO3 33.32±1.74 52.78±1.94* 
GGT 
ConttoL 2.04±0.014 11.97+098 
KEtO; 2.02±0.011 5.02+0.19* 
VC 2.07±0.15 12.86±0.63* 
V C+KBrO, 2.01 ±0.12 11.01 +0-49 
Taurine 1.96±0.008 12.27±1.12 
'famne+KBrO j  2.05±0.011 10.74=0.66 
Maltase 
Control 17.69±1.48 291.86±9.45 
KB4O, 15.38±0.98 181.12+7.14* 
VC 16.37±159 288,94±8.63 
VC+KJlrO, 1701!178 247.37±7.63* 
Tauune 16-66+1175 293.14+11.01 
Taunne I KBrO, 1639±1.01 230.45±10.74' 
K.., and Vm,,, were calculated from double reciprocal (1/v vs 1/[Sj) Lineweavet-Burk plots. 
Results are mean+_SPM of four different preparations. 
`Signi&xrantly different from control at pc 0.05. 
LAP, leuciue arnnopeptidase; Al', alkaline phoaphatace; GGT, y-glutavnyl tratrsferase. 
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3. Effect of taurine and VC pre-treatment on KBrO3-induced changes in total 
ATPase and ACP activities 
Treatment of rats with KBrO; alone resulted in significant alterations in the activities of 
ACP and total X -ease when compared to respective controls. VC and taurine pre-
treatment resulted in a significant amelioration in the KBrO;- induced alterations in the 
activities of both these enzymes. The enzyme activities recovered significantly in rats 
treated with KBrO, and VC or taurine, although the activity levels were not completely 
restored to normal values [Table 121. VC was more effective than taurine in ameliorating 
the KBrO, induced alterations. Administration of either VC or taurine alone had no 
effects on the activities of these enzymes and they were the same as in the control group. 
4. Effect of taurine and VC pre-treatment on KBrO3-induced changes in the 
activities of enzymes of carbohydrate metabolism 
'l he effect of treatment with KBrO, alone and after administration of VC or taurine was 
determined on the activities of several enzymes of carbohydrate metabolism in the 
homogenates of renal cortex and medulla. These enzymes include LDH and HK 
(glycolysis), MIDH (citric acid cycle), G6P and FBP (gluconeogenesis), G6PD (pentose 
phosphate pathway) and M (NADPH generation). KBrO, treatment significantly 
increased the activity LDFI while the activity of MDH was decreased [fable 13]. 
Administration of KBrO3 also decreased the activities of gluconeogenic enzymes, glucose 
6-phosphatase and fructose 1,6-bisphosphatase, in cortex and medulla. '11ie effect of 
KBrO, was also determined on G6PD and NIl; that are the major source of NADPI-I 
which is needed in various anabolic reactions. Treatment with KBrO, alone significantly 
decreased G6PD but increased ME activity. However, in the taurine+KBrO. and 
VC+KBr(); groups there was significant attenuation in the KBrO;-induced alterations in 
the activities of all these metabolic enzymes. This suggests that VC and taurine restore 
the metabolic pathways that are altered by administration of KBrO,. Treatment with VC 
or taurine alone did not significantly change the activities of any of these enzymes, 
suggesting that they do not alter the cellular metabolic pathways on their own. 
5. Effect of taurine and VC pre-treatment on KBrO,-induced changes on some 
parameters of OS 
The ROS generated under conditions of OS cause increase in LPO, protein oxidation as 
well as oxidation of protein and non-protein (mainly GSH) sulfhydryl groups. These 
parameters were determined in renal cortical and medullary homogenates prepared from 
animals in the six groups. 
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Table 12: Effect of taurine and VC pre-treatment on KBrO,-induced changes in total 
ATPase and acid phosphatase activity in cortical and medullary homogenates. 
Control KBrO3 alone 	VC alone 	VC+KBr03 	Taurine alone 	Taurine+KBrOz 
Total ATPase 
Cortex 	8.04±0.48 1.68±0.17* 	8.14±0.62 	7.61±0.39 	8.11±0.57 	6.48±0.37` 
Medulla 	6.41±0.46 1.32±0.15* 	6.57±0.29 	5.71±0.19 	6.57±0.29 	4.82±0.24* 
ACP 
Cortex 	0.72±0.09 2.97±0.16* 	0.69±0.04 	0.87±0.07* 	0.70±0.05 	0.96±0.09* 
Medulla 	1.25±0.06 3.30±0.16* 	1.23±0.04 	1.34±0.08 	1.22±0.08 	1.41±0.09* 
Results are mean ± SEM of six different preparations. 
Specific activities are in µmoles/mg protein/hr. 
*Significantly different at p< 0.05 from control. 
ACP, acid phosphatase. 
Table 13: Effect of taurine and \'C pre-treatment on KBrO,-induced changes in the 
activities of enzymes of carbohydrate metabolism in homogenates of renal 
cortex and medulla. 
Control 	KBr03 alone 	VC alone 	V'C+KBrOi 	Taurine alone 'faurine+KBrO; 
LDH 
Cortex 19.85±1.26 58.07±3.12* 20.71±1.81 22.54±1.31 20.54±1.31 24.63±2.44* 
Medulla 22.71±2.15 50.04±2.55* 24.01±2.04 24.11±1.94 23.87±1.94 27.14±2.01* 
HK 
Cortex 7.89±0.18 19.15+1.62' 7.92±0.24 8.79±0.29 8.04±0.51 10.06±0.57* 
Medulla 6.42±0.16 16.14±0.74* 6.53±0.21 7.43±0,26' 7.04±0.24 8.17±0.23* 
AMDH 
Cortex 15.02±1.43 4.73±0.45* 15.11±1.88 13.47±1.46 15.30±1.33 12.50±0.97* 
Medulla 13.21±0.94 3.19±0.29* 13.46±1.49 12.27±127 13.70±1.01 10.82±0.84* 
ME 
Cortex 1.82±0.14 15.45±1.86* 1.86±0.25 4.84±0.18* 1.95±0.22 7.64±0.42* 
Medulla 3.16±0.47 24.42±1.94* 3.57±0.31 5.68±0.21 * 3.42±0.61 10.42±0.88' 
FBP 
Cortex 1.11±0.09 0.22±0.03* 1.14±1.88 1.01±0.08 1.15±0.08 0.90±0.06* 
Medulla 1.36±0.11 0.71±0.04* 1.42±1.88 1.22±0.09' 1.47±0.13 1.15±0.09* 
G6P 
Cortex 0.44±0.05 0.19±0.01 0.50±0.04 0.38±0.07 0.49±0.04 0.30±0.02* 
Medulla 0.61±0.04 0.30±0.02* 0.68±0.05 0.57±0.04 0.70±0.04 0.45+0.03* 
G6PD 
Cortex 14.89±1.74 6.62±0.38' 15.01±0.27 13.52±0.38 15.26±1.43 12.41±1.85 
Medulla 12.18±1.33 4.04±0.18* 12.51±0.19 11.01±0.17 12.44±1.22 10.45±1.05 
Results are mean ± SEM of six different preparations. 
Specific activities of LDI1, MDI I, ME and G6PD are in nmoles/mg protein/min while FBP and 
G6P are in µmoles/mg protein/hr. 
*Significantly different from control at p< 0.05. 
Ilk, hexokinase; LD11, lactate dchydrogenasc; MIDI1, malate dehydrogenase; ME, malic enzyme; 
FBP, fructose 1,6-bisphosphatase; G6P, glucose 6-phosphatase; G6PD, glucose 6-phosphate 
dchydrogcnase. 
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I,PO was determined from levels of MI).\ which reacts with thiobarbituric acid to give a 
pink coloured product. Protein oxidation increases carbonyl groups which were 
determined after reaction with 2,4-dinitrophenv1 hvdrazine. Administration of KBr0 3 
alone greatly enhanced both I.PO and protein oxidation as reflected in elevated levels of 
malondialdehyde (2-fold) and protein carbonyls (3-fold) compared to the control group. 
It also resulted in significant reduction in total SH and GSFI content [Table 14]. There 
was also a marked increase in the level of H,0, in renal homogenates in KBrO, treated 
animals. Ilowever, these KlirO-induced changes were significantly attenuated by 
administration of either VC or taurine prior to treatment with KBr03. 'Treatment with 
VC or taurine alone did not significantly alter any of these parameters. The results 
indicate marked protection by both VC and taurine against K13r0, induced OS in renal 
tissue. \'C was more effective than taurine in protecting against KBrO.-induced oxidative 
damage to renal cortex and medulla. 
Table 14: Effect of taurine and VC pre-treatment on KBrO,-induccd changes in some 
parameters of oxidative stress in homogenates of renal cortex and medulla. 
Control 1BrO1 alone VC alone \'C+KBrOi Taurine alone Taurine+KBrOi 
MIDA 
(;c,rtex 68.85±2.01 145.01 ±6.12 66.42±3.01 -'3.21 ±3.67  66.1)1 +2.86 S2.14±3.97 
Medulla 47.76±1.11 110.54±3.85« 45.01±1.86 49.14±1.15 44.21±1.59 56.23±2.1 	` 
Carbony l 
(Cortex 90.15±4.17  26821±10.01* .S.15±1.1 113.01±-.86' 88.63±3.11 130.64±8.31` 
Medulla 62.23±1.94 1-9.65 '?.63` 61.14±3.61 "0.01±3.45' 60.91±1.91 86.53±2.14k 
Total SH 
Cortex 17.15±1.30 '.68±0.24-  18.52±1.61 15.19±1.24 18.01±1.73 14.28±1.97k 
Medulla 13.63±0.47 6.89±0.21' 15.18±1.2- 12.01±1.06 14.66±0.86 11.89±(1.84" 
GSH 
Cortex 2.84±0.11 0.93±0.0-' 3.01±0.16 2.11 ±0.04* 2.96±0.09 1.96±0.11' 
Medulla 1.94±0.07  0.78±0.04' 2.21+0.18 1.61±0.t)T' 2.05±0.03 1.38±0.05' 
F1202 
Cortex 248.34±10.4 71)128±25.68* 221.01±8.86 291.01±9.51' 244.01±12.9 386.55±13.64* 
Medulla 1-5.64± 7.14 331.4-±18.-4* 166.01+,.41 201.01±676' 1-2.96±8.86 234.67±12.74` 
Results are meantSEM of six different preparations. 
MDA, carbonyl content and H2O2 levels are in nmoles/g tissue while total SI I and GSI I are in 
µmoles/g tissue. 
*Sigiiiticantly diftcrent from control at p< 0.05. 
dill-\, malondialdehrde; SI i sulf1ydn.l; GSI 1 glutathionc; 11202 hydrogen peroxide. 
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6. Effect of taurine and VC pre-treatment on KBrO3- induced DNA damage and 
DNA-protein cross-linking 
The single cell gel electrophoresis assay (Comet assay), is a simple and sensititive 
technique for the evaluation of DNA damage/repair and genotoxicity testing in 
mammalian cells, was used to study DNA damage in kidney. Administration of KBrO, to 
rats caused major DNA damage in renal tissue as evidenced by elongated tail length with 
respect to the control. This indicates increased level of DNA strand breaks and alkali 
labile sites in the renal cells [Figure 3, 4]. Significant DNA damage was observed in the 
renal cortex in KBrO, treated rats as compared to untreated control. Pre-treatment either 
with VC or taurine reduced the extent of KBrO;-induced DNA damage a% shown by 
decrease in comet tail length. VC and taurine by themselves did not damage the DNA in 
the renal tissue and the comet tail length was the same as in control cells. 
Oral administration of KBrO3 led to significant formation of DNA-protein cross-links 
(DPC) both in renal cortex and medulla when compared to the untreated control group. 
The magnitude of DPC was much greater in cortex than medulla (Table 151. 
Administration of IC13tO3 also induced DNA fragmentation with release of acid soluble 
nucleotides in the supernatant as measured by the diphenylanvne assay. The magnitude 
was again higher in cortex (167%) than medulla (120%). Pre-treatment with VC or 
taurine significantly decreased KBrO3  induced DNA Fragmentation and DPC in renal 
tissues while VC and taurine alone had no effect [Figure 5]. 
7. Histology 
Histological examination of the kidney from control animals revealed normal histology 
including normal corpuscle and tubular epithelium. Marked histological changes were 
observed in kidneys in KBrO-treated rats and extensive damage and renal injuries were 
visible [Figure 6]. KBtO, treatment resulted in cellular swelling and tubular dilatation with 
damage to renal corpuscles and tubules. Pie-treatment with uauuoe and VC greatly 
attenuated the changes induced by KBrO, with the kidney showing much reduced 
damage. The V(: and taurine alone groups showed reasonably well preserved condition 
of both the components. Thus VC or taurine by themselves did not induce any lesions in 
the kidney. 
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Control KBrO; ab,ui- 
VC+KBt03 	 Taurine alone 	 Taurine+KBrO3 
Figure 3: DNA damage by comet assay. Renal cortical cells were subjected to alkaline single cell 
gel electrophoresis (comet assay) to assess the degree of DNA breakage. 
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Figure 4: Comet tail lengths. The results of comet assay (Figure 3) are represented as mean 
values of tail lengths. 
'Significantly different at p < 0.t)5 from control. 
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Table 15: Effect of taurine and VC pre-treatment on KBrO -induced DPC formation in 
renal cortex and medulla. 
Protein cross linked DNA °'0a 	 DPC coefficient b 
Control 
Cortex 3.13±0.25 1 
Medulla 1.92±0.07 1 
KBrO3 alone 
Cortex 14.21±0.75* 4.53 
Medulla 5.06±0.19* 2.64 
VC alone 
Cortex 3.33±0.27 1.03 
Medulla 1.95±0.09 1.01 
VC+K:BrO3 
Cortex 7.06±0.04* 2.26 
Medulla 3.12±0.03* 1.63 
Taurine alone 
Cortex 3.48±0.18 1.11 
Medulla 2.11±0.09 1.09 
Taurine+KBrO3 
Cortex 9.17±053* 2.93 
Medulla 1.03±0.37 2.09  
Results are mean±SEMf of six different preparations. 
-Protein cross-linked DNA/ total DNA. 
bProtein cross-linked DNA (%) in treated animals/protein cross-linked DNA (o/) in control 
animals 
*Significantly different at p< 0.05 from control. 
DPC, DNA-protein cross-links. 
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Control 	KBrO3 	VC 	VC+KBrO3 Taurine Taurine+KBrO3 
Figure 5: DNA fragmentation in renal cortex and medulla determined by diphenylamine assay. 
Results are mean±SEMI of six different preparations. 
* Significantly different at p < 0.05 from control. 
100 
cart-II: 9psufu anu(Drscussion 
;t 	(' 'mss_ 
r r%# 
Figure 6: Histology of hematoxvlin and eosin stained sections of rat kidney showing glomerular 
capillary tuft (red *) in the renal corpuscle and renal tubule (curved yellow—+). Kidney 
in the untreated control [A] shows normal corpuscle and tubular epithelium whereas 
KBrOi treated group [B] reveals extensive damage to both components. Kidneys 
from VC alone treated animals (C] and taurine alone treated animals P1 show 
preserved conditions of both the components while VC+Kl3rO, [E] and 
taurine+KBrO,groups [F] show resumption in the morphology of renal corpuscle as 
well as renal tubule. 
I i&E stain. X 400, scale bar [—] _ 50 µm. 
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DISCUSSION 
The kidney is of paramount importance in the excretion of many drugs and chemicals, 
some of which are toxic to it. Nephrotoxicity is the most common problem associated with 
various drugs and xenobiotics used in our daily life and this leads to attrition in renal 
excretory function, cell necrosis and death. Investigations into the renal toxicity of such 
xenobiotics aid in providing information about the mechanism invohred in renal 
dysfunction. KBrO; is a widely used food additive that is added to flour during the bread 
making process. Most of the bromate is lost during the baking process but residual 
amounts can still be detected in the baked bread. Rats fed bread prepared from flour 
containing I BrO3 showed alterations in marker enzymes of liver and kidney damage 
[Oloyedc and Sunmonu, 20091. There are several reports documenting the nephrotoxicity 
of KBrO, but most of them involve subcutaneous or, more cotmnonly, intraperitoneal 
administration of bromate. However, the primary exposure of humans to bromate is via 
the oral route. We have, therefore, investigated the muhifaceted biochemical effects of 
orally administered KBrO, in the medulla and cortex legions of the kidney. The activities 
of various enzymes of energy metabolism (glycolysis, TCA cycle, gluconeogenesis, hexose 
monophosphate shunt pathway), enzymes of renal BBM and parameters of OS were 
determined to understand the biochemical mechanism of KBrO3 -induced nephrotoxicity. 
The activities of BB.M enzymes were significantly decreased in cortical :md medullary 
homogenates after KBrO, administration with the cstrnt of decrease being grcaier in 
cortex than medulla. These enzyme activities also declined in the BBMV prepared from 
animals 48 1a after administration of KBrO,. There was a greater decrease in the enzyme 
activities in the BBMV than in the cortical homogenates. 'Iltus, the membrane bound 
enzymes appear to be more sensitive to KBrO, than the soluble enzymes. Kinetic studies 
showed that the decrease in activities of BBM enzyme was largely due to decrease in Vm ,. 
with no effect on K,,t values indicating reduction/loss of active enzyme molecules from the 
membranes while their affinities for the substrate remained unchanged. 
'there are several reasons that could result in the reduced activity of BBM enzymes. Firstt 
there could be loss of the 13BM or enzyme molecules into the lumen of the tubule due to 
toxic damage, as suggested for some nephrotoxicants [Fatima of al., 2005; Scherberich el a/., 
1993]. The second possibility is inactivation by oxidative modification of these enzymes 
due to the KBrO,-induced ROS and OS. Third, there could be inhibition due to direct 
modification of die enzymes by KBr03, as suggested by the at vitro experiment. However, 
direct rnQdifieation cannot be the only reason for reduced activities of BBM enzymes since 
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maltase, AP and GGT which were inhibited less than 25% in the in vitro experiment 
showed ?50° inactivation under in nri) conditions. Thus, a combination of the above 
mentioned reasons could have resulted in reduced activities of BBMM enzymes upon 
administration of KBrO. 
The activities of various enzymes involved in glvcoh•sis, TCA cycle, gluconcogenesis and 
hexose monophosphate shunt pathway were affected by KBrO) treatment. 
Administration of KBrO, significantly increased the activity of LDH with greater 
increase in the cortex compared to medulla. The marked decrease in NIDH activity 
indicates an impaired oxidative metabolism of glucose and decreased _1"I'P production 
and hence depressed renal reabsorptive properties. Although the actual rates of glycolysis 
and other pathways were not determined, the increased activity of LDH along with 
simultaneous decline in MMD! I may suggest a shift in energy production from oxidative 
phosphorylation to glycolysis due to mitochondria) damage caused by KBrO.. This is 
supported by earlier studies of Ahlborn et ra/. [20091 which have shown up-regulation of 
several glycolytic genes in response to KBrO, exposure accompanied by severe loss of 
mitochondrial function. The decrease in activities of gluconcogenic enzymes, FBP and 
GOP, may be the result of decrease in TCA cycle enzyme activities. This can be explained 
by the fact that the reduced activities of TC:1 cycle enzymes, especially that of \IDH, 
may have reduced the production of oxaloacetate from malate which is required not only 
for the continuation of TCA cycle but also for gluconcogenesis. 
The oxidarive conversion of glucose or glucose 6-phosphate to 6-
phosphogluconolacto ne which is catalysed by G6PD, the first enzyme of hexose 
monophosphate shunt pathway, was found to be lowered due to administration of 
KBrO,. The lower generation of NADPH by GGPD, which is essential for many 
reductive anabolic reactions, may have been compensated to some extent by the 
increased activity of \ADP-malic enzyme. Total ATPase activity was decreased 
suggesting that the basolateral membrane was also damaged while acid phosphatase 
activity was increased indicating an increased number/size of lvsosomes in proximal 
tubule epithelial cells. 
The underlying mechanism by which KBrO, causes nephrototicityy is not well 
understood. However, there are reports suggesting that ROS are important mediators of 
KBrO; nephropathv %hang rt al, 201O; ').hang el a1., 21)11). ROS are by-products of 
aerobic metabolism and excess production causes cellular injury and necrosis via several 
mechanisms including oxidation of lipids, proteins and llNA (Sai etal., 1994; Karbownik 
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el al., 20061. Decreased GSH and total SH content accompanied by increase in I.PO and 
protein oxidation suggest induction of OS in the kidney. The level of H2O,, a potent 
oxidant and ROS, was also greatly increased in KBrO, treated animals. The severity of 
the damage appeared to be more pronounced in renal cortex than in medulla in almost all 
the parameters except TBARS. Increase in I,PO and protein oxidation in the kidney by 
intraperitoneally administered KBrO3 have been reported previously [Sai el al., 1994; 
Khan and Sultana, 2005b; Bao el al., 2008J. However, this is the first report in which the 
effect has been studied separately in the medulla and cortex. 
The changes introduced by single oral dose of KBrO,, in all the above mentioned 
parameters, showed a similar pattern. Alterations were seen even at the earliest time point 
(12 h) followed by further changes at 2.1 h. After this the magnitude of KBrO,-induced 
changes peaked and was maximum at 48 h after treatment. This was followed by a 
recovery towards control values on subsequent days. However, the nephrotoxicity was 
not completely reversed at 168 h since urea nitrogen and plasma creatinine levels had not 
completely returned to control values. However, the results show that nephrotoxicity, 
and the accompanying biochemical changes induced by a single oral dose of KBrO,, 
appears to be reversible and the kidney can repair much of the damage caused by 
bromate. 'Iliese results are in agreement with previously published reports in which the 
nephrotoxicity upon accidental exposure of humans to bromate was shown to be 
reversible and no renal effect was seen after several days ILPA, 2001]. Other studies 
investigating renal injury in response to oxidant chemical exposure have also shown that 
the effects are reversible and renal function is restored several days after withdrawal of the 
nephrotoxic agent [Nowak, 2002; Fatima etal., 2005; Naqshbandi el al., 2012]. 
It has been earlier reported that protection against KBrO,-induced damage can be 
achieved by various AO, since they can easily reduce KBrO, [Khan and Sultana, 2005a; 
Bao et al., 2008; Khan et al, 2012a; Sultan el nl., 20121. VC and taurine are dietary 
compounds which are found in several foods and have been shown to reduce the risk of 
various forms of cancer, cardiovascular and renal disorders and exhibit protective effects 
against several environmental agents due to their AO, antimutagenic and anticarcinogenic 
properties. In this study, VC and taurine have been used as potential protective agents 
against KI3rO, induced nephrotoxicity. Rats in the VC+KBrO, group were given two 
oral doses of VC (each of 250 mg/kg body weight) at 24 h intervals. Then 6 h after the 
second dose of VC, they were given a single dose of KBrO; (100 mg/kg body weight). In 
the taurine+KBrO, group, rats were given taurine (100 mg/kg body weight/ day) orally 
104 
Part-11: ?putts and Discussion 
for five days and KBrO., (1U() mg/kg body weight) was given 6 h after the last dose of 
taurine. .\l1 animals were sacrificed 48 h after the administration of KBrO. Pre-treatment 
with either VC or taurine resulted in the significant recovery in BUN, creatinine, Pi, and 
glucose levels. Administration of either \'C or taurine prior to treatment with KBrO, 
resulted in significant recovery in the activity of all BBhf marker enzymes. This implies 
that both VC and taurine can reduce nephrototicity and BBM damage induced by 
KBrO,. Pre-treatment with VC or taurine also resulted in significant recovery in LPO, 
protein carbonyl, H,U_ levels, total 511 and GSH content while the alterations in 
carbohydrate metabolism were also attenuated. The altered enzyme activities returned to 
near control values exhibiting the A0 and protective role of both VC and taurine against 
KBrO induced OS and subsequent nephropatht•. I lowever, \•C was more effective than 
taunne in preventing the KBrO mediated free radical damage to rat kidney. The 
protective effect of VC and taurine on the enzyme activities is probably due to the 
quenching of free radicals/ROS induced by KBrO; treatment. 
Oral administration of KI3rO, induced DNA fragmentation, as monitored by release of 
nucleotides from damaged DNA, both in renal cortex and medulla when compared to 
control. This was confirmed by the Comet assay which showed increased level of DNA 
single strand breaks and alkali labile sites in the kidney. DNA-protein cross-links (DPC), 
which impede the activities of proteins involved in DNA replication, transcription and 
repair, were also significantly enhanced in rats treated with KBrO,. However, pre-
treatment of animals with either VC or taurine reduced the level of DNA damage and 
DPC formation induced by KBrO, probably by their free radical scavenging action. 
Histological observations of the kidney strongly support the biochemical results. The 
kidneys from KBrU, treated animals showed extensive ultrastructural damage, with the 
renal tubule and the glomeruli being severely affected. These changes were greatly 
reduced by prior administration of either VC or taurine to the animals. 
The above results have been summarized in Figure 7. KBrO~ enters the cell where it is 
reduced to bromide by intracellular reductants. This process is known to generate free 
radicals and ROS which then mediate tissue damage by oxidative modification of cellular 
components. l aurine and VC either stop this reduction process or directly 
quench/scavenge the free radicals and ROS thereby reducing oxidative damage to the 
cell and restoring normal tissue morphology. 
In conclusion, the results of the present study indicate that KBrO; elicited deleterious 
nephrotoxic and other adverse alterations in rat kidney by causing damage to 
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mitochondria, h•sosomes, basolateral and brush border membranes as reflected by 
significant alterations in the activities of specific biomarkers of these organelles. Most, if 
not all, of these effects, can be attributed to excessive ROS production caused by KBrO; 
administration. These damaging effects were greatly reduced upon pre-treatment of 
animals with VC or taurine. Both VC and taurine are inexpensive, non-toxic and can be 
administered safely to persons who are exposed to KBrO3 and related compounds. 
Based on our present observations and already known health benefits of VC and taurine, 
we propose that either VC or taurine may protect the kidney from damage induced by 
KBrO3 and perhaps other structurally related compounds like chlorates and iodates. 
KBrO3 
y enters the cell 
Cell membrane 
K r03 
VC/T 	Intracellular reduction process 
ROS 
KBr -~- VC/T 
Oxidative stress 
VC/T 
Lipid peroxidation and protein oxidation 	toehondrial dysfunction 
Late
DNA damage 
Damage to BBM and 	Altered carboh 	metabolism 
decreased activities ofBBM 
enzymes  
Tissue injury 
1 
lephi-opath~ 
Figure 7: Summary of KBrO3 induced alterations in renal cell metabolism, membrane integrity 
and oxidative stress and its amelioration by VC:/taurine. 
13B11, brush border membrane; KBr, potassium bromide; KBrO;, potassium 
bromate; ROS, reactive oxygen species; T: taurine; VC: vitamin C. 
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PART-III A 
EFFECT OF KBrO3 ON SMALL INTESTINE OF RATS 
Experimental design: Adult male Wistar rats were orally given a single dose of KBrO3 
(100 mg/kg body weight) and the animals were sacrificed 12, 24, 48, 96 and 168 h later. 
Control animals were given an equivalent volume of water by gavage. There were six 
animals in each group (one control and five KBrO3 treated). The entire small intestine 
was removed, washed and slit open. The mucosa was gently scraped with a glass slide 
and used for the preparation of homogenates and brush border membrane vesicles 
(BBMIV) as described in "Methods". 
Results 
The effect of KBrO; treatment alone on various parameters in intestinal mucosal 
homogenates was determined. 
1. Effect of KBrO3 on the activities of BBM marker enzymes 
The effect of in vitro incubation of BBMV with KBrO3 on BBM marker enzymes (LAP, 
AP, GGT and sucrase) was first studied. BBMIV from control rats were separately 
incubated with different concentrations of KBrO3 (0, 0.1, 0.25, 1.0 and 2.0 mM at 37 °C. 
At different tithes, aliquots were withdrawn and assayed for enzyme activities. All 
enzymes were inhibited, although to different extents. LAP was the most sensitive 
enzyme under these conditions showing 65"'o inhibition after 2 hr incubation with 
KBrO,. AP and sucrase showed 32% and 23°'o inhibition, respectively, while GGT was 
least inhibited (20%). There was no decline in the activities of these enzymes in BBh1V 
samples incubated at 37 °C in absence of KBrO, [Figure 1]. Thus, the inactivations seen 
here are due to KBrO, and not simple thermal inactivation of enzymes at 37 °C. 
The effect of KBrO; administration to rats on BBM enzymes in intestinal homogenates 
and isolated BBM\ was studied next. A significant decrease in the activities of all four 
enzymes was observed in the homogenates at 12, 24, 48 and 96 h after administration of 
KBrO ; to animals, when compared to the control group [fable 11. The maximum 
decrease in activities of all enzymes was 48 h after administration of KBrO);. _after this, 
recovery took place and at 168 h all enzyme activities had recovered to almost control 
values. The enzymes were then assayed in BB\IV prepared from intestines of animals in 
the 48 h group where maximum alteration in activities was seen. A significant decline in 
the specific activities of all enzymes was seen in the purified BBMV also (Table 21. The 
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magnitude of decrease in the specific activities of all these enzymes was similar in both 
homogenates and BBMV. 
Since KBrO, profoundly altered the activities of the enzymes in BBMV, their kinetic 
parameters, Michaelis constant (KM) and maximum velocity (Vm, J, were also determined 
in RI3MV prepared from animals 48 h after treatment with KBrO5. The enzymes were 
assayed at different substrate concentration and K., and Vm„ were determined from 
double reciprocal Lineweaver Burk plots (1/v vs 1/[S]). The Vm,a values of all four 
enzymes were significantly lowered in the BBMV from KBrOj treated rats compared to 
untreated controls. However, there was no change in the Kh1 of the enzymes [fable 3]. 
2. Effect of KBrO, on total ATPase and acid phosphatase (ACP) activities 
The effect of KBrO, treatment on the activity of total ATPase and ACP, a lysosomal 
marker enzyme, was determined in homogenates at different times after administration 
of KBrO3. The activities of both enzymes were altered differently [Table 4]. Total 
ATPase activity was decreased while the activity of ACP was increased. The changes in 
activities of both enzymes were maximum 48 h after treatment with KBrO,. However, 
recovery to almost control values was observed at 168 halter KBrO, treatment. 
3. Effect of KBtO3 on the activities of enzymes of carbohydrate metabolism 
The administration of KBrO3 to animals induced changes in the specific activities of 
various enzymes of carbohydrate metabolism in the intestinal homogenates [Table 5]. 
Treaunent of rats with KBrO3 significantly increased the activity of LDH (a marker of 
anaerobic glycolysis) while the activity of tcicatboxylic acid enzyme, malate 
dehydmgennsc (Mlles) was decreased ITable 5].'11te activities of gluconeogenic enzymes 
G6P and FBP in intestinal homogenates were decreased to a similar extent. The activity 
of G6PD was decreased while ME was significantly increased upon KBrO, treatment. 
The changes in activities of all carbohydrate metabolic enzymes were maximum 48 h 
after administration of KBrO~. Subsequent recovery in enzyme activities to almost 
control values took place in all cases with the exception of LDH and Mh'.. 
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Figure 1: Effect of in vitro incubation of BBM[V with KBrOi on the activities of LAP, AP, 
GGT and sucrase. 
BRNIV (protein concentration I mg/tnt) in 50 mkt sodium maleate buffer, pI1 6.0, 
from control animals were incubated with different concentrations of KBrO; at 37 °C 
in a total reaction volume of 0.5 ml. At different tines after the addition of KBrO,, 
aliquots were removed from the reaction mixture and assayed for enzyme activities. 
Results arc expressed relative to enzyme activities in KlirO;-untreated BBNIV samples 
kept on ice which served as the control. 
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Table 1: Effect of KBrO, treatment on the activities of BBN,l enzymes in intestinal 
homogenates. 
Control 12 h 
Duration after administration of KBrO, 
24 h 	 48 h 	 96 h 168 h 
LAP 3.35±0.32 3.04±0.14 2.41± 0.28* 1.71±0.13 2.37±0.24* 3.17±0.16 
AP 2.75±0.12 2.41±0.11 * 1.80±0.21 * 1.16±0.12* 2.06±0.22* 2.45±0.17* 
GGT 2.06±0.16 1.67±0.11* 1.20±0.07* 0.93±0.04* 1.37±0.12* 1.91±0.09 
Sucrase 26.30±2.45 20.07±1.17* 16.29±1.21 * 12.95±1.14* 21.75±2.05* 25.7±71.8 
Results are mean±SEM of six different preparations. 
Specific activities of LAP, AP, GGT and sucrase are in unoles/mg protein/hr. 
*Significantly different at p < 0.05 from control. 
LAP, leucine aminopeptidase; AP, alkaline phosphatase; GGT, y-glutamyl transferase. 
Table 2: Effect of KBrO, treatment on the activities of BBB enzymes in isolated 
BBMV. 
Control 	KBrO treated 	%, Decrease 
LP 15.00±1.22 7.86±0.48*  
AP 12.89±0.93 6.02±0.64* 53.3 
GGT 9.98±0.79 4.10±0.29* 58.9 
Sucrase 134.1±6.12 62.6±3.58* 53.3 
BBNfV were prepared from animals 48 h after administration of KBrO3 
Results are mean±SEM of four different BB0R' preparations. 
Specific activities are in µmoles/mg protein/hr. 
*Significantly- different at p< 0.05 from control. 
LAP, leucine aminopeptidase; AP, alkaline phosphatase; GGT, y-glutamyl transferase. 
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Table 3: l :ffcct cif KBr( ), treatment on kinetic parameters of BBN1 enzymes in isolated 
BBNIV. 
Decrease in 
LAP 
Control 0.061±0.004 3.95±0.21 
KBrO1 0.056±0.002 2.25±0.15 43.04 
AP 
Control 32.3±1.89 14.81±1.18 
KBrOi 31.6±1.64 11.34±0.91* 23.65 
GGT 
Control 161011 7.26±0.81 
KBr03 1.55±0.17 5.05±0.371 30.44 
Sucrase 
Control 38.5±2.01 100.2±3.41 
KBrOf 3'.2±1.96 5'.45±1.97*" 32.55 
K:,t and V,,,l, were calculated from double reciprocal (1/v vs 1/[S]) Lineu•eaeer-Burk plots. 
Ka, is in mmoles/L, and Vm is in unolcs/mg protein/hr. 
*Significantly different from control at p< 0.05. 
LAP, leucine arninopeptidase; AP, alkaline phosphatase; GGT, y-glutamvl transferase. 
Table 4: Effect of KBr03 treatment on total XI'Pase and acid phosphatase activities in 
intestinal homogenates. 
Duration after administration of KBrO; 
Control 	12h 	24 h 	48 h 	96 h 	168 h 
Total ATPase 	8.50±0.71 	6.31±0.31' 	4.53±0.28k 	2.31±0.1 P 	5.78±0.27' 	7.53±0.43 
.MCP 	 1.85±0.09 	2.41±0.l1 • 	3.05±0.23 ` 	4.76±0.31w 	3.13±0.15' 	1.94±0.11 
Results are mean±SEM of six different preparations. 
Specific activitiy is in lImUTGs/mg protein/hr. 
*Significantly different at p< 0.05 from control. 
.MCP, acid phosphatase. 
111 
Part-111: Qasults and Discussion 
4. Effect of KBrO3 on some parameters of OS 
To ascertain the induction of OS in the intestine after administration of KBrO3, several 
parameters of OS were assayed in the intestinal mucosal homogenates of control and 
KBrO3 treated rats. There was a significant increase in LPO after KBrO, administration 
with MDA levels being higher at all times in the KBrO,-treated groups compared to the 
untreated control. The maximum increase in I,PO was 48 h after KBrO3 treatment. 
Treatment of rats with KBrO1 increased the content of protein carbonyl groups, a 
measure of protein oxidation, in a time dependent manner. At 48 h there was maximum 
increase in carbonyl content in KBrO, administered animals when compared to the 
control group [Table 6]. Administration of KBrU, also resulted in significant reduction in 
total SH and GSH content at 24 h followed by a further decrease at 48 h followed by 
recovery. There was a marked increase in HZOZ levels with maximum increase again 
observed at 48 h. In all cases, recovery took place in the 96 and 168 h groups. 
5. Effect of KBrO, on the activities of some AO enzymes 
Oral administration of KBrO,- induced OS in the intestine that manifested as altered 
activities of various AO enzymes. The activity of SOD was greatly increased while that of 
CAT declined significantly in mucosal tissue of KBrO,-treated animals [Table 7]. 
However, there was a decline in the activities of GPx, GR and TR but the activity of 
GST was significantly enhanced. The changes in activities of these enzymes were again 
maximum 48 h after treatment with KBrO3. Subsequently, recovery in enzyme activities 
took place in all cases but, with the exception of GR, they still remained significantly 
different from the control values [Table 7]. 
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Table 5: I .ffect of KBrO; treatment on the activities of enzymes of carlx>hv-drate 
metabolism in intestinal homogenates. 
Control 12h 
Duration after administration of KBrO, 
24h 	 48h 	 96h 168h 
LDH 12.61±1.08 1 7.89±1.87* 24.52±2.01 43.21±3.14' 32.69±2.81* 23.35±1.62* 
MDII 10.22±0.82 8.31±0.39* 5.71+u.22,  3.53±0.20' 6.42±0.38* 9.41±0.51 
CIE 1.15±0.15 277±0.34' 6.73±0.44* 15.41±1.91 * 8.72±0.44' 5.90±054* 
FBP 0.98±0.09 0.88±0.06* 0.68±0.05* 0.48±0.03' 0.65±0.05* 0.90±0.07 
G6P 0.28±0.05 0.23±0.03* 0.18±0.02* 0.14±0.01 -  0.21±0.01* 0.25±0.01* 
GGPD 6.24±0.85 4.48±0.32' 2.85±0.31 * 0.90±0.04* 3.19±0.17* 5.73±0.32* 
Results are mean±SETA of six different preparations. 
Specific activities of LDH, HK, :MIDI I. ME and G6PD are in nmoles/ mg protein/min while 
FBI' and GGP are in µmoles/mg protein/hr. 
*Significantly different at p< 0.05 from control. 
LDI-1, lactate dehv-rogenase; HK, hexokinase; MIDI-1, malate dehydrogenase; MI, malic enzyme; 
FBP, fructose 1,6-bisphosphatase; GGP, glucose 6-phosphatase; GGPD, glucose 6-phosphate 
dchydrogenasc. 
Table 6: F ffect of KI3rO, treatment on some parameters of oxidative stress in intestinal 
homogenates. 
Control 12 h 
Duration after administration of KBrO, 
24h 	 48h 	 96h 168h 
MDA 43.51±1.95  .0±27 108.5±4.49' 161.9±6.61 `  147.01±4.91' 116.02±3.33* 
Carbonyl 52.8± 2.86 81.4±5.79` 164.6±6.19` 220.9±9.69' 148.2±7?5* 99.12± 5.10* 
'Total SH 15.12±1.13 1 1T1±1.8 9.34±1.92' 6.31±0.6 10.12±1.08* 12.54±1,21* 
GSH 1T±0.14 1.50±0.15' 1.10±0.08' 0.6 '±O.i)i `  1.30±0i1' 1.42±0.13* 
H20. 136.81±9.05 215.3±15.51 `  274.84±22.18' 360.01±24.56' 191.05±l4.61 `  169.22±7.25* 
Results are mean±SEMI of six different preparations. 
\ID.\. carbon%-] content and H=O: levels are in nmoles/g tissue while total SH and GSH are in 
umoles/g tissue. 
'Significantly ditlerent at p< 0.05 from control. 
MDA, nsalondialdetwdc: SH, sult1g-dn-a; (S1-I, reduced glutathffone; H_C)_, hydrogen peroxide. 
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6. Effect of K13rO3 on DNA damage and DNA-protein cross-finking 
The effect of KBrO3 on DNA-protein cross-linking (DPC) was studied since they are 
frequently produced by various xenobiotics/carcinogens especially under conditions of 
OS. Exposure to KBrO, enhanced DPC in animals by 2.33 fold at 24 It compared to the 
control value. DPC formation was again maximum at 48 h after administration of KBrO, 
(3.2 fold increase) followed by subsequent decline at 96 h and 168 h [Table 8]. 
KBrO- tareatinent induced DNA degradation, as shown by the diphenylamine 
coloritnctdc assay, in a time dependent manner. There was a significant increase in DNA 
degradation in the intestinal tnucosa of KBtO3 treated animals, which was almost two 
tunes the control value in the 48 h group [Figure 2]. this was confirmed by the alkaline 
single cell gel electrophoresis assay (comet assay). Administration of KBrO3 induced 
DNA damage in the mucosal cells of animals (as evidenced by increased comet tail 
length) when compared to control. This indicates increased level of DNA single strand 
breaks and alkali labile sites in the mucosal cells [Figure 3, 4]. In both the diphenylatnine 
and comet assays, the maximum damAge was observed at 48 la which then declined 
subsequently. 
Table 7: Effect of KBrO3 treatment on the activities of some anti-oxidant enzymes in 
intestinal homogenates. 
Duration after ndmthdtration of KBrO3 
Control 	12 Ii 	 24 h 	 48 h 	 96 h 	 168 h 
CAT 11.32±1.51 7.76+0,72* 5.35±0.44* 3.83±0.32* 5.67±0.18* 8.4,30.27* 
SOD 80.21}4.35 106.4±5.65* 148.9±4.46* 174.3±7.13* 128.6±3.07* 90.5±3.73* 
GPx 3.96±0.21 2.87±0.11* 2.34±0.08* 1.79±0.15* 2.16+_0.32* 3.01±0.25' 
GST 13.67±1-17 18.45±1.82* 26.59±1.50* 33.233291 23.35±2.15-^  17.29± 0.87k 
GR 21.60+1.83 17.79±1.05" 12.3330.66* 7.80!0.22* 1450±0.47* 18.96+1 74 
TR 7.49±0.18 5.84x0.29* 3.76±0.41" 2.03±0.14* 4.16+0.48* 5571-0.61* 
Results are tnean±SEM of six different preparations. 
Specific activity of SOD is in units/mg protein. 
Specific activities of CAT, GPx, GST, CR and TR are in nmol/mg Protein/min. 
*Significantly different at p< 0.05 from control. 
CAT, catalase; SOD, Cu-Zu superoxide dismutase; GPx, glutathione peroxidase; 
CST, g1irntMone-S-transferase; GR, ghtrithione reductase; TR thiotedoxin reducrase. 
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Table 8: kffect of 1<l;r( ), treatment on U\\.\-protein cross-linking in intestine. 
Group 	 Protein cross-linked I)N;V-k' 	DPC coefficients' 
Control 2.58±(1.12 1 
121i 3.75*_uu. I s 1.4.5 
24h ('.t11±I. 	r1 2.33 
-18 It 8.25±1,44' 3.20 
,)G h 6.81 +t ).8- • 2.64 
168 h 5.68±0.24 2.20 
Results are mean±SI;l\I of six different preparations. 
.`Protein cr()ss-linkcci D\.\; total D\.\. 
1,Protein cross-linked 1)N.\ 	o) in KBrO -treated animals/protein cross-linked DN. \ (°. o) in 
control annuals 
'Si;Wilicanthv Glitferent at p< ().O5 from control. 
DPC, 1)\.1-pr<,tcin cross-links. 
Control 12 h 	24h 	48 h 	96h 	168h 
Figure 2: 1)N.\ fragmentation in intestinal in mo gcn;ncs determined bt- the cliphenvlarnine assay. 
Result., are moan±SE~l of six different preparations. 
'Significantly different at p < 0.05 from control. 
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Control 	 121)  
4M;h 	 96h 	 1 Gish 
Figure 3: DNA damage by comet assay. Intestinal mucosal cells from untreated control and 
KBK)i-treated animals were subjected to alkaline single cell gel electrophoresis 
(comet assay) to assess the degree of DNA breakage. 
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Control 12 h 	24 h 	48 h 	96 h 	168 h 
Figure 4: Comet tail lengths. The results of comet assay (Figure 3) are represented as mean 
values of tail lengths. 
*Significantly different at p < 0.05 from control. 
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7. Histology 
Histological examination of duodenum from control animals revealed normal appearance 
of villi, brush border bearing enterocctes and intestinal crypts containing different types 
of cells with clear lumen (Figure 5AJ. In the 48 h treated group, extensive intestinal 
damage was observed. The lumen was full of debris; inflammatory cells and intestinal villi 
had lost their contour; prominence of mucus secreting cells was observed, both in the 
remnants of villi as well as in the intestinal crypts (Figure 5B]. The 168 h group showed 
clear lumen, viii of variable shape and the lining of epithelial cells appeared normal and 
associated with brush borders. Inflammatory cells in the lamina propria and epithelial 
lining were still prominently seen JFigure 5CJ. 
IC 
~rA 	I _ 1 
A.' 
Figure 5: 1- I1stol(%g - of rat intrsnnc~11u 1 ill rcu n) shc,aing intr'ttnal villi Vii; and crypt 
(b) regions from (.1) untreated control (B) 48 h and (C) 168 Ii after treatment 
with K.Br(-),. 
Magnification is 1001, scale bar (—) =1(X) mm. 
117 
Pan-III: !4esu£ts and Discussion 
PART-III B 
PROTECTIVE EFFECTS OF TAURINE AND VITAMIN C AGAINST KBrO, 
I 	 INDUCED INTESTINAL TOXICITY IN RATS 
Experimental design: Administration of KBrO3 to rats caused significant alterations in 
several parameters of small intestine, including induction of OS, compared to untreated 
control group. VC and taurine were used to see if they could protect against KBrO, 
induced toxicity in the intestine. Animals were first given VC or taurine followed by a 
single oral dose of KBrO; (100 mg/kg body weight). The rats were then sacrificed 48 It 
after administration of KBrO3. This duration was selected since there is maximum 
KBtOvinduced gastrointestinal toxicity at this time. There were six groups: control, 
KBrO3 alone, VC alone, VC+KBrO.b taurine alone and taurine-~KBrO.,. There were six 
animals in each group. Animals were sacrificed after the completion of dosage. The entire 
small intestine was removed, mucosa scraped and used for the preparation of BBMV and 
Itomogena es as described in "Methods". 
Results 	a 
The effect of KBtO,, alone and in combination with VC or tautine, on various parameters in 
intestinal homogenates was determined. 
1. Effect of taurine and 'IC  pre-treatment on KBrOc induced changes in the activities 
of BBM enzymes 
llae specific activities of BBM enzymes (AP, GGT, I.AP and sucrase) were assayed in 
mucosal homogenates and isolated BBMV prepared from animals in the six groups. 
Treatment of rats with KBrO, alone resulted in a significant decrease in the activities of these 
marker enzymes in the homogenates [table 9]. A decrease in the activities of these enzymes 
(47-59°in) was observed In isolated R HMV also, compared to untreated controls Tablc 101. 
VC and taurine pre-treatment resulted in significant amelioration in the KBrO, induced 
reduction in the activities of these BBM enzymes, compared to control. 'l he activities of 
BBM enzymes recovered s'igaificandy in VC -KBrC, and taurine+KRrOa groups, although 
the activity levels were not completely restored to normal values. VC was more effective than 
taurine in ameliorating the KBrO, induced alterations in BBM marker enzymes. 
Admivsuation of either VC or tauñne alone had no effect on the activities of these enzymes 
and they were the same ae in die control group. 
The kinetic parameters (KM and Vm,) of LAP, ~1P, GGT and sucrase were determined in 
BBMV prepared from intestinal homogenates of all six groups. K, t and Vm„ of these 
enzymes were determined from Lineweaver-Burk plots by assaying the enzymes at different 
substrate wmccntrations. Treatment with KIitO, led to significant lowering of V values of 
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all BBM enzymes [Table 11]. However, pre-treatment With VC and taunne led to significant 
recovery in the V,, values of these enzymes. Administration of VC and taurinc alone did not 
result in significant changes in V compared to control group. "I'he K., values of VC alone, 
taurinc alone, KBrO3 alone, VC+KBr(), and taurine+Kl3rO, treated groups were similar and 
showed insignificant changes compared to, the control group. 
2. Effect of taurine and VC pre-treatment on KBrO;  induced changes in total ATPase 
and ACP activities 
Treatment of rats with KBrO, alone resulted in significant alterations in the activities of ACP 
and total ;Vi1'ase when compared to untreated controls. VC and taurine pre-treatment led to 
significant amelioration in the KBrO- induced alterations in the activities of both these 
enzymes [fable 12]. 1 lowcver, the activities were not completely restored to normal values. 
VC was more effective than taurine in ameliorating the KBrO, induced alterations. 
Administration of either \'C or taurine alone had no effects on the activities of these 
enzymes and they were similar to the control group ]'fable 12]. 
3. Effect of taurine and VC pre-treatment on KBrOj induced changes on some 
parameters of OS 
Several parameters suggestive of induction of OS were determined in intestinal 
homogenates prepared from animals in the six groups. LP() was determined from levels 
of malondialdchyde which reacts with thiobarbituric acid to live a pink coloured 
product. Protein oxidation increases carbonyl groups which were determined after 
reaction with 2,4-dinitrophenyl hlsdra•r.inc. .ldroinistration of KBrO, alone greatly 
enhanced both LPO and protein oxidation as reflected in elevated levels of 
malondialdehyxde (4-fold) and protein carbonyls (4-fold) compared to the control group. 
It also resulted in significant reduction in total SH and GSH content [fable 13]. 
There was also a marked increase in the level of H2O, in intestinal homogenates in 
KBr(); treated animals. However, these KBrO;-induced changes were significantly 
attenuated by administration of either VC or taurinc prior to treatment with KBr(),. 
Treatment with VC or taurine alone did not significantly alter any of these parameters. 
The results indicate marked protection by both VC and taurine against K13r( ),-induced 
OS in intestinal mucosal tissue. \1 was more effective than taurine in protecting the 
intestine against free radical mediated damage. 
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)le 9: Effect of taurine and VC pre-treatment on KBr03-induced changes in the 
activities of BBM marker enzymes in intestinal homogenates. 
Control 	KBrOi alone 	VC alone 	VC+KBrOi Taurine alone Tauriisc+KBrO3 
LAP 3.76±0.29 1.89±0.08* 3.72±0.27 3.24±0.22 
AP 2.37±0.19 1.01±0.09* 2.32±0.14 2.18±0.19 
GGT 2.26±0.09 0.98±0.07* 2.24±0.11 2.12±0.11 
Sucrase 27.12±2.77 13.11±2.12*  26.92±2.42 24.92±2.57 
3.81±0.22 
2.40±0.18 
2.34±0.12 
27.65±2.89 
3.08±0.18* 
2.05±0.11 * 
1.92±0.09* 
23.14±2.06 
Results are mean ± SEM of six different preparations. 
Specific activities of enzymes are in lunoles/mg protein/hr. 
*Significantly different from control at p< 0.05. 
LAP, leucinc aminopeptidase; AP, alkaline phosphatase; GGT, y-glutamyl transferase. 
Table 10: 1.ffect of taurine and VC pre-treatment on KBrO,-induced changes in the 
activities of BBM enzymes in isolated BBMV. 
Control KBrOi alone VC alone V'C+KBrOi Taurine alone Taurine+KBrO3 
LAP 30.96±3.29 15.86±2.08* 29.94±3.11 27.24±2.86 30.48±3.17 24.84±2.74* 
AP 20.14±2.37 9.16±1.01* 19.45±2.07 18.75±2.19 20.01±2.28 17.42±2.01' 
GGT 18.48±1.89 8.15±0.97* 18.59±2.01 17.59±1.89 18.38±1.97 15.55±1.28* 
Sucrase 230.87±10.97 109.93±7.54 228.82±9.84 214.42±8.67 232.11±10.21 196.79±7.64-  
Results are mean ± SEM of four different preparations. 
Specific activities of enzymes are in µmoles/mg protein/hr. 
*Significantly different from control at p< 0.05. 
LAP, leucine aminopeptidase; AP, alkaline phosphatase; GGT, y-glutatnyl transferase. 
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Table 11: Effect of taurine and \'C pre- treatment on KBrO,-induced changes in the 
kinetic parameters of I111MI marker enzymes. 
Groups 	 Km (mil) 	 \'ma; (}tmoles/mg protein/h) 
LAP 
Control 0.11±0.002 12.27±1.38 
KBrO; alone 0.09±0.001 6.1. ±0.47* 
VC alone 0.12±0.002 12.08±1.06 
VC t- KBr(); 0.1.±0.003 10.65±0.98 
Taurine 0.11±0.002 12.11±1.16 
Taurine+ KBrO t 0.12±0.001 9.86±0.77* 
AP 
Control 32.12±2.21 42.07±3.35 
KBrOi alone 30.98±1.9'7 30.12±2.79* 
\'C alone 33.47±2.44 41.56±4.14 
VC+KBrO, 31.66±1.8') 30.0-±3.96 
Taurine alone 32.48±2.r 41.84±4.31 
Taurine+KBrOi 31.79±2.01 39.87±3.86 
GGT 
Control 1.88±0.09 11.12±1.18 
KI3rO, alone 1.76+0.04 6.45±0.17j 
VC alone 1.69±0.02 11.28±1.33 
\"C + KBrOi 1.94±0.11 10.17±1.04 
'faurine alone 1.66±0.03 11.69±1.11 
Taurine+ KB rO; 1.71±0.02 9.42±1.04* 
Sucrase 
Control 39.78±2.4 180.68±7.51 
KBrO-i alone 40.01±3.01 92.33±5.47 * 
\"C alone 38.96±2.56 18.94±8.63 
vC+K13r03 37.73±2.12 167.07±6.14 
Taurine alone 39.64±2.86 181.13±9.42 
'l'aurine+KBrO; 38.69±2.4-' 154.2-±6.83* 
K,5 and \'m,r were calculated from double reciprocal 1 /v vs 1 /[S1  I.ine-weaver-Burk plots. 
Results are mean ± St IM of four different BBNlA' preparations. 
`Significantly different from control at p< 0.05. 
LAP, leucine aminopeptidase; AP, alkaline phosphatase; GGT, y-glutamyl transferase. 
Table 12: Effect of taurine and VC pre-treatment on KBrO,-induced changes in total 
A'l'Pase and acid phosphatase activities in intestinal homogenates. 
Control 	KBrOi alone 	\'C alone 	\'(:+KBrOti 	Taunne alone 	Taurine+KlirO; 
Total :1TPasc 	8.14±0.42 	4.25±0.1 1 `  	8.66±0.48 	't.01±0.33 	8.34±0.41 	6.29±0.28t 
.\CP 	1.79±0.09 	4.69±(1.16' 	1.T6+ 1.08 	2.12±0.0' 	1.T4±0.05 	2.86±0.09* 
Results arc mean±Sl :Nl of six different preparations. 
Specific activities are in µmoles/mg pre>tein/hr. 
"Significantly different at p< 0.05 from control. 
ACP, acid phosphatase. 
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4. Effect of tanrine and VC pre-treatment on KBrO,-induced changes in the 
activities of some AO enzymes 
The effect of tauxine and VC pre-treatment on I BrOvinduced alterations on some AO 
enzymes in mucosal homogenates was determined [Table 14]. Administration of KBrO;  
to rats caused marked alterations in the activities of major detoxifying enzymes like SOD, 
CAT and GPx, Treatment with KI1rO3 resulted in a decline in the activities of Glt, TR 
while the activity of CST was significantly enhanced. However, these KBrO., induced 
changes were significantly attenuated by administration of either VC or taurine prior to 
treatment with KBrO,. The results show marked protection by both VC and taurine 
against ICBrOOç induced changes in cellular AO defence of intestinal mucosal tissue. VC 
was snore effective than taut-inc in protecting against KBrO,-induced changes in AO 
enzymes in small intestine. 
5. Effect of taurine and VC pre-treatment on KBrO3 induced changes in activities 
of enzymes of carbohydrate metabolism 
The effect of tretment with KBrO, alone and after administration of VC and taurine 
was determined on the activities of several enzymes of carbohydrate metabolism in 
intestinal homogenates. These include LDII (glycolysis), MDII (citric acid cycle), G6P 
and HIP (gluconeogenesis), GOD (pentose phosphate pathway) and ME (VADPH 
generation). KBrO, treatment significantly increased the activity of LDH while the 
activity of MDH was decreased [Table 15]. Administration of KBrO3 also decreased the 
activities of gILIConeogenllc enzymes, glucose 6-phosphatase and fructose 1,6-
bisphosphatase in intestinal homogenates. The effect of KBrO, was also determined on 
G6PD and ME that are the major source of NADPH which is needed in various 
anabolic reactions. Treatment with KBxO, alone significantly decreased G6PD but 
increased ME activity. However, in the taurine+KBrO3 and VC+KftO; groups there 
was significant attenuation in the KBrO,-induced alterations in the activities of all these 
metabolic enzymes. This suggests that VC and taurine restore the metabolic pathways 
that were altered by administration of KBrO,. Treatment of rats with VC of taurine alone 
did not significantly alter die activities of any of these metabolic enzymes. 
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Table 13: Effect of taurine and VC pre-treatment on KBrO,-induced changes in some 
parameters of oxidative stress in intestinal homogenates. 
Control 	KBr03 alone 	VC alone 	VC t-KBrO; 	'I'aunnc alone 	Taurine+KBrO 
MDA 41.39±2.31 162.61±7.82* 
Carbonvi 60.81±4.17 233.85+10.01" 
Total SI I 13.25±1.30 5.39±0.24* 
GSH 1.98±0.13 0.76±0.0'7 ' 
11202 129.22±8.14 329.54±14.86' 
36.92±2.11 55.54±3.17' 38.59±2.09 '1 .67±4.01 * 
52.94±3.11 80.11 +5.86-  57.96±3.28 110.64±8.51 
14.28±122 11.76±1.19 13.87±1.73 10.92±1.17* 
2.19±0.15 1.71±0.12 2.03±0.12 1.57±0.11' 
101.14±7.96 164.21 ±9.22' 105.22±8.01 182.88±8.64' 
Results are mean±SE`I of six different preparations. 
MDA, carbonyl content and 11202 levels are in nmoles/g tissue while total SlI and GSH are in 
µmoles/g tissue. 
*Significantly different from control at p< 0.05. 
tiID_1, malondialdcbyde; SI I su1thydryl; GSH glutathione; 11202 hydrogen peroxide. 
Table 14: Effect of taurine and VC pre-treatment on K13r0,-induced changes in the 
activities of some anti-oxidant enzymes in intestinal homogenates. 
Control 	KBr03 alone 	VC alone 	VC+KBrO3 	Taurine alone Taurine+KBr03 
CAT 12.86±121 422±0.86 13.01±1.28 10.27±1.16 12.94±1.18 9.54±1.01* 
SOD -8.66±2.47 173.68±7.01 * 79.86±3.01 85.46±2.86* 79.04±3.28 97.84±4.01 * 
GPx 4.12±0.24 1.71±0.18' 425±0.82 3.77±0.39 4.38±0.31 3.21±0.28* 
GST 12.97±1.86 31.68±224' 13.22±1.54 14.46±1.94 13.01±0.12 16.37±2.11' 
GR 23.4±2.01 8.56±1.01' 24.04±2.06 2029±2.22' 23.89±2.19 18.87±1.63* 
TR 728+0.89 2.09±0.08' 8.14±0.94 6.18±0.37* -.94±0.91 5.88±0 26' 
Results are mean±Sl?`I of six different preparations. 
Specific activit y of SOD is in units/mg protein (One unit is the amount which causes 
inhibition of pv-rogallol auto-oxidation in a reaction volume of 3 ml). 
Specific activities of C:1'1*, GPx, GST, GR and 'FR are in nmol/mg protein/min. 
*Significantly different at p < 0.05 from control. 
CXI', catalase; SOD, Cu-Zn superoxide dismutase; GPx, glutatluone perox.idase; GST, glutathione- 
S-transfcrase; GR, glutathione reductase-'lR thioredoxin reductase. 
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Table 15: Effect of taurine and VC pre-treatment on KRrO,-induced changes in the 
activities of enzymes of carbohydrate metabolism in intestinal homogenates. 
Control KBrO; alone VC alone VC+KBr03 Taurine alone Taurine+KBrO3 
LDH 13.81±2.14 47.70±3.42* 14.01±2.01 16.07+2.38 14.55±1.58 17.01±2.04* 
MDH 11.42±1.13 4.09±0.35* 12.08±1.88 10.14±1.46 11.77±1.07 9.48±1.01* 
ME 1.18±0.12 16.08±1.96* 1.24±0.25 3.67±0.24` 1.57±0.22 4.15±0.48* 
FI3P 1.01±0.09 0.51±0.04* 1.11±0.08 0.97±0.05 1.07±0.06 0.90±0.02* 
G6P 0.31±0.05 0,16±0.01* 0.37±0.04 0.28±0.07 0.35±0.04 0.26±0.02* 
G6PD 6.64±1.19 1.01±0.08* 6.84±1.11 6.01±1.11 6.92±1.13 5.24±1.01* 
Results are mean±SEMI of six different preparations. 
Specific activities of LDI 1, MDI-1, ME and G6PD are in nmoles/mg protein/min while FBP and 
G6P are in lunoles/mg protein/hr. 
*Significantly different from control at p< 0.05. 
LDH, lactate dehydrogenase; MDI-I, malate dehydrogenase; ME, malic enzyme; FBP, fructose 
1,6-bisphosphatase; G6P, glucose 6-phosphatase; G6PD, glucose 6-phosphate dehydrogenase. 
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6. Effect of taurine and VC pre-treatment on KBrO, induced DNA damage and 
DNA-protein cross-linking (DPC) 
Oral administration of Klir(_), led to significant induction of DPC in mucosal 
homogenates when compared to the untreated control group [Table 16]. It also induced 
DNA fragmentation with the release of nucleotides as measured by the diphenylamioe 
assay. Pre-treatment with VC or taurine significantly decreased KBrO j induced DNA 
fragmentation and DPC in intestinal mucosal tissues while VC and taurine alone had no 
effect [Figure 61. 
The single cell gel electrophoresis assay (Comet assay) was used to study DNA damage in 
the small intestine.:\deninistrariors of KBrOZ to rats caused significant DNA damage in 
intestinal mucosal tissue as evidenced by elongated tail length with respect to the control. 
This indicates increased level of DNA single strand breaks and alkali labile sites in the 
mucosal cells [ Figures 7, 8. 
Pre-treatment either with VC or taurine reduced the extent of KBrO,-induced DNA 
damage and resulted in decrease in comet tail length. VC and taurine alone did not cause 
DNA damage in the mucosal tissue and the comet tail length was the same as in control 
cells. 
7. Histology 
Histological examination of the duodenum section of intestine from control animals 
revealed normal appearance of viii, brush border bearing enterocytes and intestinal 
crypts containing different types of cells with clear lumen [Figure 9]. In the KBrO, 
treated group, extensive intestinal damage was observed. The lumen was full of debris; 
inflammatory cells and intestinal villi had lost their contour and prominence of mucus 
secreting cells was observed, both in the remnant of villi as well as in the intestinal crypts. 
Pre-treatment with taurine and VC greatly attenuated the changes induced by KlirO, 
with the duodenum showing much reduced damage. The VC and taurine alone groups 
showed reasonably well preserved condition of both the components and thus VC or 
taurine themselves do not induce any lesions in the small intestine of rats. 
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Table 16: Effect of taurine and VC pre-treatment on KBr03-induced DPC formation in 
intestinal mucosal homogenates. 
Protein cross linked DNA %, 	DPC coefficient h 
Control 	 2.65±0.11 1 
KBrO3 alone 	 7.88±1.05* 2.97 
VC alone 2.87±0.17 1.08 
VC +K-BrO; 	 4.01±0.24* 1.51 
Taurine alone 	 2.93±0.19 1.10 
Taurine+KBrOi 	 4.67±0.53* 1.76 
Results are mean±SEM of six different preparations. 
aProtcin cross-linked DNA/ total DNA. 
bprotein cross-linked DNA (%) in treated animals/protein cross-linked DNA (%) in 
control animals 
*Significantly different at p< 0.05 from control. 
DPC, DNA-protein cross-links. 
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Figure 6: DNA fragmentation in intestinal mucosal homogenates determined by the 
diphenylamine assay. 
Results are mean±SEM of six different preparations. 
*Significantly different at p < 0.05 from control. 
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VC+KBrO3 	 Taurine alone 	 Taurine+KBrO3 
Figure 7: DNA damage by comet assay. Intestinal mucosal cells from different groups were 
subjected to alkaline single cell gel electrophoresis (comet assay) to assess the degree 
of DNA breakage. 
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Control KBrO3 	VC VC-KBrO3 Taurine Tauane+KBrO3 
Figure 8: Comet tail lengths. The results of comet assay (Figure 7) are represented as mean 
values of tail lengths. 
'Significantly different at p < 0.05 from control. 
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Figure 9: Histology of hematoxvlin and eosin stained sections of rat intestine (duodenum 
section) showing intestinal villi (red *) and intestinal glands/crypts (yellow —i) in 
control (Al with normal epithelia of both villi and intestinal glands whereas KBrO' 
treated group [B] reveals extensive damage of both components to the extent the 
lumen is filled with degeneration debris. VC treated [C] and taurine treated groups 
[D) shoe- reasonably well preserved condition of both components. The 
V'C+KBrO3 treated group [E] shows better protection of both components than 
taurine+KBr03 treated group [F]. 
11 & F stain, X 400, scale bar [—} = 50 µm. 
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DISCUSSION 
the small intestinal mucosa is one of the largest areas of contact of the human organism 
with the environment. The intestinal mucosa is almost continuously exposed to 
potentially harmful xenobiorics in food and other ingested material. •fbc ingested 
substances pass the pre-epithelial compartment and reach the intestinal mucosa. At this 
location the enterocvtes are protected during their sensitive mitotic phase and can rarely 
be reached by contaminants. If the ingesta contain cytotoxic substances, the enterocytes 
are exfoliated into the intestinal lumen at a higher rate [Circu and _1w, 2011 J. The 
structural integrity of the mucosa is maintained by a sensitive balance between the rate of 
mitosis and the migration rate of enterocvtes along the crypt-villus axis. Cytotoxic 
compounds increase the mitotic activity, the proliferation compartment in the crypts is 
elongated and the villi become shorter as the exfoliation zone at the tip of the villi 
increases. Due to these changes, the period during which the single enterocyte is exposed 
to cytotoxic food contaminants and during which it serves its functions becomes shorter 
(hyper regenerative transformation). Due to high cell turnover, the intestinal mucosa 
regenerates quickly even after substantial damage and after an experimental interruption, 
the villi in ileum recover again with an epithelial layer. 
During evolution, several specific and unspecific mechanisms have evolved to protect the 
intestine against noxious agents. fl e microvillus surface of the small intestine represents a 
highly differentiated and metabc,licallt active compartment which, apart from contributing to 
the terminal stages of digestion and active transport of nutrients, provides an important 
barrier to the penetration of toxic substances. Exposure to a multitude of harmful 
contaminants in air, food or water has become inevitable in modem societies. Many of these 
agents are severely toxic and compromise the functioning of several organs in humans. 
KRr<);, a food additive and a major by-product of water disinfection by ozonation, is 
reported to have toxic and carcinogenic effects in rodents. It is classified as a complete renal 
carcinogen in animals and a probable human carcinogen (Group 2R carcinogen) by the 
International Agency for Research on Cancer 11•:1'.\, 2001J. Orally administered KIirO is 
rapidly absorbed from the gastrointestinal tract and appears in blood from where it is 
distributed to other tissues [Fujii e! ax, 1984]. Inside the cells, KBrO, is reduced to bromide 
and this reduction process generates ROS that are thought to mediate cellular damage 
[Chipman ri al, 2006J. Although a number of studies have examined the effects of ldC( ); on 
various animal tissues, there are no reports concerning its effect on the small intestine. 
Therefore, a comprehensive study was done that revealed the drastic changes induced by this 
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compound in the intestine. Since exposure to KBrO; is primarily through the oral route, the 
toxic effects of orally administered KBrO3 on the small intestine of rats were studied. 
Oral administration of KBrO, caused a significant decrease (50-60%) in the specific 
activities of all BBM enzymes both in mucosal homogenates and BBMV. The extent of 
decline was similar in homogenates and BBMV. This severe decrease in BBM enzyme 
activities is an indicator of KBrO,-induced epithelial cell injury in the intestine. Kinetic 
studies showed that the changes in enzyme activities were due to decrease in V,,... with no 
significant difference in K,,, values. Thus, the affinity of these enzymes for their 
substrates was not altered upon treatment with KBrO3. 
Several reasons are possible for the reduced activity of BBM enzymes. 'There could be 
loss of the BBM/enzyme molecules due to loss of structural integrity of the membrane 
or enzyme inactivation by oxidative modification due to bromate induced OS. There 
could also be inhibition due to direct modification of the enzymes by KBrO3, as also 
shown by in vitro experiment. However, GGT and sucrase, which were inhibited only 
20% under in vitro conditions, declined by —50% after administration of KBrO1 to 
animals. Thus direct modification of BBMI enzymes by KBrO3 cannot be the only reason 
for their inactivation. Therefore, either one, or a combination of the above mentioned 
reasons, could be responsible for reducing the activity of BBM enzymes. 
The epithelial cells lining the intestine are rich in anti-oxidants and detoxifying enzymes 
since they are constantly exposed to dietary lipids, drugs, variety of oxidants and pro-
oxidants and metal ions [Manohar and Balasubramanian, 1986; Circu and .\w, 2011]. A 
marked increase in SOD activity was observed upon KBrO, exposure. G6PD activity 
decreased and this could have resulted in lowered activity of GR, which uses NADPH 
produced by G6PD, to convert oxidized glutathione to GSH. This will lead to lowered 
levels of GSH which is a necessary cofactor for the detoxification of H2O, and 
hydroperoxides. GSH levels can also be lowered by the direct oxidation of its SH group 
by bromate ions. The reduced GSH levels along with lowered activity of CAT and GPx 
will cause an increase in H2O, levels and consequent 1,PO. The reduced level of 
NADPH will also lead to lower activity of TR, an enzyme that is part of the thioredoxin 
system which is the major cellular disulfide reductase and also functions in defence 
against OS. The reduced activities of C;VL', CSR, GPx and 1R must have overcome the 
enhancement In the activities of GST (which is involved in the detoxification of drugs 
and poisons by conjugating them with CASH) and SOD. These results indicate that 
KBrO has an inhibitory effect on the endogenous enzymatic AO defence system, thus 
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strongly suggesting the involvement of ROS in KBrO, toxicity. This has been reported 
previously in blood and renal system also [Sai el al., 1994; Umemura et al., 2009; 
Ahmad el al., 2011; Zhang el al., 20111. 
An increase in the generation of free radicals can lead to oxidation of lipids and proteins, 
which are important components of biomembranes [Brasitus and Schachter, 198.1]. 
Increase in I.PO, protein carbonyl content, H2O~ levels and depletion of SH groups was 
seen upon KBrO, treatment. This again indicates that KBrO, induces OS in the intestine 
as has also been reported for human cell lines and kidney [Umemura et aL, 2009; Zhang et 
al., 2010]. 
The effect of KBr03 on enzymes involved in glycolysis, tricarboxylic acid (I CA) cycle, 
gluconeogenesis and hexose monophosphate-shunt pathway was also examined. KBrO3 
administration significantly increased the activity of LDH and decreased the activity of 
MMD1I suggesting a shift in energy production from aerobic mode to 
glycolysis [Khan et al., 2009]. However, it should be noted that LDH activity also 
increases in cell death [Legrand et a/., 1992] and this possibility cannot be ruled out. The 
decrease in activities of gluconeogenic enzymes FBP and G6P may be due to the reduced 
activities of TCA cycle enzymes. This can be explained by the fact that the lower 
activities of 'I'CA cycle enzymes, especially that of NIDH, will reduce the production of 
oxaloacetate from malate which is required not only for the continuation of TCA cycle 
but also for gluconeogencsis. The oxidative conversion of glucose or glucose 6-
phosphate to 6-phosphogluconate by hexose monophosphate-shunt pathway, which is 
catalyzed by G6PD, was also found to be lowered upon KBrO, treatment. The lower 
generation of NADPH by G6PD, which is essential for many reductive anabolic 
reactions, may have been compensated to some extent by the increased activity of the 
mitochondrial NADP-malic enzyme. 1'his impairment in metabolic function may be a 
direct effect of KBrO, or an indirect action causing free radical production that affects 
cellular pathways. 
The diphenylaminc assay showed that KBr<), treatment induced DNA degradation in a 
time dependent manner. There was a significant increase in DNA degradation in the 
intestine of KlirO, treated animals, which was almost two times the control value in the 
48 h group. Administration of KBrO, induced DNA damage in the mucosal cells of 
animals, as evidenced by increased comet tail length, when compared to control. This 
indicates increased level of DNA single strand breaks and alkali labile sites in the mucosal 
cells. In both the diphemy'lamioe and comet assays, the maximum damage was observed 
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at 48 In which then declined subsequently. However, even at 168 h it did not reach the 
control values. Thus dhe repair of bromate-induced DNA damage was still incomplete 
even 168 h after the administration of KBrO3. It is known that rejoining of DNA strand 
breaks and base excision repair, the main mechanisms invoked in the repair of oxidative 
DNA damage, are completed in few hours Jamga and Dizdaroglu, 1996]. Since damage 
persisted even after 168 h it is suggestive that KBrO, may damage DNA by other 
mechanisms also (besides oxidative modification) leading to secondary damage or it 
could be due to DNA-protein cross-links (DPC) which are themselves repaired with 
difficulty and slow down the normal cellular repair mechanisms [Barker et ad., 2005; 
Di2dstoglu and Jaruga, 20121. 
The effect of KBrO, on DPC formation was then examined since they are frequently 
produced by various xenobiotics/carcinogens. Exposure to KBrO, induced formation of 
DPC in animals which was 3.2 times the control value at 48 h. DPC formation was again 
maximum at 48 h after administration of KBrO, followed by subsequent decline. Since 
DPC are formed under conditions of OS, a large proportion of bromate-induced DNA 
damage and DPC could be due to direct oxidative mechanisms. Increased levels of ROS 
due to KISrO, exposure will result in free radical accumulation, thereby increasing 
oxidative damage, including strand breaks and DPC. Increased formation of DPC 
reduces the repair capacity of the cells and can result in DNA stand breaks observed in 
the comet assay and accounts for the persistence of damage even after 168 h_ 
The changes introduced by the single oral dose of K13rO3 were maximum 48 It after 
treatment at which time there was almost complete destruction of viL and filling of 
intestinal lumen with necrotic debris as shown by histological observahons. However, the 
crypts being hidden were least affected. There was resumption of normal morphology of 
villi, enterocytes, brush borders and clearing of intestinal lumen at 168 h. Thus the 
bromate induced effects appear to be reversible as most biochemical parameters and 
intestinal morphology recovered towards control values 168 h after treatment. 
Several approaches have been used to prevent the unwanted and harmful physiological 
effects of KBrO,. In studies aimed at abrogation of bromate toxicity, OS has been 
targeted for chemoprotective/therapeutic research and several plant based AO have been 
explored [Sai et aL, 1992; Cadenas and Barja, 1999; Khan and Sultana, 2005a: Chipman el 
al,, 2006; Nishioka et al, 2006; Yilmaz eI al., 2007]. In the present study, taunne and VC 
were used to protect against bromate induced intestinal toxicity. Administration of either 
taurive or VC prior to treatment with KBrO, resulted in significant recovery in the 
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activities of all Biel marker enzymes. This implies that both taunne and VC can reduce 
intestinal epithelial cell injury induced by administration of KBrO. Administration of 
either taurine or VC, prior to treatment with KBrO3, also resulted in significant recovery 
in LPO, total SH groups and the activities of various AO enzymes like CAT, SOD, GR, 
TR and GST. The altered activities returned to near control values exhibiting the AO and 
protective role of both taurine and VC in KBrO,-induced toxicity. The protective effect 
of either taurine or VC on the enzyme activities is probably due to the quenching of free 
radicals/ROS induced by KBrO, treatment. Histological observations of the intestine 
strongly support the biochemical results. The intestine from KBrO, treated animals 
showed extensive ultrastructural damage, with complete destruction of villi and filling of 
intestinal lumen with necrotic debris. These changes were greatly reduced by prior 
administration of either VC or taurine to the animals. 
The above results have been summarized in Figure 10. KBrO3 is reduced to bromide 
inside the cell. This process is known to generate free radicals and ROS which then 
mediate tissue damage by oxidative modification of cellular components. Taurine and VC 
either stop this reduction process or directly quench/scavenge the free radicals and ROS 
thereby reducing oxidative damage to the cell and restoring normal tissue morphology. 
This studs' shows that pre-treatment with taurine or VC greatly reduces KBr03-induced 
intestinal toxicity. Thus taurine and VC can be potentially used as chemoprotective 
agents against gastrointestinal toxicity of KBrO,. 
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Figure 10: Summary of KBrO, induced alterations in intestinal cell metabolism, membrane 
integrity and oxidative stress and its amelioration by VC/taurine. 
I3BM, brush border membrane; DPC: DNA-protein crosslinks; KBr, potassium 
bromide; l rO;, potassium bromate; ROS, reactive oxygen species; T: taurine; VC: 
vitamin C. 
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SUMMARY 
KBrO, has been extensively used in food industries and is formed during ozonation of 
bromide containing water. The use of KBrO, has been associated with human health 
hazard since it exhibits multiple organ toxicity and carcinogenicity. IDespite a number of 
reports documenting its toxic effects the mode of action of bromate is still not clear. It 
has been suggested that ROS and OS may contribute to its toxicity. 
All tissues/cells alleviate the effects of OS by means of enzymatic and non-enzymatic 
AO which scavenge the free radicals and ROS. Free radical mediated damage can also be 
attenuated by the administration of AO. Lately much research has focused on the use of 
naturally occurring dietary AO for the control and management of various chronic 
diseases such as cancer and cardiovascular disorders that involve excess production of 
ROS. These studies also give an insight into the mechanism of action of the toxicants. 
We have studied the effect of I BrO, both under in nihn and in t'ipo conditions and also 
the protective effect of several naturally occurring .\O (vitamin C, taurine and reduced 
glutathione) against KBrO,-induced tissue damage. The in r'ibn studies involved 
incubating human erythrocytes with KBrO, alone or in presence of VC, GSH or taurine. 
The in tiro studies used male rats that ,%-ere given a single oral dose of KBrO, at 100 
mg/kg body weight, either alone or after administration of VC or taurine. 'I7ie effect on 
blood, kidney and intestine of animals was studied. 
The results obtained are summarized below: 
(a) Generation of ROS: The intracellular formation of ROS was determined by using 
2,-'-dichlorodihvvdrotluorescein diacetate and showed that treatment of human 
crvthrocvtes with NBrO, under in i'i/ro conditions increases ROS production. 
(b) Hemolysis: 'There was a marked increase in hemolvsis of human envthrocvtes with 
increasing concentration of KBrO i  with release of hemoglobin in the medium. 
(c) MetHb and MetHbR: Tremendous increase in MetHb levels was observed in 
erythrocytes both under in ,itro and in riro conditions. The increase in NIetHb was 
accompanied by a concomitant increase in NIetHb reductase activity. 
(d) Parameters of oxidative stress: Administration of KBrO, greatly enhanced both 
lipid peroxidation and protein oxidation as reflected in elevated levels of 
maloadialdehvde and protein carhonyls. It also resulted in significant reduction in 
total SH and GSH content. There was also a marked increase in level of I-i,(), in all 
the tissues studied. 
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(e) Anti-oxidant enzymes: Treatment with KBr0 significantly altered the activities of 
several AO enzymes both under ur vitro and in vivo conditions. A similar pattern was 
seen in all tissues; the activities of SOD and GST were enhanced while those of 
CA`I', GP:;, GR, TR and G6PD declined. 
(f)Anti-oxidant power: The intracellular AO power was measured by ferric 
reducing/antioxidant power and 2,2-dipheny>1-1-picrylhydrazyl radical reduction 
assays. The ferric reducing and free radical scavenging activities of cells were 
significantly decreased upon treatment with KBrO3. 
(g) Plasma parameters: Oral administration of KBrO, to rats resulted in marked 
nephrotoxicity as manifested by increased plasma BUN and crcaciniHe and decreased 
glucose and inorganic phosphate levels. I iepatotoxicity was also evident from 
increased activities of aspartate transaminase and alanine transaminase. Decrease in 
vitamin C levels and dramatic increase in the activity of the pro-oxidant enzyme 
xanthine oxidase were also seen. 
(h) BBM enzymes: In til m incubation of BBMV with KBrO, resulted in inhibition of all 
marker enzymes (LAP, AP, GGT, sucrase and maltase), although to different extents. 
LAP was the most sensitive enzyme under these conditions. 
KBr(), treatment to rats caused significant reduction in the specific activities of BBM1 
enzymes in isolated BBMV and homogenates of both kidney and intestine. Kinetic 
studies showed that the affinity of these enzymes for their substrates was unaltered 
while the maximum velocity was reduced. 
(i) Carbohydrate metabolism: The enzymes of major metabolic pathways were 
altered upon administration of KBrO, to animals. The results show that 
gluconeogenesis and tricarboxylic acid cycle were decreased while glycolysis was 
enhanced. Thus, lowered glucose synthesis and a shift from aerobic to anaerobic 
mode of glucose metabolism was evident. 
(j) DNA damage and DNA-protein cross-links: The Comet assay showed major 
I)N:1 damage in renal and intestinal tissue of KBrO, treated animals as evidenced by 
elongated tail length. This suggests increased level of DNA strand breaks and alkali 
labile sites. Increased 1DN1\ fragmentation, with release of acid soluble nucleotides in 
the supernatant, and INA-protein cross-linking was also evident in animals given 
KBrO;. 
136 
Summary 
(k) Histology: Histological examination of the kidney and intestine from untreated 
control animals revealed normal histology but extensive damage and tissue injuries 
were visible in KBrO ;-treated rats. 
Protection by antioxidants: In animals given vitamin C or taurine prior to 
administration of KBrO,, significant protection was observed in all the biochemical 
parameters mentioned above. "These results were corroborated bN• the histological studies 
where greatly reduced tissue damage was seen in these animals when compared to those 
given KBrO, alone. Vitamin C and taurine by themselves had no effect on any of these 
parameters and the tissue morphology was also the same as of untreated control animals. 
GSH was used only in the in li/ro studies with human crvthrocvtes (in addition to vitamin 
C and taurine) and was also effective in blunting the effects of KBrO;. Vitamin C was 
found to be more effective than GSI I and taurine in protecting against KBrO-induced 
damage  and this could be because it is a stronger anti-oxidant than the other two. 
In conclusion, administration of KBrO, elicited deleterious effects by causing major 
damage to erythrocytes, kidney and intestine showing that these tissues arc prime targets 
of KBrO. These toxic and other adverse effects appeared to be mediated by KBrO, 
elicited oxidative damage and were alleviated by dietary anti-oxidant. Based on our 
present observations, we pr )SC that vitamin C and taurinc may provide protection 
against tissue damage and toxicity induced by KBrO and other structurally related 
compounds. 
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Potassium Bromate Causes Cell Lysis and 
Induces Oxidative Stress in Human Erythrocytes 
Mir Kai sar Ahmed, Samreen Amani, Riaz Mahmood 
Department of Biochemistry, Faculty of Life Sciences, Aligarh Muslim University, 
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ABSTRACT: In the present study, we have studied the effect of KBrox on human erythrocytes under in'vitro 
conditions. Erythrocytes were isolated from the blood of healthy nonsmoking volunteers and ,rcubated 
with different concentrations of KBrOa  at 37 0 for 60 ruin. This resulted :n marked hemolysis in a KBrOa-
concentration dependent manner. Lysates v✓ere prepared from KOrO,-treated and control erythrocytes and 
assayed for various parameters. KBrO treatment caused significant increase in protein oxidation, lipid per-
oxidation, hydrogen peroxide levels, and decrease in total sulfiyd yl content, which indicates induction of 
oxidative stress in r:uman erythrocytes. Methemoylobin levels and methemoglobin reductase activity were 
significantly increased .vhile the total antioxidant poorer of lysates was greatly reduced upon KBr0 treat-
ment. Intrace lula r production of reactive oxygen species increased in a dose dependent manner. Exposure 
of erythrocytes to KBrC also caused decrease in the activities of catalase, glutathione peroxidase, thiore-
doxin reductase, glucose 6-phosphate dehydrogenase and glutathione reductase whereas the activities of 
Cu-Zn superoxide dismutase and glutathione-S-transferase were increased. Ttese results show that 
KBr03 induces oxldalve stress in human erythrocytes through the generation of reactive oxygen species 
and alters the cellular antioxidant defense system. it 2011 w'dcy rcdiyIiems, Inc. Environ To.i.nl to Coo-000, 2011. 
Keywords; bromele; oxidative stress; erythrocytes; antioxidant; hemolysis; methemoglobin; enzymes 
INTRODUCTION 
Potassium promote IKBrO1) is a widely used food additive 
that is added to flour as maturing agent in the bread-making 
process, to fiali paste as conditioner ''arid  also to beer and 
cheese (EPA, 2001), It is a constituent of cold wave hair 
solutions, used in cleaning boilers and oxidation of sulfur 
and at dyes. Bromate is generated as a disinfection by-
product during the oxonation of bromide containing 
water and is, therefore, frequently detected in tap water 
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(Weinberg et al., 2003). The increasing use of ozonation 
for treatment of drinking water increases to the health risks 
associared with exposure of humans to bromate. Studies 
have shown a correlation between urinary bladder and co-
lon cancel and the chronic consumption of surface water 
containing disinfection by-products (Bull, 1999). 
Several cases of acute bromide intoxication have been 
reported in humans, some of them following, accidental or 
suicidal ingestion of permanent hair wave neutralizers 
which usually contain 2-10% bremate (Warshaw et al., 
I9K9). Accidental poisoning in children the to ingestion of 
KBr01 solution and sugar contaminated with bmmafe 
caused an outbreak of mild poisoning (Paul, 1966.1 The 
most common signs of bromute ingestion are severe gastro-
intestinal irritation, depression of the central nervous sys-
tem. anemia, renal injury, and hearing loss (EPA, 2001). 
No epidemiological studies on long term human exposure 
C ?011 Wiley Periodicals, nc 
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Oral administration of potassium brom ate, a major water disinfection 
by-product, induces oxidative stress and impairs the antioxidant power of rat blood 
Mir Kaisar Ahmad, Riaz Mahmood ' 
Department of Biorhemtsiry, Faculty of Life Science.., Alp arh Muslim university, Aligarh 202 002. U.P. India 
ARTICLE INFO 	 ABSTRACT 
Artuk hwory. Potassium bromate (KBrO,) is a widely used food additive, a water disinfection by-product and a known 
Received 15 September 2011 nephrotoxic agent. The effect of KBrO, on rat blood, especially on the anti-oxidant defense system, was 
Received in revised form IS December 2011 studied in this work. Animals were given a single oral dose of KBr03 (100 mg/kg body weight) and sac- 
Accepted 30 December 2011 rificed 12, 24.48.96 and 168 h after this treatment. Blood was collected from the animals and separated Available online 25 January 2012 into plasma and erythrocytes. KBr03 administration resulted in increased lipid peroxidation. protein oxi- 
-- K 	~. dation. hydrogen peroxide levels and decreased the reduced glutathione content indicating the induction 
of oxidative stress in blood. Methemoglobin levels and methemoglobin reductase activity were signifi- Anti-oxidant cantly increased while the total anti-oxidant power was greatly reduced upon KBr03 treatment. Nitric 
Erythrocytes oxide levels were enhanced while vitamin C concentration decreased in KBr03 treated animals. The activ- 
Opid pero,tidation ities of major anti-oxidant enzymes were also altered upon KBrO, treatment. The maximum changes in 
Oxidative stress all these parameters were 48 h after the administration of KBrO, and then recovery took place. These 
Potassium bromate results show for the first time that KBrO3 induces oxidative stress in blood and impairs the anti-oxidant 
defense system. Thus impairment in the anti-oxidant power and alterations in the activities of major 
anti-oxidant enzymes may play an important role in mediating the toxic effects of KBrO, in the rat blood. 
The study of such biochemical events in blood will help elucidate the molecular mechanism of action of 
KBr01 and also for devising methods to overcome its toxic effects. 
0 2012 Elsevier Ltd. All rights reserved. 
1. Introduction 
Exposure of living organisms to xenobiotics leads to their inter-
actions with biological systems, which may give rise to biochemi-
cal disturbances resulting in cytotoxicity. KBrO, is one such agent 
that is widely used as a food additive where it is added to flour as 
maturing agent in bread making process, to fish paste as condi-
tioner and also to beer and cheese (IARC, 1986). It is used in phar-
maceutical and cosmetic industries and is a constituent of cold 
wave hair solutions. More importantly, bromate is formed as a 
Abbreviations ALT. alanine ammotransferase: AO. antioxidant: AST. aspartate 
aminotransferase; BUN, blood urea nitrogen; CAT. catatase; DTNB. 5,5'-dithiobis- 
nitrobenzok acid; DPPH. 2,2-diphenyl-l-picrythydraryl: FRAP. (emc reducing 
ability of plasma: G6PD. glucose 6-phosphate dehydrogenase; GPx. giutathrone 
peroxidise; GSH. reduced glutathione: CST. glutathione-S-transferase: GR, gluta- 
thione reductase: H2O1. hydrogen peroxide: Hb. hemoglobin: KBrO3. potassium 
bromate: LPO. lipid peroxidation; MDA. malonaldehyde; MetHb, methemoglobin; 
MetHbR, methemoglobin reductase: NADP and NADPH, oxidised and reduced 
niconnamide adenine dinucleotide; NO. nitric oxide; OS. oxidative stress: Pi, 
inorganic phosphate: ROS. reactive oxygen species; SH. sulflrydryl: SOD, superoxide 
dismutase: TR. thioredoxin reductase; VC, vitamin C; XO. xanthine oxidase. 
s Corresponding author. Tel.: +91 571 2700741. 
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by-product of water disinfection by ozonation and is. therefore. 
frequently detected in tap and bottled water (Magazinovic et al.. 
2004). In fact bromate is one of the most prevalent disinfection 
by-products associated with ozonation of water (Glaze. 1986: 14u 
and Mou, 2004). However. KBr03 exposure is injurious to tissues 
especially kidney and the central nervous system. Ingestion of 
KBrO3 causes renal failure, methemoglobinemia and deafness 
(Kurokawa et al., 1990; FPA, 2001). In humans, bromate has been 
reported to cause neuro- and nephro-toxicity. Long term exposure 
of animals to KBrO, results in development of tumors at multiple 
sites (Kurokawa et al., 1990; De Angelo et al., 1998). KBr03 is 
now classified as a complete carcinogen in animals and a probable 
human carcinogen (IARC. 1986). 
Many xenobiotics can cause oxidative stress (OS) in biological 
systems, therefore, elucidating the mechanism surrounding the 
production and control of reactive oxygen species 'ROS) and subse-
quent oxidative damage is of great interest. Blood is a target ofsev-
eral xenobiotics which induce OS and compromise its anti-oxidant 
(AO) defence mechanism (Edwards and Fuller. 1996: Nohl and 
Stolze, 1997). These include pesticides, herbicides, various metals 
and drugs (Rice-Evans and Baysal. 1987; Banepee et al.. 2001; 
Orhan and Sahin. 2001: Valko et al., 2005; Bukowska et al., 2008; 
Ahmad et al.. 2011). Besides cigarette smoking and exposure to 
Fort Chcnusiiy 134 21i12' 986-98i 
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Oral administration of a nephrotoxic dose of potassium bromate, a food 
additive, alters renal redox and metabolic status and inhibits brush border 
membrane enzymes in rats 
Mir Kaisar Ahmad .1, Ashreeb Naqshbandi a, Mohd Fareed h, Riaz Mahmood a•* 
'Department of Biochemistry. Foculry of Life Sciences. Aligarh Muslim University. Aligarh 202002. U.P. India 
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ARTICLE 	INFO ABSTRACT 
Article history: The time dependent effect of orally administered KBrO, on redox status and enzymes of brush border 
Received 27 October 2011 membrane (BBM) and carbohydrate metabolism has been studied in rat kidney. Animals were given a 
Received in revised form 30 January 2012 single oral dose of K8r05 (100 mg/kg body weight) and sacrificed at different times after this treatment; Accepted I March 2012 control animals were not given KBrOj. The administration of KBrO 3 resulted in nephrotoxici.ty. a decline Available online 7 March 2012 in the specific activities of several BBM marker enzymes and also induced oxidative stress in kidney. The 
specific activities of enzymes of carbohydrate metabolism were also altered and suggest a shift in energy 
r 	°` ds  metabolism from the aerobic to anaerobic mode. The renal effects of single oral dose of KBrO3 appeared to Brush border membrane 
Carbohydrate metabolism be reversible: maximum changes in all the parameters were 48 h alter administration of KBr03 after 
Kidney which recovery took place, in many cases almost to control values, after 168 h. These results suggest that 
Oxidative stress 	 the administration of a single nephrotoxic dose of KBr03 inhibits brush border membrane enzymes, 
Potaccium bromate induces oxidative stress and alters energy metabolism of the renal system in a reversible manner. 
Z 2012 Elsevier Ltd. All rights reserved 
1. Introduction 
Potassium bromate (KBr03) is extensively used in food and cos-
metic industries (IARC. 1986). It is used in bakeries as a flour im-
prover giving strength and elasticity to the dough during the 
baking process while also promoting the rise of bread. The result-
ing bread tends to be strong and spongy with fine crumb structure. 
Bromate also promotes gluten development in dough. KBrO; is 
used in treating barley in beer making, in cheese production and 
is commonly added to fish paste products in Japan. KBrO3 is a com-
ponent of permanent hair weaving solutions. Bromate is also a ma-
jor disinfectant by-product generated from bromide containing 
raw waters that undergo ozonation and chlorination, and is fre-
quently detected in tap-water and bottled water. Acute human 
exposure to KBrO3 has occurred primarily by accidental or pur-
poseful ingestion of KBrO3 solutions from permanent hair-wave 
kits (IARC, 1986). Nephrotoxicity is the primary response to KBrO3 
intoxication with death occurring from solutions containing 12g 
KBrO3 (EPA. 2001 ). Acute exposure to bromate causes not only kid-
ney failure but also neuropathological disorders such as vertigo, 
tinnitus and irreversible deafness (EPA. 2001). Chronic exposure 
to KBrO;  causes renal cell carcinomas in rats, hamsters and mice 
and thyroid and mesothelioma tumours in rats (DeAngelo. George, 
• Corresponding author. Tel.. -91 571 2700741. 
Email address: nannahrnoud2(Xi2vyahar.cu.rn (R. Mahmood} 
0308-8146/S - see front matter v 2012 Elsevier Ltd. All rights reserved. 
http:lldx.dol.org/ 10.1016/j.foodchem.2012.03.004 
Kilburn. Moore. & Wolf. 1998; Kurokawa. Mackawa. Takahashi. & 
Hayashi, 1990). Due to its cross species carcinogenicity, bromate 
is considered a probable human carcinogen and a complete carcin-
ogen in animals. 
Effective prevention of KBr03 toxicity by antioxidants (Farombi. 
Alabi, % Akuro, 2002: Nishioka. Fujii, Sun, & Aruoma. 2006) and 
induction of 8-hydroxy deoxyguanosine by KBrO- in vitro and 
in vivo strongly suggest a role for oxidative stress in KBrO3 toxicity 
and carcinogenesis (Ballmaier & Epe, 1995; Murata et at.. 2001; 
Umernura, Kitamura, Kanki, et al.. 2004). A link between lipid per-
oxidation (LPO) and renal DNA damage has been observed (Sai, 
Takagi. Umemura. Hasegawa, & Kurokawa, 1991). Alterations in 
gene expression in the kidney, the target tissue, and oxidative 
modifications of proteins and lipids have been reported (Ahlborn 
et al., 2009: Khan & Sultana, 2005). Thus, generation of reactive 
oxygen species (ROS) and consequent oxidative modifications of 
biomolecules are thought to contribute to the toxicity of bromate. 
The plasma membrane of epithelial cells lining the renal proxi-
mal tubule is composed of two morphologically and functionally 
distinct regions, the luminal brush border and the basolateral 
membranes. The brush border membrane (BBM) faces the lumen 
and is the first barrier for various solutes during absorption in 
the kidney. The BBM contains a number of hydrolytic enzymes 
and transport systems (Murer & Biber, 1993). Several studies have 
shown that the renal proximal tubule, and its BBM in particular, is 
a major target of renal injury due to ischemia and nephrotoxic 
Sirxhic e 44 11012 271b-17W2 
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Alterations in brush border membrane enzymes, carbohydrate metabolism 
and oxidative damage to rat intestine by potassium bromate 
Mir Kaisar Ahmad a, Aijaz Ahmed Khan h, Riaz Mahmood a-.  
' Deportment of Biochemistry. Faculty of Life Sciences. Aligarh Muslim University. Aligarh 202002, UP- India 
b Department of Anatomy, Faculty of Medicine. J. N. Medical College. Aligarh Muslim University. Aligarh 202002. U.P_ India 
ARTICLE INFO 	 ABSTRACT 
Article h;unry. The acute toxicity of potassium bromate (KBrO3) on rat small intestine was studied in this work. Animals 
Received 29 February 2012 were given a single oral dose of KBrO3 (100 mg/kg body weight) and sacrificed 12.24.48.96 and 168 h 
Accepted 3 September 2012 after the treatment: control animals were not given KBrO3. The administration of KBrot resulted in Available online 10 September 2012 a reversible decline in the specific activities of several BBM enzymes. lipid peroxidation, protein 
oxidation and hydrogen peroxide levels increased while total sulfhydryl groups and reduced glutathione 
l 	orth' decreased in KBrO3-treated rats indicating induction of oxidative stress in the intestinal mucosa. The Anti-oxidant 
Brush border membrane activities of anti-oxidant and carbohydrate metabolic enzymes were also altered upon KBrO3 treatment. 
Carbohydrate metabolism The maximum changes in all the parameters were 48 h after administration of KBrO3 after which 
Intestine recovery took place, in many cases almost to control values after 168 h. Histopathological studies sup- 
Jusslien broinatr ported the biochemical findings showing extensive damage to the intestine at 48 h and recovery at 168 h. 
These results show that a single oral dose of KBrO3 causes reversible oxidative damage to the intestine. 
© 2012 Elsevier Masson SAS. All rights reserved. 
1. Introduction 
Potassium bromate (KBrO3 ) is used in the bread making process 
and is added to flour, fish paste, beer and cheese (1(. It is 
a constituent of cold wave hair solutions, used in cleaning boilers 
and oxidation of sulphur and vat dyes. Bromate is also a major by-
product formed during the ozonation process used for the disin-
fection of drinking water. The increasing use of ozonation for 
treatment of drinking water increases the health risks associated 
with exposure of humans to bromate (21. Studies have shown 
a correlation between urinary bladder and colon cancer and the 
chronic consumption of surface water containing disinfection by- 
Abbrevianonc: AO. anti-oxidant: AP. alkaline phosphatase; BBM. brush border 
membrane; BBMV, BBM vesicle: CAT. catalase. FBP. fructose 1.6-bisphosphatase; 
G6PO. glucose rrphosphtte dehydrogense. G6P. glucose 6-phosphatase; GGT, y-
gluunryi transfuse, GPx, glutathione peroxtdase; GIL glutathione reductase. GST, 
glutamyl-S-transferase: GSH. reduced glurathione: Hs02. hydrogen peroxide; 
KBrO,. potassium bromate; LAP. leucine aminopeptidase: IDH. lactate dehydroge-
nase: 1PO, lipid peroxidation; MDA, malondialdehyde; MDH, malate dehydroge-
nase. NADP-, nicotinamide adenine dmudeotide phosphate; NADPH, tucotinamide 
adenine dinucleotide phosphate reduced; OS. oxidative stress: ROS, reactive oxygen 
species; SH. sulthydryl. SOD, Cu-Zn superoxide dismutase: TG, tricarboxylic acid; 
TR. thioredoxin reductase. 
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products (3). While renal toxicity is a hallmark of KBr03 expo-
sure, this compound has been shown to be a multisite carcinogen in 
several studies, inducing mesothelioma, kidney tumors, and 
thyroid tumors (4(. The toxic effects of KBrO3 in humans arise from 
acute poisoning causing renal failure and deafness (5(. Although the 
mechanism of KBr43 toxicity is unknown, it has been strongly 
suggested that reactive oxygen species (ROS) might contribute to 
its carcinogenicity and toxicity (6-9]. 
Small intestine is the primary site for great exposure to 
hazardous materials and the intestinal mucosa is continuously 
exposed to potentially harmful effects of xenobiotics in food, water 
and other ingested materials. The brush border membrane (BBM) 
lining the epithelial cells of intestine comes in direct contact with 
these ingested substances. The BBM is highly differentiated to 
perform a variety of digestive and transport functions through 
a number of membrane proteins, the activities of which are known 
to be influenced by a number of factors like diet, fasting, drugs. 
metals, industrial and other toxic pollutants 1 101. Although the 
primary exposure of humans to bromate is via the oral route, there 
are very few reports about the gastrointestinal effects of ingested 
bromate compounds (111. The present study examines the effect of 
a single oral dose of KBrO3 on the functional integrity of intestinal 
mucosal membrane, (as determined from the activity of BBM 
enzymes) metabolic enzymes and the anti-oxidant (AO) status of 
rat small intestine. 
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DNA damage and DNA-protein cross-linking induced in rat intestine 	CrossMark 
by the water disinfection by-product potassium bromate 
Mir Kaisar Ahmad, Haseeb Zubair, Riaz Mahmood 
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HIGHLIGHTS 
P. Oral administration of potassium bromate induces DNA damage to the rat intestine. 
p. Bromate induces the formation of DNA-protein cross-links in the intestine. 
s Effect of bromate is reversible; it is maximum at 48 h and then recovers. 
ARTICLE INFO 	 ABSTRACT 
Artitk histumy. 
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Keywords' 
Comet assay 
DNA damage 
DNA-protein cross-links 
Genotoxicity 
Potassium bromate 
The genotoxic effects of potassium bromate (KBrO3 ), a food additive and water disinfection by-product, 
on the small intestine of rats are reported here. Adult male rats were given a single oral dose of KBrO3 
(100 mg kg body weight) and sacrificed 12.24.48.96 and 168 h after this treatment while control ani-
mals were not given KBrO 4. Administration of KBr01 caused a significant increase in DNA damage when 
analyzed by the comet assay which suggests the induction of DNA strand breaks. This was also shown by 
colorimetric assay of nucleotides formed upon DNA degradation. KBrO3 treatment also resulted in 
increased formation of DNA-protein cross-links in the intestine. The maximum changes in these param- 
eters were 48 h after administration of KBrO, after which recovery took place. Thus, a single oral dose of 
KBrO3 exerts gene toxic eftectc in the inteaine of iii'.. possibly through the mechanism of oxidative DNA 
damage. 
C 2013 Elsevier Ltd. All rights reserved. 
1. Introduction 
Potassium bromate (KBr03) is a common food additive that is 
used in bakeries as a flour improver giving strength and elasticity 
to the dough during the baking process while also promoting the 
nse of bread (EPA. 2001). It is used in treating barley dunng beer 
making, in cheese production and is commonly added to fish paste 
products in Japan. KBr03 is also a component of permanent hair 
weaving solutions. More importantly, bromate is formed as a by-
product of water disinfection by ozonation and is, therefore, fre-
quently detected in tap and bottled water (Magazinovic et al.. 
2004). In fact bromate is one of the most prevalent disinfection 
by-products associated with ozonation of water. implying a poten-
tial human hazard (Bull. 1999). Kidney is considered to be the pri-
mary target organ of KBrO, and nephrotoxicity is a hallmark of 
exposure to this compound (EPA, 2001). However, it is found in 
many other organs of treated rodents including liver, thyroid, 
Abbreviations: DPC, DNA-protein cross-links: KBrO,. potassium bromate: ROS. 
reactive oxygen species: RPMI. Roswell Park Memorial Institute 1640. 
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and testes (Delker of al., 2006). KBrO 4 increases the formation of 
tumors in the kidney, peritoneal mesotheliomas and thyroid tu-
mors in rats as well (EPA, 2001). 
Oxidative damage to cellular components is caused by reactive 
oxygen species (ROS) derived from various processes of cellular 
metabolism, especially metabolism of exogenous mutagens and 
carcinogens. KBr03 increases lipid peroxidation and protein oxida-
tion in kidney and blood of treated animals showing the induction 
of ROS and oxidative stress (Gin et al., 1999; Ahmad et al., 2012; 
Ahmad and Mahmood, 2012). Effective prevention of KBr03 clas-
togenicity by antioxidants, both in vitro and in vivo, strongly sug-
gests that this oxidative stress plays a key role in KBrOj toxicity 
(Sal et al.. 1992: Nishioka et al.. 2006). 
Small intestine is the primary site for great exposure to hazard-
ous materials and its principal functions are subject to the toxic ef-
fects of chemicals. The intestinal mucosa is continuously exposed 
to potentially harmful effects of xenobiotics in food, water and 
other ingested materials. Although the primary exposure of hu- 
mans to KBr03 is via the oral route, very little is known about its 
gastrointestinal effects. The genotoxicity and mutagenicity of 
KBr03 has been studied in humanlrenal cell lines and in cultured 
bacterial animal cells under in vitro conditions (Harrington-Brock 
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Abstract The effect of potassium dichromate (K,Cn07),  a hexavalent chromium 
compound, on human erythrocytes was studied under in vitro conditions. Incubation of 
erythrocytes with different concentrations of K2Cr2O7 resulted in marked hemolysis in a 
concentration-dependent manner. K2Cr2O7 treatment also caused significant increase in 
protein oxidation, lipid peroxidation and decrease in total sulthydryl content, indicating that 
it causes oxidative stress in human erythrocytes. However, there was no concomitant 
nitrosative stress as the nitric oxide levels in hemolysates from K2Cr2O7-treated 
erythrocytes were lower than in control. Exposure of erythrocytes to K,Cr107 decreased 
the activities of catalase, glutathionc peruxidasc, thioredoxin reduetase, glucose-6-
phosphate dehrydrogenase, and glutathionc reductose, whereas the activities of Cu—Zn 
superoxide disc n Lase and glutathione S-transferase were increased. These results show that 
K2Cr_O7 induces oxidative stress and alters the antioxidant defense mechanism of human 
erythrocytes. 
Keywords Chromium Lipid peroxidation - Protein oxidation - Oxidative stress 
Erythrocytes- I lemolysis 
Introduction 
Chromium (Cr) is considered an essential trace element which is believed to be involved in 
glucose and lipid metabolism, and to potentiate the action of insulin in peripheral tissues [I, 
21, causing chromium supplements to be widely taken by persons suffering from diabetes, 
obesity, and heart disease [3]. Among the different oxidation states of the clement, the 
trivalent [Cr(nl)] and hexavalent [Cr(VI)] forms are the most important, the former in 
biological systems, the latter as sources of exposure at the workplace [I, 4]. Human 
exposure to Cr(VI) compounds can be by three possible routes, viz, inhalation, dermal 
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